Sentence,class,file
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/c9/3f/WJG-23-2044.PMC5360646.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ashwin D Dhanda, BSc (Hons),  MBChB, MRCP, PhD,  Institute of Translational and Stratified  Medicine, Plymouth University Peninsula Schools of Medicine  and Dentistry, John Bull Building, Research Way, Plymouth PL6  8BU, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/3f/27/WJG-23-2052.PMC5360647.pdf
"2052 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Infection does not increase long-term mortality in  patients with acute severe alcoholic hepatitis treated with  corticosteroidsObservational Study Ashwin D Dhanda, Ashish Sinha, Vicky Hunt, Sarah Saleem, Matthew E Cramp, Peter L CollinsSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2052World J Gastroenterol   2017 March 21; 23(11): 2052-2059  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/3f/27/WJG-23-2052.PMC5360647.pdf
World J Gastroenterol  2017; 23(11): 2052-2059  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i11/2052.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i11.2052 INTRODUCTION Alcoholic hepatitis is an acute syndrome characte­ rised by recent onset jaundice and coagulopathy in a  patient with a history of prolonged and heavy alcohol consumption[1].,Non-OADS,/arxiv_data1/oa_pdf/3f/27/WJG-23-2052.PMC5360647.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/3f/27/WJG-23-2052.PMC5360647.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Tsuyoshi Fujita, MD, PhD,  Division  of Gastroenterology, Department of Internal Medicine, Kobe  University Graduate School of Medicine, 7-5-1 Kusunoki-cho,  Chuo-ku, Kobe, Hyogo 650-0017,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/12/0d/WJG-23-2060.PMC5360648.pdf
"2060 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Factors associated with residual gastroesophageal reflux  disease symptoms in patients receiving proton pump  inhibitor maintenance therapyObservational Study Fumiaki Kawara, Tsuyoshi Fujita, Yoshinori Morita, Atsushi Uda, Atsuhiro Masuda, Masaya Saito, Makoto Ooi,  Tsukasa Ishida, Yasuyuki Kondo, Shiei Yoshida, Tatsuya Okuno, Yoshihiko Yano, Masaru Yoshida,  Hiromu Kutsumi, Takanobu Hayakumo, Kazuhiko Yamashita, Takeshi Hirano, Midori Hirai, Takeshi AzumaSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2060World J Gastroenterol   2017 March 21; 23(11): 2060-2067  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/12/0d/WJG-23-2060.PMC5360648.pdf
World J Gastroenterol  2017;  23(11): 2060-2067  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/12/0d/WJG-23-2060.PMC5360648.pdf
com/1007-9327/full/v23/i11/2060.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/0d/WJG-23-2060.PMC5360648.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/12/0d/WJG-23-2060.PMC5360648.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Masazumi Takahashi, MD, PhD, Chief,   Division of Gastroenterological Surgery, Yokohama Municipal  Citizen’s Hospital, 45 Okazawa-cho, Hodogaya-ku, Yokohama  240-8555, Japan.",Non-OADS,/arxiv_data1/oa_pdf/17/a6/WJG-23-2068.PMC5360649.pdf
"6330  Fax:  +81-45-3311960  2068 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Quality of life after total vs distal gastrectomy with Roux- en-Y reconstruction: Use of the Postgastrectomy Syndrome  Assessment Scale-45Observational Study Masazumi Takahashi, Masanori Terashima, Hiroshi Kawahira, Eishi Nagai, Yoshikazu Uenosono,  Shinichi Kinami, Yasuhiro Nagata, Masashi Yoshida, Keishiro Aoyagi, Yasuhiro Kodera, Koji NakadaSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2068World J Gastroenterol   2017 March 21; 23(11): 2068-2076  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/17/a6/WJG-23-2068.PMC5360649.pdf
World J Gastroenterol  2017; 23(11): 2068-2076   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i11/2068.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/17/a6/WJG-23-2068.PMC5360649.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/17/a6/WJG-23-2068.PMC5360649.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Jinsil Seong, MD, PhD,  Department of  Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 06351,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/17/0f/WJG-23-2077.PMC5360650.pdf
"For extrahepatic FFS, AFP was significant ( P =  2077 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comORIGINAL ARTICLE Multi-analyte analysis of cytokines that predict outcomes  in patients with hepatocellular carcinoma treated with  radiotherapyProspective Study Hyejung Cha, Eun Jung Lee, Jinsil SeongSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2077World J Gastroenterol   2017 March 21; 23(11): 2077-2085  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/17/0f/WJG-23-2077.PMC5360650.pdf
World J Gastroenterol  2017;  23(11): 2077-2085  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/WJG-23-2077.PMC5360650.pdf
com/1007-9327/full/v23/i11/2077.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/WJG-23-2077.PMC5360650.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/17/0f/WJG-23-2077.PMC5360650.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Philip G Ferstl,  Department for  Internal Medicine I/Gastroenterology and Hepatology, University  Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am  Main, Germany.",Non-OADS,/arxiv_data1/oa_pdf/13/d0/WJG-23-2086.PMC5360651.pdf
"The pathogen was supposedly acquired during a trip  to Thailand, causing severe fever, cholangitis and CASE REPORT 2086 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2086World J Gastroenterol   2017 March 21; 23(11): 2086-2089  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/13/d0/WJG-23-2086.PMC5360651.pdf
World J Gastroenterol  2017;  23(11): 2086-2089  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/13/d0/WJG-23-2086.PMC5360651.pdf
com/1007-9327/full/v23/i11/2086.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/d0/WJG-23-2086.PMC5360651.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/13/d0/WJG-23-2086.PMC5360651.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Sung Eun Ahn, MD, Director,   Department of Radiology, Kyung Hee University Hospital,  Graduate School, Kyung Hee University, Dongdaemun-gu,  Hoegi-dong, Seoul 130-872, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/b7/WJG-23-2090.PMC5360652.pdf
"83ahnse@hanmail.ne t  Telephone:  +82-2-9589502 Fax:  +82-2-9680787CASE REPORT 2090 March 21, 2017 |Volume 23 |Issue 11 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.3748/wjg.v23.i11.2090World J Gastroenterol   2017 March 21; 23(11): 2090-2094  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/25/b7/WJG-23-2090.PMC5360652.pdf
"World J  Gastroenterol  2017; 23(11): 2090-2094  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i11/2090.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i11.2090 INTRODUCTION Inflammatory fibroid polyp (IFP) is a rare non-neoplastic  cellular proliferation, composed of fibrous tissue, blood  vessels, and an inflammatory cell infiltrate dominated  by eosinophils within an edematous and collagenous  stroma[1].",Non-OADS,/arxiv_data1/oa_pdf/25/b7/WJG-23-2090.PMC5360652.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 451   1",Non-OADS,/arxiv_data1/oa_pdf/25/b7/WJG-23-2090.PMC5360652.pdf
"Gastroenterology Review 2017; 12 (1)Review paper Allergic enteritis in children Mieczysława Czerwionka-Szaflarska, Ewa Łoś-Rycharska, Julia Gawryjołek Department of Paediatrics, Allergology, and Gastroenterology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus  University in Torun, Poland Gastroenterology Rev 2017; 12 (1): 1–5 DOI: https://doi.org/10.5114/pg.2017.65677 Key words: food allergy, children, enteritis, enteropathy.",Non-OADS,/arxiv_data1/oa_pdf/6d/07/PG-12-29358.PMC5360665.pdf
"Gastroenterology Review 2017; 12 (1)Original paper Relationship between Helicobacter pylori infection  and celiac disease: a cross-sectional study and a brief review of the literature Sebahat Basyigit1, Oktay Unsal2, Metin Uzman3, Ferdane Sapmaz3, Ozlem Ceylan Dogan4, Ayse Kefeli5,   Zeliha Asilturk2, Abdullah Ozgur Yeniova6, Yasar Nazligul3 1Department of Gastroenterology, Artvin State Hospital, Artvin, Turkey  2Department of Internal Medicine, Kecioren Research and Training Hospital, Ankara, Turkey  3Department of Gastroenterology, Kecioren Research and Training Hospital, Ankara, Turkey  4Department of Biochemistry, Kecioren Research and Training Hospital, Ankara, Turkey  5Department of Gastroenterology, Siirt State Hospital, Siirt, Turkey  6Department of Gastroenterology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey Gastroenterology Rev 2017; 12 (1): 49–54 DOI: https://doi.org/10.5114/pg.2017.65681 Key words: immunoglobulin A, Helicobacter pylori, celiac disease.",Non-OADS,/arxiv_data1/oa_pdf/26/7c/PG-12-29359.PMC5360666.pdf
"z o.o., Krakow, Poland 3 Polish Association Supporting People with Inflammatory Bowel Disease “J-elita”, Warsaw, Poland 4 Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland Gastroenterology Rev 2017; 12 (1): 60–65 DOI: https://doi.org/10.5114/pg.2017.66324 Key words: ulcerative colitis, quality of life, indirect costs, productivity loss.",Non-OADS,/arxiv_data1/oa_pdf/51/cf/PG-12-29578.PMC5360667.pdf
http://www.euroqol.org/ Last Access: October 2015.,Non-OADS,/arxiv_data1/oa_pdf/51/cf/PG-12-29578.PMC5360667.pdf
"Central Statistical Office of Poland, http://stat.gov.pl/en/ Last  access: January 2016.",OADS,/arxiv_data1/oa_pdf/51/cf/PG-12-29578.PMC5360667.pdf
"Economic Papers 535, November 2014, http://ec.europa.",Non-OADS,/arxiv_data1/oa_pdf/51/cf/PG-12-29578.PMC5360667.pdf
On-line access; http://m2w.ceestahc.org/media/ M2W_Koszty_posrednie_IMIDs_w_Polsce_podsumowanie.,Non-OADS,/arxiv_data1/oa_pdf/51/cf/PG-12-29578.PMC5360667.pdf
2 Methods The protocol for this review was published in PROSPERO(http://www.crd.york.ac.uk/PROSPERO/ ) with the acces- sion number 42016038496.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
•meta Register of Controlled Trials ( www.controlled- trials.com ); •US National Institutes of Health Ongoing Trials Register ( http://www.clinicaltrials.gov ); •Australian New Zealand Clinical Trials Registry ( http:// www.anzctr.org.au ); •World Health Organization International Clinical Trials Registry Platform ( www.who.int/trialsearch ); •EU Clinical Trials Register ( https://www.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
https://rayyan.qcri.org/ .Accessed 3 Nov 2106.,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
GRADE proﬁler version 3.6. http://tech.cochrane.org/revman/ other-resources/gradepro/download .,OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
Malaysian clinical practice guideline 2012. http://www.moh.gov.my/attachments/ 7190.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8f/ff/40257_2016_Article_245.PMC5360829.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017The response of γδT-cell subsets to tumors DW u et al 253 Cellular & Molecular Immunology",Non-OADS,/arxiv_data1/oa_pdf/f7/3e/cmi201655a.PMC5360884.pdf
"@ERSpublications Transbronchial cryobiopsy in interstitial lung disease http://ow.ly/jz1F309tMyf Cite this article as: Bango-Álvarez A, Ariza-Prota M, Torres-Rivas H, et al .",Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
ERJ Open Res 2017; 3: 00148-2016 [https://doi.org/10.1183/23120541.00148-2016].,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 ERJ Open Res 2017; 3: 00148-2016 ORIGINAL ARTICLE INTERSTITIAL LUNG DISEASE,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
RLL: right lower lobe; ML: middle lobe; LLL: left lower lobe; LUL: left upper lobe.#: two of the patients had pneumothoraces and required placement of chest tube for 48 h. https://doi.org/10.1183/23120541.00148-2016 2INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 3INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 4INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 5INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 6INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 7INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
https://doi.org/10.1183/23120541.00148-2016 8INTERSTITIAL LUNG DISEASE | A. BANGO-ÁLVAREZ ET AL.,Non-OADS,/arxiv_data1/oa_pdf/44/c2/00148-2016.PMC5360885.pdf
"@ERSpublications Bile acid exposure has a significant effect on cytokine production which could contribute to airway injury http://ow.ly/Jwfa309jRqu Cite this article as: Aldhahrani A, Verdon B, Ward C, et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 ERJ Open Res 2017; 3: 00107-2016 ORIGINAL ARTICLE LUNG BIOLOGY,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
"BEAS-2B cells were seeded in 24-well plates at a density of 6 to 7×l0 5cells·mL−1and were grown in 500 µL bronchial epithelial growth medium (BEGM) (Lonza, Cambridge, MA, USA) at 5% CO 2 https://doi.org/10.1183/23120541.00107-2016 2LUNG BIOLOGY | A. ALDHAHRANI ET AL.",OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 3LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 4LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 5LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 6LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 7LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 8LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
https://doi.org/10.1183/23120541.00107-2016 9LUNG BIOLOGY | A. ALDHAHRANI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c3/6e/00107-2016.PMC5360888.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/main.PMC5360978.pdf
http://dx.doi.org/10.1016/j.btre.2015.12.003 2215-017X/ ã  2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/4e/a5/main.PMC5360978.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  31–37 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/main.PMC5360978.pdf
"(2015)  ,  doi:http://dx.doi.org/10.3389/ fmicb.2015.0005  Published  :  06  February  2015 .",Non-OADS,/arxiv_data1/oa_pdf/4e/a5/main.PMC5360978.pdf
"12  (2014)  275–287, doi:http://dx.doi.org/10.1007/s10311-014-0466-2 .",Non-OADS,/arxiv_data1/oa_pdf/4e/a5/main.PMC5360978.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e1/7a/main.PMC5360979.pdf
http://dx.doi.org/10.1016/j.btre.2015.12.001 2215-017X/ ã  2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/e1/7a/main.PMC5360979.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  15–24 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/e1/7a/main.PMC5360979.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/3c/main.PMC5360980.pdf
http://dx.doi.org/10.1016/j.btre.2015.11.002 2215-017X/ ã  2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/15/3c/main.PMC5360980.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  9–14 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/15/3c/main.PMC5360980.pdf
"<http://www.healthtech.com/ biodiesel2020 />,  Multi-Client  Study.",Non-OADS,/arxiv_data1/oa_pdf/15/3c/main.PMC5360980.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/18/6b/main.PMC5360981.pdf
http://dx.doi.org/10.1016/j.btre.2015.11.001 2215-017X/ ã  2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/18/6b/main.PMC5360981.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  1–8 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/18/6b/main.PMC5360981.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/28/0b/main.PMC5360982.pdf
http://dx.doi.org/10.1016/j.btre.2016.01.001 2215-017X/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/28/0b/main.PMC5360982.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  66–73 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/28/0b/main.PMC5360982.pdf
http://dx.doi.org/10.1016/j.btre.2015.12.004 2215-017X/ ã  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/2c/05/main.PMC5360983.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  74–81 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/2c/05/main.PMC5360983.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/86/8c/main.PMC5360984.pdf
http://dx.doi.org/10.1016/j.btre.2015.12.005 2215-017X/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/86/8c/main.PMC5360984.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  38–45 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/86/8c/main.PMC5360984.pdf
"Standard  C33,  Speci ﬁcation  for  Concrete  Aggregates,  ASTM, International,  West  Conshohocken,  PA,  2003,  doi:http://dx.doi.org/10.1520/ C0033-03E01 .",Non-OADS,/arxiv_data1/oa_pdf/86/8c/main.PMC5360984.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ed/44/main.PMC5360985.pdf
http://dx.doi.org/10.1016/j.btre.2015.12.002 2215-017X/ ã  2016  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/ed/44/main.PMC5360985.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  57–65 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/ed/44/main.PMC5360985.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/1f/main.PMC5360988.pdf
http://dx.doi.org/10.1016/j.btre.2016.01.003 2215-017X/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/29/1f/main.PMC5360988.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  9  (2016)  53–56 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/29/1f/main.PMC5360988.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/12/90/jpts-29-378.PMC5360993.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/dd/fa/jpts-29-384.PMC5360994.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b2/9f/jpts-29-387.PMC5360995.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c8/c2/jpts-29-390.PMC5360996.pdf
"2014, http://www.epuap.org/guidelines/.",Non-OADS,/arxiv_data1/oa_pdf/c8/c2/jpts-29-390.PMC5360996.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/41/3e/jpts-29-394.PMC5360997.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/27/84/jpts-29-401.PMC5360998.pdf
"http://www.iihs.org/iihs/topics/t/older-drivers/fatalityfacts/older-people/2013 (Ac - cessed Feb. 1, 2016) 3) Insurance Institute for Highway Safety: Older drivers: license renewal procedures.",Non-OADS,/arxiv_data1/oa_pdf/27/84/jpts-29-401.PMC5360998.pdf
"http://www.iihs.org/iihs/topics/laws/olderdrivers?topicName=older-driv - ers (Accessed Sep. 1, 2016) 4) Ferreira IS, Simões MR, Marôco J: The Addenbrooke’s Cognitive Examination Revised as a potential screening test for elderly drivers.",Non-OADS,/arxiv_data1/oa_pdf/27/84/jpts-29-401.PMC5360998.pdf
"http://www.racfoundation....ces-for-the-older-motorist (Accessed Feb. 1, 2013).",Non-OADS,/arxiv_data1/oa_pdf/27/84/jpts-29-401.PMC5360998.pdf
"https://www.aaafoundation.org/sites/default/files/driver65.pdf (Accessed Dec.  16, 2013) 19) Mathias JL, Lucas LK: Cognitive predictors of unsafe driving in older drivers: a meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/27/84/jpts-29-401.PMC5360998.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/86/2f/jpts-29-405.PMC5360999.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ea/f9/jpts-29-409.PMC5361000.pdf
"http://www.isek.org/wp-content/uploads/2015/05/Standards-for-Reporting-EMG-Data.pdf (Accessed Oct. 9, 2016) 6) Kizuka T, Masuda T, Kiryu T, et al.",OADS,/arxiv_data1/oa_pdf/ea/f9/jpts-29-409.PMC5361000.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8f/85/jpts-29-413.PMC5361001.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/jpts-29-419.PMC5361002.pdf
"http://www.who.int/dietphysicalactivity/pa/en/ (Accessed Sep. 10, 2016) 3) World Health Organization: Physical Activity and Older Adults.",Non-OADS,/arxiv_data1/oa_pdf/d7/ac/jpts-29-419.PMC5361002.pdf
"http://www.mhlw.go.jp/file/04-Houdouhappyou-12601000-Seisa - kutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/002.pdf (Accessed Sep. 10, 2016)",Non-OADS,/arxiv_data1/oa_pdf/d7/ac/jpts-29-419.PMC5361002.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/jpts-29-425.PMC5361003.pdf
http://www.j-circ.or.jp/guideline/pdf/JCS2012_nohara_h.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/jpts-29-425.PMC5361003.pdf
[Medline]   [CrossRef] 7) http://www.srl.info/srlinfo/kensa_ref_CD/otherdata/57–0833.html.,Non-OADS,/arxiv_data1/oa_pdf/1c/d1/jpts-29-425.PMC5361003.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6d/36/jpts-29-432.PMC5361004.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/54/b9/jpts-29-438.PMC5361005.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8f/8f/jpts-29-442.PMC5361006.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a7/a1/jpts-29-448.PMC5361007.pdf
http://www.mhlw.go.jp/ toukei/saikin/hw/kanja/05/toukei03.,Non-OADS,/arxiv_data1/oa_pdf/a7/a1/jpts-29-448.PMC5361007.pdf
"http://www.mhlw.go.jp/ toukei/saikin/ hw/kanja/11/dl/kanja.pdf#search (Accessed Sep. 22, 2015) 3) Hosoi T, Makino E: A survey on falling accident cases of patients in psychiatric wards in Japan.",OADS,/arxiv_data1/oa_pdf/a7/a1/jpts-29-448.PMC5361007.pdf
"http://www.mext.go.jp/a_menu/ sports/stamina/05030101/003.pdf (Accessed Aug. 15, 2014) 14) Suzuki K, Imada G, Iwaya T, et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/a1/jpts-29-448.PMC5361007.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1a/0d/jpts-29-452.PMC5361008.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/61/23/jpts-29-457.PMC5361009.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/35/7f/jpts-29-461.PMC5361010.pdf
"http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k- tyosa10/ (Accessed Sep. 30, 2016) 2) Mat S, Tan PJ, Ng CT, et al.",OADS,/arxiv_data1/oa_pdf/35/7f/jpts-29-461.PMC5361010.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4d/6c/jpts-29-465.PMC5361011.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2f/ca/jpts-29-470.PMC5361012.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0a/6e/jpts-29-476.PMC5361013.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/aa/85/jpts-29-478.PMC5361014.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/48/fa/jpts-29-484.PMC5361015.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/02/29/jpts-29-487.PMC5361016.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/68/2b/jpts-29-491.PMC5361017.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bd/d5/jpts-29-495.PMC5361018.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f1/91/jpts-29-498.PMC5361019.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b7/7b/jpts-29-505.PMC5361020.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/06/21/jpts-29-508.PMC5361021.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/89/ac/jpts-29-511.PMC5361022.pdf
4) American College of Physicians: http://annals.org/article.,Non-OADS,/arxiv_data1/oa_pdf/89/ac/jpts-29-511.PMC5361022.pdf
"3, 2017 5145) American Pain Society: http://americanpainsociety.org uplords/education/guidelines/education/gui/evaluation-management-lowback-pain.pdf (Accessed Feb.  10, 2016) 6) Funakoshi Y, Ohmori K, Takeda S: [Drainage for subcutaneous emphysema after pulmonary resection].",Non-OADS,/arxiv_data1/oa_pdf/89/ac/jpts-29-511.PMC5361022.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bd/da/jpts-29-515.PMC5361023.pdf
"[Medline]   [CrossRef] 13) Ministry of Health, Labour and Welfare: The National Health and Nutrition Survey in Japan, 2013, 08. http://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/h25-houkoku.pdf.",Non-OADS,/arxiv_data1/oa_pdf/bd/da/jpts-29-515.PMC5361023.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4e/15/jpts-29-519.PMC5361024.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cb/a1/jpts-29-523.PMC5361025.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fc/bd/jpts-29-527.PMC5361026.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/51/dd/jpts-29-531.PMC5361027.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2b/5d/jpts-29-536.PMC5361028.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/63/85/jpts-29-539.PMC5361029.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/96/a9/jpts-29-543.PMC5361030.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/19/e6/jpts-29-548.PMC5361031.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/6c/2c/jpts-29-556.PMC5361032.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/90/16/jpts-29-558.PMC5361033.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/24/62/bmjqir.u206639.w6166.PMC5361065.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
http://www.awp.nhs.uk/services/community/ early-intervention/ 4.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
https://www.nice.org.uk/guidance/qs80/chapter/quality-statement-6-assessing-physical-health.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
https://www.england.nhs.uk/wp-content/uploads/2014/02/sc-cquin-guid.pdf https://www.england.nhs.uk/wp-content/uploads/2014/06/cquin-add-mh-guid.pdf http://www.rcpsych.ac.uk/workinpsychiatry/qualityimprovement/cquin.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
http://www.rcpsych.ac.uk/pdf/RCP_ 11049_Positive%20Cardiometabolic%20Health%20chart-%20website.pdf 2014.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
Available at https://www.england.nhs.uk/nhs-standard-contract/cquin/cquin-16-17/ 2016.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
http://www.awp.nhs.uk/ advice-support/medicines/guidance-alerts/ 2014 13.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
"Pay scales for NHS nursing staff in England, Wales, Scotland and Northern Ireland from 1 April 2015. https://www.rcn.org.uk/employment-and-pay/nhs-pay-scales-2015-16 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
http:// www.cfmsr.org.uk/ http://phlebotomytraining.co.uk/courses/book-a-course/.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
Preventing Type 2 Diabetes: Risk Identification and Interventions for Individuals at High Risk.https://www.nice.org.uk/guidance/ph38 2012.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
https://www.diabetes.org.uk/ Documents/Diabetes%20UK%20Cost%20of%20Diabetes% 20Report.pdf 2014 22.,Non-OADS,/arxiv_data1/oa_pdf/b5/3d/bmjqir.u209141.w3798.PMC5361066.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/9e/bmjqir.u212969.w5171.PMC5361067.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/93/f8/bmjqir.u212152.w5721.PMC5361068.pdf
http://dx.doi.org/10.1016/j.btre.2016.08.001 2215-017X/ ã  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/44/e4/main.PMC5361069.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  12  (2016)  1–5 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/44/e4/main.PMC5361069.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC5361072.pdf
http://dx.doi.org/10.1016/j.btre.2016.11.001 2215-017X/©  2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC5361072.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  1–7 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/e9/ce/main.PMC5361072.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/0e/main.PMC5361073.pdf
http://dx.doi.org/10.1016/j.btre.2016.10.002 2215-017X/ ã  2016  The  Author(s).,OADS,/arxiv_data1/oa_pdf/ba/0e/main.PMC5361073.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  12  (2016)  52–61 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/ba/0e/main.PMC5361073.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.10.002 .References [1]  E.  Abadulla,  K.-H.  Robra,  G.M.",OADS,/arxiv_data1/oa_pdf/ba/0e/main.PMC5361073.pdf
"New  York  USA,  http://data.un.org  (2015).",Non-OADS,/arxiv_data1/oa_pdf/ba/0e/main.PMC5361073.pdf
http://dx.doi.org/10.1016/j.btre.2016.10.004 2215-017X/ ã  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/96/07/main.PMC5361074.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  12  (2016)  40–51 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/96/07/main.PMC5361074.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.10.004 .",OADS,/arxiv_data1/oa_pdf/96/07/main.PMC5361074.pdf
"191 –214,  doi:http://dx.doi.org/10.1533/9781908818355.2.191 .",Non-OADS,/arxiv_data1/oa_pdf/96/07/main.PMC5361074.pdf
http://dx.doi.org/10.1016/j.btre.2016.07.002 2215-017X/ ã  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/df/4c/main.PMC5361075.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  12  (2016)  13–25 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/df/4c/main.PMC5361075.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.07.002 .",OADS,/arxiv_data1/oa_pdf/df/4c/main.PMC5361075.pdf
"(2015), doi:http://dx.doi.org/10.1080/00405000.2015.1086196 .",Non-OADS,/arxiv_data1/oa_pdf/df/4c/main.PMC5361075.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/eb/main.PMC5361076.pdf
http://dx.doi.org/10.1016/j.btre.2016.11.002 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/eb/main.PMC5361076.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  19–25 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/d9/eb/main.PMC5361076.pdf
"References [1]  World  Health  Organization,  The  Promotion  and  Development  of  Traditional Medicine,  World  Health  Organization,  Geneva,  1978  (Online]  Available  from: http://apps.who.int/medicinedocs/documents/s7147e/s7147e.pdf  [Accessed on  25th  May,  2015).",Non-OADS,/arxiv_data1/oa_pdf/d9/eb/main.PMC5361076.pdf
http://dx.doi.org/10.1016/j.btre.2016.09.001 2215-017X/ ã  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/9d/2d/main.PMC5361077.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  12  (2016)  6–12 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/9d/2d/main.PMC5361077.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.004 2215-017X/©  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/07/9d/main.PMC5361125.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  26–29 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/07/9d/main.PMC5361125.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/73/main.PMC5361127.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.002 2215-017X/©  2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7e/73/main.PMC5361127.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  13–18 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/7e/73/main.PMC5361127.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.12.002 .020406080 AOB NO  B OthersBacteria fractions (%) Bacter ia spec ies1st d ay 30 th d ay Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/73/main.PMC5361127.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/42/main.PMC5361128.pdf
http://dx.doi.org/10.1016/j.btre.2017.01.002 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/42/main.PMC5361128.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  42–48 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/84/42/main.PMC5361128.pdf
"On  the  basis  of  sequence  annotation  and  blast search  analysis  at  TAIR  database  (http://www.arabidopsis.org/ ), the  Arabidopsis  genome  appears  to  contain  25  chitinase  or chitinase-like  proteins  put  together  from  GH18  and  GH19  families.",OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
http://dx.doi.org/10.1016/j.btre.2017.01.001 2215-017X/©  2017  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  72–79 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2017.01.001 .",OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
"57  (2)  (2013)  351–358,  doi:http://dx.doi.org/10.1007/s10535-012- 0291-z .",Non-OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
"19  (10)  (2006)  1127 –1137,  doi:http://dx.doi.org/10.1094/MPMI-19- 1127 .",Non-OADS,/arxiv_data1/oa_pdf/b5/3b/main.PMC5361129.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.003 2215-017X/©  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/1b/e5/main.PMC5361130.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  30–36 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/1b/e5/main.PMC5361130.pdf
a0020366)  http://www.els.net .,Non-OADS,/arxiv_data1/oa_pdf/1b/e5/main.PMC5361130.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/84/main.PMC5361131.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.005 2215-017X/©  2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ae/84/main.PMC5361131.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  49–57 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/ae/84/main.PMC5361131.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2016.12.005 .",OADS,/arxiv_data1/oa_pdf/ae/84/main.PMC5361131.pdf
[32]  http://www.theproteinfactory.it/strain/strain_new.html.,Non-OADS,/arxiv_data1/oa_pdf/ae/84/main.PMC5361131.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
"In  2004,  about 30%  of  the  infections  in  hospital  intensive-care  units  were  caused by  VRE  strains  (https://www.niaid.nih.gov/research/vre-over- view ).",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.008 2215-017X/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  37–41 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
"References [1]  R.  Laxminarayan,  A.  Malani,  Extending  the  Cure:  Policy  Responses  to  the Growing  Threat  of  Antibiotic  Resistance,  Earthscan,  2007.  http://www.cddep.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
"[3]  WHO,  Antimicrobial  Resistance,  WHO,  2011.  http://www.who.int/ mediacentre/factsheets/fs194/en/ .",OADS,/arxiv_data1/oa_pdf/b7/a0/main.PMC5361133.pdf
http://dx.doi.org/10.1016/j.btre.2016.12.006 2215-017X/©  2016  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/04/06/main.PMC5361134.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Biotechnology  Reports  13  (2017)  58–71 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/04/06/main.PMC5361134.pdf
http://www.ats.ucla.edu/stat/spss/faq/compreg2.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/39/srep45118.PMC5361152.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/   © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/20/39/srep45118.PMC5361152.pdf
"Published by Taylor & Francis Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License(http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.CONTACT Joseph Curtin j.curtin@neu.eduACTION LEARNING: RESEARCH AND PRACTICE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/e2/a4/calr-13-151.PMC5361392.pdf
"2, 151 –159 http://dx.doi.org/10.1080/14767333.2016.1170975",Non-OADS,/arxiv_data1/oa_pdf/e2/a4/calr-13-151.PMC5361392.pdf
( n.d.).Developing Your Leadership Capability LDR 6100 Description .http://www.cps.neu.edu/courses/detail/LDR6100 .,Non-OADS,/arxiv_data1/oa_pdf/e2/a4/calr-13-151.PMC5361392.pdf
Protein bands were quanti ﬁed using ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/d1/5b/494.PMC5361402.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/f6/6c/ipri-35-1.PMC5361412.pdf
"1, 1 –2 http://dx.doi.org/10.1080/02813432.2017.1288818",Non-OADS,/arxiv_data1/oa_pdf/f6/6c/ipri-35-1.PMC5361412.pdf
"However, as part of a new initiative to pro- vide accessible health research output statistics, the HealthCare21Monitor (https://www.helseomsorg21mo- nitor.no/), a report on primary care research output and funding, was published recently [ 6].",Non-OADS,/arxiv_data1/oa_pdf/f6/6c/ipri-35-1.PMC5361412.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"1, 10 –18 http://dx.doi.org/10.1080/02813432.2017.1288680",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"Oslo, Norway: Norwegian Institute of Public Health; 2015.Available from: http://www.whocc.no/filearchive/publi- cations/2015_guidelines.pdf [12] Truyers C, Goderis G, Dewitte H, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
Available from: http://www.grace-lrti.org/portal/en-gb/publications/grace-02%20patient%20pathways/ grace02 [18] antimicrobial resistance_outline - eb445_amr_general- factsheet_en.pdf [Internet].,Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"Available from: http://ec.europa.eu/dgs/health_food-safety/amr/docs/ eb445_amr_generalfactsheet_en.pdf [19] Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM.",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"Available from: http://ecdc.europa.eu/en/publications/ [21] Willems CSJ, D ’Obrenan J, van den B, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
Available from: https://www.nhg.org/nhg-standaarden [28] Recommendations for management of infections in primary care.,Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"Availablefrom: http://strama.se/behandlingsrekommendationer/ [29] Venezia RA, Domaracki BE, Evans AM, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/57/ipri-35-10.PMC5361413.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/ipri-35-105.PMC5361414.pdf
"1, 105 –110 http://dx.doi.org/10.1080/02813432.2017.1288819",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/ipri-35-105.PMC5361414.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/16/85/ipri-35-19.PMC5361415.pdf
"1, 19 –26 http://dx.doi.org/10.1080/02813432.2017.1288683",Non-OADS,/arxiv_data1/oa_pdf/16/85/ipri-35-19.PMC5361415.pdf
We calculated a minimal sample size of n¼368 for a 95% confidence interval with an error margin of 5% (http://www.surveysystem.,Non-OADS,/arxiv_data1/oa_pdf/16/85/ipri-35-19.PMC5361415.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/72/4a/ipri-35-27.PMC5361416.pdf
"1, 27 –34 http://dx.doi.org/10.1080/02813432.2017.1288692",Non-OADS,/arxiv_data1/oa_pdf/72/4a/ipri-35-27.PMC5361416.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/4e/f4/ipri-35-3.PMC5361417.pdf
"1, 3 –9 http://dx.doi.org/10.1080/02813432.2017.1287518",Non-OADS,/arxiv_data1/oa_pdf/4e/f4/ipri-35-3.PMC5361417.pdf
Availablefrom: http://www.wma.net/en/30publications/30ethics- manual/pdf/ethics_manual_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4e/f4/ipri-35-3.PMC5361417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/5e/2c/ipri-35-35.PMC5361418.pdf
"1, 35 –45 http://dx.doi.org/10.1080/02813432.2017.1288817",Non-OADS,/arxiv_data1/oa_pdf/5e/2c/ipri-35-35.PMC5361418.pdf
"ORCID Sven Eirik Ruud http://orcid.org/0000-0003-2906-3702 Per Hjortdahl http://orcid.org/0000-0002-7315-7805 Bård Natvig http://orcid.org/0000-0001-8931-9496 References [1] Starfield B, Shi L, Macinko J.",Non-OADS,/arxiv_data1/oa_pdf/5e/2c/ipri-35-35.PMC5361418.pdf
"Available from:http://www.helfo.no/privatperson/fastlegeordningen/ Sider/hvem-har-rett-til-fastlege.aspx[18] Rue M, Cabre X, Soler-Gonzalez J, et al.",OADS,/arxiv_data1/oa_pdf/5e/2c/ipri-35-35.PMC5361418.pdf
"Available from: http://www.ssb.no/befolkning/statistik-ker/innvbef/aar/2013-04-25?fane ¼om#content [26] Alyasin A, Douglas C. Reasons for non-urgent presen- tations to the emergency department in Saudi Arabia.Int Emerg Nurs.",Non-OADS,/arxiv_data1/oa_pdf/5e/2c/ipri-35-35.PMC5361418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/f8/18/ipri-35-46.PMC5361419.pdf
"1, 46 –53 http://dx.doi.org/10.1080/02813432.2017.1288813",Non-OADS,/arxiv_data1/oa_pdf/f8/18/ipri-35-46.PMC5361419.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/6f/39/ipri-35-54.PMC5361420.pdf
"1, 54 –63 http://dx.doi.org/10.1080/02813432.2017.1288702",Non-OADS,/arxiv_data1/oa_pdf/6f/39/ipri-35-54.PMC5361420.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/a9/7f/ipri-35-64.PMC5361421.pdf
"1, 64 –74 http://dx.doi.org/10.1080/02813432.2017.1288815",Non-OADS,/arxiv_data1/oa_pdf/a9/7f/ipri-35-64.PMC5361421.pdf
Available from: http://www.fyss.se/fyss-in-english/ [8] World Health Organization (WHO).,Non-OADS,/arxiv_data1/oa_pdf/a9/7f/ipri-35-64.PMC5361421.pdf
"The National Board of Health and Welfare (Socialstyrelsen); 2015 [cited 2016 Nov 3].Available from: http://www.socialstyrelsen.se/national- guidelines/ nationalguidelinesformethodsofpreventingdisease [22] Jansen MJ, Hendriks EJ, Oostendorp RA, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/7f/ipri-35-64.PMC5361421.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
"1, 75 –83 http://dx.doi.org/10.1080/02813432.2017.1288812",Non-OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
"Stata/SE 14.1 (StataCorp LP, College Station, TX) and R for Windows (version 3.0.1; https://cran.r-project.org/bin/windows/base/old/3.0.1/).",OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
Funding Funding for the study was granted by the Institute of Healthand Society within the University of Oslo and the NorwegianResearch Fund for General Practice (http://legeforenin-gen.no/Allmennmedisinsk-forskningsfond/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
http://www.msis.no/ .82 K. E. ELIASSEN ET AL.,OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
https://www.fhi.no/ml/skadedyr/flatt/fakta-om-borreliose/ .,Non-OADS,/arxiv_data1/oa_pdf/6c/fb/ipri-35-75.PMC5361422.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/df/a8/ipri-35-84.PMC5361423.pdf
"1, 84 –88 http://dx.doi.org/10.1080/02813432.2017.1288820",Non-OADS,/arxiv_data1/oa_pdf/df/a8/ipri-35-84.PMC5361423.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/f3/18/ipri-35-89.PMC5361424.pdf
"1, 89 –97 http://dx.doi.org/10.1080/02813432.2017.1288811",Non-OADS,/arxiv_data1/oa_pdf/f3/18/ipri-35-89.PMC5361424.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2017 VOL.",Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
"1, 98 –104 http://dx.doi.org/10.1080/02813432.2017.1288816",Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
The population size used for calculating incidence rate was based on the number of residents in V€asterbotten by the end of 2013 according to Statistics Sweden (http://www.scb.se).,OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.scb.se/sv_/Hitta-statistik/Publiceringskalender/Visa-detaljerad-information/?publobjid ¼23327 .,OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.vardbarometern.nu/PDF/ VB Landstingsj%C3%A4mf%C3%B6rande rapport_2013.pdf .,OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.vardbaro- metern.nu/PDF/V%C3%A5rdbarometern2013%C3%A5 rsrapport 2014-03-20.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.1177.se/rgswebb/ .,Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.scb.se/ulf .,Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.socialstyrelsen.se/Lists/ Artikelkatalog/Attachments/19238/2013-12-1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
"Publicerad http://www.socialstyrelsen.se : National Board of Health and Welfare, 2014 [cited 2015 Apr 6].",Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19621/2014-12-13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/39/14/ipri-35-98.PMC5361425.pdf
Available from:  https://www.drugs.com/breastfeeding/melatonin.html.,Non-OADS,/arxiv_data1/oa_pdf/53/00/JRMS-22-2.PMC5361446.pdf
Available from: http://www.dancesinthefarsouth.weebly.com/ information/bhedas.,Non-OADS,/arxiv_data1/oa_pdf/5d/72/IJOrtho-51-123.PMC5361461.pdf
Available from: http://www.census.,OADS,/arxiv_data1/oa_pdf/60/5d/IJOrtho-51-139.PMC5361463.pdf
Available from: http://depts.washington.,Non-OADS,/arxiv_data1/oa_pdf/60/5d/IJOrtho-51-139.PMC5361463.pdf
Available from: http://www.healio.com/ orthopedics/hip/news/online.,Non-OADS,/arxiv_data1/oa_pdf/a4/43/IJOrtho-51-155.PMC5361465.pdf
Available from: http://www.tribuneindia.com/2004/20041219/ spectrum/book8.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/IJOrtho-51-232.PMC5361480.pdf
Available from: http://www.slideplayer.com/slide/4338104/.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/IJOrtho-51-232.PMC5361480.pdf
Available from: https://www.geni.com/people/Dr-Karam- Singh-Grewal/6000000005589140184.,Non-OADS,/arxiv_data1/oa_pdf/8a/79/IJOrtho-51-232.PMC5361480.pdf
"www.nrronline.org197 NEURAL REGENERATION RESEARCH  February 2017 ,Volume 12 ,Issue 2The exciting potential of nanotherapy in brain-tumor  targeted drug delivery approaches Introduction According to the National Brain Tumor Society, in 2016,  approximately 688,096 Americans are living with a  brain-tumor (http://braintumor.org/brain-tumor-informa - tion/brain-tumor-facts/).",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/NRR-12-197.PMC5361495.pdf
"Under the standard treatment regi - men (resection followed by radiotherapy and/or chemother - apy), the average survival rate for malignant brain-tumor  patients is ~34.4% whereas, for GBM, the five-year relative  survival rate is ~5.1% (http://braintumor.org/brain-tu - mor-information/brain-tumor-facts/).",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/NRR-12-197.PMC5361495.pdf
This figure was produced using  Servier Medical Art (http://www.servier.com).,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/NRR-12-212.PMC5361501.pdf
This figure was produced  using Servier Medical Art (http://www.servier.com).,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/NRR-12-212.PMC5361501.pdf
"fMRI data analysis Preprocessing was performed using Statistical Parametric  Mapping software (SPM8, http://www.fil.ion.ucl.ac.uk/ spm/).",OADS,/arxiv_data1/oa_pdf/6c/8d/NRR-12-250.PMC5361509.pdf
"The software package NIRS-SPM (http://bisp.kaist.ac.kr/ NIRS-SPM) implemented in the MATLAB environment (The  Mathworks, Natick, MA, USA) was used in analysis of fNIRS  data.",OADS,/arxiv_data1/oa_pdf/b3/87/NRR-12-317.PMC5361518.pdf
"Upon thawing flow cytome-try was performed according to standard protocols ( SDC, Materials and Methods, http://links.lww.com/TXD/A33).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"Results are expressed as mean counts per minute of triplicate wells ( SDC, Materials and Methods, http://links.lww.com/TXD/A33).",OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"Alemtuzumab plasma levels were de- termined using an enzyme-linked immunosorbent assay(lower limit of detection 0.01 μg/mL) ( SDC, Materials and Methods, http://links.lww.com/TXD/A33).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"No Difference in Survival, Graft Function and Metabolic Parameters Mean 3-year patient survival rate was 93.7% with no dif- ference between both groups, also after correcting for po- tential confounders ( Table S2, SDC, http://links.lww.com/ TXD/A33).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"0 5 1 )( Table S2, SDC, http://links.lww.com/TXD/A33).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"This also applied to CD4+CD25hiCD127low regulatory T cells ( Figure S1A, SDC, http://links.lww.com/ TXD/A33).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
"The percentage of CD19+B cells was also com- parable in both groups (Figure 3C), as well as transitional B cells (CD19+CD24hiCD38hi), which have been described to be enriched for Bregs22(Figure S1B, SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/88/f8/txd-3-e124.PMC5361562.pdf
Sequence reads were mapped to 5020 conserved-sequence stretches of genes involved in hereditary visual impairment using the Fast Alignment Search Tool suite (mrsFAST-ultra- 3.2.0; http://sourceforge.net/projects/mrsfast/; in the public domain).,OADS,/arxiv_data1/oa_pdf/06/72/i1552-5783-58-3-1577.PMC5361581.pdf
These conserved sequences were obtained by aligning 242 human genes listed in the Retinal InformationNetwork (https://sph.uth.edu/Retnet/disease.htm; in the pub- lic domain) (RetNet) to the sheep genome (v3.1) using the UCSC genome browser and the Galaxy Web-based platform (https://usegalaxy.org/; in the public domain).,OADS,/arxiv_data1/oa_pdf/06/72/i1552-5783-58-3-1577.PMC5361581.pdf
"For each polymorphic site, homozygous variations for the day-blind sheep and heterozygosity or homozygosity for the alternative allele in the normal Awassi sheep were further evaluated by scoring amino acid substitutions using Grantham scores 18and PROVEAN analysis v1.1 (http://provean.jcvi.org/ seq_submit.php; in the public domain),19which scores the effect of protein-sequence variation on protein function.",OADS,/arxiv_data1/oa_pdf/06/72/i1552-5783-58-3-1577.PMC5361581.pdf
Available at: https://ghr.nlm.nih.gov/condition/retinitis-pigmentosa#genes.,Non-OADS,/arxiv_data1/oa_pdf/a2/21/i1552-5783-58-3-1709.PMC5361582.pdf
"The cavity size was measured from bitmap images created by averaging 10 framesof linear B-scans from the same horizontal plane of the optic nerve (ImageJ, http://imagej.nih.gov/ij; provided in the public domain by the National Institutes of Health, Bethesda, MD,USA).",OADS,/arxiv_data1/oa_pdf/5d/71/i1552-5783-58-3-1656.PMC5361586.pdf
"3, 608 –624 http://dx.doi.org/10.1080/15548627.2016.1271512",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"ORCID David Llobet-Nav /C18as http://orcid.org/0000-0003-1443-7003 References [1] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi.org/ 10.1002/ijc.25516 [2] Siegel RL, Miller KD, Jemal A.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
CA Cancer J Clin 2015; 65:5-29; PMID:25559415; http://dx.doi.org/10.3322/ caac.21254 [3] Sorosky JI.,OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Obstet Gynecol 2012; 120:383-97; PMID:22825101; http://dx.doi.org/10.1097/AOG.0b013e3182605bf1 [4] Bokhman JV.,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Gynecol Oncol 1983; 15:10-7; PMID:6822361; http://dx.doi.org/10.1016/0090-8258(83)90111-7 [5] Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Lan- cet 2010; 375:816-23; PMID:20206777; http://dx.doi.org/10.1016/ S0140-6736(09)62163-2 [7] Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, Eisenhauer E, Bacon M, Tu D, Parmar MK.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Lancet 2009; 373:137-46;PMID:19070891; http://dx.doi.org/10.1016/S0140-6736(08)61767-5 [8] Tangjitgamol S, See HT, Kavanagh J.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Int J Gynecol Cancer 2011; 21:885-95;PMID:21697679; http://dx.doi.org/10.1097/IGC.0b013e3182169239 [9] Fleming GF.,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Clin Oncol 2007; 25:2983-90; PMID:17617530; http://dx.doi.org/10.1200/JCO.2007.10.8431 [10] Gschwind A, Fischer OM, Ullrich A.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Nat Rev Cancer 2004; 4:361- 70; PMID:15122207; http://dx.doi.org/10.1038/nrc1360AUTOPHAGY 621,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Philos Trans RSoc Lond B Biol Sci 1998; 353:583-605; PMID:9602534; http://dx.doi.org/10.1098/rstb.1998.0228 [12] Knight ZA, Lin H, Shokat KM.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Rev Cancer 2010; 10:130-7; PMID:20094047;http://dx.doi.org/10.1038/nrc2787 [13] Bruix J, Sherman M. Management of hepatocellular carcinoma: an update.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Hepatology 2011; 53:1020-2; PMID:21374666; http://dx.doi.org/10.1002/hep.24199 [14] Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"N Engl J Med 2007;356:125-34; PMID:17215530; http://dx.doi.org/10.1056/NEJMoa060655 [15] Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Res 2004; 64:7099-109; PMID:15466206; http://dx.doi.org/10.1158/0008-5472.CAN-04-1443 [16] Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S. Discovery and development of sor- afenib: a multikinase inhibitor for treating cancer.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Rev Drug Dis-cov 2006; 5:835-44; PMID:17016424; http://dx.doi.org/10.1038/nrd2130 [17] Kamat AA, Merritt WM, Coffey D, Lin YG, Patel PR, Broaddus R, Nugent E, Han LY, Landen CN Jr, Spannuth WA, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Clin Cancer Res 2007; 13:7487-95; PMID:18094433; http://dx.doi.org/10.1158/1078-0432.CCR-07-1017 [18] McMeekin DS, Sill MW, Benbrook D, Darcy KM, Stearns-Kurosawa DJ, Eaton L, Yamada SD, Gynecologic Oncology Group.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Gynecol Oncol 2007; 105:508-16; PMID:17306350;http://dx.doi.org/10.1016/j.ygyno.2007.01.019 [19] Ninomiya Y, Kato K, Takahashi A, Ueoka Y, Kamikihara T, Arima T, Matsuda T, Kato H, Nishida J, Wake N. K-Ras and H-Ras activationpromote distinct consequences on endometrial cell survival.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"CancerRes 2004; 64:2759-65; PMID:15087391; http://dx.doi.org/10.1158/ 0008-5472.CAN-3487-2 [20] Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost JA, Wade JL 3rd, Agamah E, Vokes EE, Fleming GF.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Gynecol Oncol 2010;117:37-40; PMID:20117828; http://dx.doi.org/10.1016/j.ygyno.2010.01.013 [21] McDermott U, Sharma SV, Dowell L, Greninger P, Montagut C, Lamb J, Archibald H, Raudales R, Tam A, Lee D, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Proc Natl Acad Sci U S A 2007; 104:19936-41; PMID:18077425; http://dx.doi.org/ 10.1073/pnas.0707498104 [22] Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gil- lette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Proc Natl Acad Sci U S A 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/ pnas.0506580102 [23] Rahmani M, Davis EM, Bauer C, Dent P, Grant S. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cellsinvolves down-regulation of Mcl-1 through inhibition of translation.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Biol Chem 2005; 280:35217-27; PMID:16109713; http://dx.doi.org/ 10.1074/jbc.M506551200 [24] Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Cancer Res 2006;66:11851-8; PMID:17178882; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Cell Mol Med 2009; 13:2673-83; PMID:19220580; http://dx.doi.org/10.1111/j.1582-4934.2009.00692.x [26] Liu LP, Ho RL, Chen GG, Lai PB.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Clin Cancer Res 2012; 18:5662-71;PMID:22929805; http://dx.doi.org/10.1158/1078-0432.CCR-12-0552 [27] Rosato RR, Almenara JA, Coe S, Grant S. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells inassociation with Mcl-1 and cFLIPL down-regulation.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Res2007; 67:9490-500; PMID:17909059; http://dx.doi.org/10.1158/0008- 5472.CAN-07-0598 [28] Rahmani M, Davis EM, Crabtree TR, Habibi JR, Nguyen TK, Dent P, Grant S. The kinase inhibitor sorafenib induces cell death through aprocess involving induction of endoplasmic reticulum stress.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Cell Biol 2007; 27:5499-513; PMID:17548474; http://dx.doi.org/ 10.1128/MCB.01080-06 [29] Rahmani M, Nguyen TK, Dent P, Grant S. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl Chuman leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leuke-mia-1 down-regulation.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Pharmacol 2007; 72:788-95; PMID:17595328; http://dx.doi.org/10.1124/mol.106.033308 [30] Llobet D, Eritja N, Yeramian A, Pallares J, Sorolla A, Domingo M, Santacana M, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X. Themultikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Eur J Cancer 2010; 46:836-50; PMID:20071162; http://dx.doi.org/10.1016/j.ejca.2009.12.025 [31] Sun NK, Huang SL, Chang TC, Chao CC.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Hepatology 2010; 52:1310-21; PMID:20799354; http://dx.doi.org/10.1002/hep.23836 [33] Rahmani M, Aust MM, Attkisson E, Williams DC, Jr., Ferreira-Gon- zalez A, Grant S. Inhibition of Bcl-2 antiapoptotic members by oba- toclax potently enhances sorafenib-induced apoptosis in humanmyeloid leukemia cells through a Bim-dependent process.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Blood2012; 119:6089-98; PMID:22446485; http://dx.doi.org/10.1182/ blood-2011-09-378141 [34] Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Leh /C19ar J, Kryukov GV, Sonkin D, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Rev Cancer 2013; 13:611- 23; PMID:23969692; http://dx.doi.org/10.1038/nrc3579 [37] Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Rev Cancer 2005; 5:726-34; PMID:16148885; http://dx.doi.org/10.1038/nrc1692 [38] Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Autophagy 2011; 7:1159-72; PMID:21691147; http://dx.doi.org/ 10.4161/auto.7.10.16818622 N. ERITJA ET AL.,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Autophagy 2016; 12:1355-71; PMID:25905985; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Res 2011; 71:4955-67;PMID:21622715; http://dx.doi.org/10.1158/0008-5472.CAN-11-0898 [41] Tai WT, Shiau CW, Chen HL, Liu CY, Lin CS, Cheng AL, Chen PJ, Chen KF.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cell Death Dis 2013; 4:e485; PMID:23392173; http://dx.doi.org/10.1038/cddis.2013.18 [42] Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu B, Pan S, Dong X, Tan G, Wei Z, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Cancer Ther 2014; 13:1589-98; PMID:24705351; http://dx.doi.org/10.1158/1535-7163.MCT-13-1043 [43] Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Aro- zena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Autophagy 2012; 8:445-544; PMID:22966490;http://dx.doi.org/10.4161/auto.19496 [44] Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Sou- quere S, Eskelinen EL, Pierron G, Saftig P, Kroemer G. The apopto- sis/autophagy paradox: autophagic vacuolization before apoptoticdeath.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Cell Sci 2005; 118:3091-102; PMID:15985464; http://dx.doi.org/10.1242/jcs.02447 [45] Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem ﬂuorescent- tagged LC3.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Cell Sci 2012;125:3015-24; PMID:22797912; http://dx.doi.org/10.1242/jcs.079509 [47] Wiersma VR, de Bruyn M, Wei Y, van Ginkel RJ, Hirashima M, Niki T, Nishi N, Zhou J, Pouwels SD, Samplonius DF, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Autophagy 2015; 11:1373-88; PMID:26086204; http://dx.doi.org/10.1080/15548627.2015.1063767 [48] Inamoto T, Azuma H. Sorafenib increases endoplasmic reticulum (ER) stress in concert with vorinostat.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Biol Ther 2011; 12:1018; PMID:22095133; http://dx.doi.org/10.4161/cbt.12.12.18135 [49] Senft D, Ronai ZA.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Trends Biochem Sci 2015; 40:141-8; PMID:25656104; http://dx.doi.org/10.1016/j.tibs.2015.01.002 [50] Kang KA, Kim JK, Jeong YJ, Na SY, Hyun JW.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Cancer Prev 2014; 19:118-24; PMID:25337580; http://dx.doi.org/10.15430/JCP.2014.19.2.118 [51] Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S. 3,3 0- diindolylmethane (DIM) and its derivatives induce apoptosis in pan-creatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Carcinogenesis 2006; 27:717-28; PMID:16332727; http://dx.doi.org/10.1093/carcin/bgi270 [52] Zhang R, Kim JS, Kang KA, Piao MJ, Kim KC, Hyun JW.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression.Nucleic Acids Res 2013; 41:7683-99; PMID:23804767; http://dx.doi.org/10.1093/nar/gkt563 [54] Deegan S, Saveljeva S, Gorman AM, Samali A. Stress-induced self- cannibalism: on the regulation of autophagy by endoplasmicreticulum stress.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cell Mol Life Sci 2013; 70:2425-41; PMID:23052213; http://dx.doi.org/10.1007/s00018-012-1173-4 [55] Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Science 2000; 287:664-6; PMID:10650002; http://dx.doi.org/10.1126/science.287.5453.664 [56] Hagiwara S, Kudo M, Nagai T, Inoue T, Ueshima K, Nishida N, Watanabe T, Sakurai T. Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular car-cinoma.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Br J Cancer 2012; 106:1997-2003; PMID:22596232; http://dx.doi.org/10.1038/bjc.2012.145 [57] Wang L, Gallo KA, Conrad SE.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Oncotarget 2013; 4:1158-71; PMID:23902710; http://dx.doi.org/10.18632/oncotarget.1093 [58] Sweeney ZK, Lewcock JW.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"ACS Chem Neurosci 2011; 2:3-4; PMID:22778853; http://dx.doi.org/10.1021/cn1000793 [59] Sinha S, Levine B.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Oncogene 2008; 27 Suppl 1:S137-48; PMID:19641499; http://dx.doi.org/10.1038/onc.2009.51 [60] Giatromanolaki A, Koukourakis MI, Koutsopoulos A, Chloropoulou P, Liberis V, Sivridis E. High Beclin 1 expression de ﬁnes a poor prog- nosis in endometrial adenocarcinomas.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Gynecol Oncol 2011;123:147-51; PMID:21741077; http://dx.doi.org/10.1016/j.ygyno.2011.06.023 [61] Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J. Autophagy inhibition suppresses pulmonary metastasisof HCC in mice via impairing anoikis resistance and colonization ofHCC cells.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cell Death Dis 2010; 1:e32; PMID:21072319; http://dx.doi.org/ 10.1038/cddis.2010.9 [63] Orfanelli T, Jeong JM, Doulaveris G, Holcomb K, Witkin SS.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Int J Cancer 2014; 135:519-28; PMID:24122662; http://dx.doi.org/ 10.1002/ijc.28524 [64] Lebovitz CB, Robertson AG, Goya R, Jones SJ, Morin RD, Marra MA, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Autophagy 2015; 11:1668-87; PMID:26208877; http://dx.doi.org/10.1080/15548627.2015.1067362 [65] Sivridis E, Giatromanolaki A, Liberis V, Koukourakis MI.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Autophagy 2011; 7:74-82; PMID:21099253; http://dx.doi.org/10.4161/auto.7.1.13947 [66] Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M,et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Br J Cancer 2001; 84:1424-31; PMID:11355958; http://dx.doi.org/10.1054/ bjoc.2001.1796 [67] Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Mælandsmo GM, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Discov 2014; 4:998-1013; PMID:25185190;http://dx.doi.org/10.1158/2159-8290.CD-14-0001 [68] Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Lan- cet 2014; 384:319-28; PMID:24768112; http://dx.doi.org/10.1016/ S0140-6736(14)60421-9 [69] Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oli- veira AC, Santoro A, Raoul JL, Forner A, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
N Engl J Med 2008; 359:378-90; PMID:18650514; http://dx.doi.org/10.1056/NEJMoa0708857AUTOPHAGY 623,Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Ther Adv Urol 2012; 4:303-13; PMID:23205057; http://dx.doi.org/10.1177/1756287212457216 [71] Zhai B, Sun XY.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Int J Cancer 2012; 131:548-57; PMID:21858812; http://dx.doi.org/10.1002/ijc.26374 [73] Honma Y, Harada M. Sorafenib enhances proteasome inhibitor- mediated cytotoxicity via inhibition of unfolded protein responseand keratin phosphorylation.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Exp Cell Res 2013; 319:2166-78; PMID:23727131; http://dx.doi.org/10.1016/j.yexcr.2013.05.023 [74] Levine B, Kroemer G. Autophagy in the pathogenesis of disease.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Fertil Steril 2015; 103:1244-51e1; http://dx.doi.org/10.1016/j.fertnstert.2015.02.007 [76] Choi J, Jo M, Lee E, Oh YK, Choi D. The role of autophagy in human endometrium.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Biol Reprod 2012; 86:70; PMID:22088918; http://dx.doi.org/10.1095/biolreprod.111.096206 [77] Zhang L, Liu Y, Xu Y, Wu H, Wei Z, Cao Y.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Cell 2008; 30:678-88; PMID:18570871; http://dx.doi.org/10.1016/j.molcel.2008.06.001 [79] Luo S, Garcia-Arencibia M, Zhao R, Puri C, Toh PP, Sadiq O, Rubinsztein DC.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Cell 2012; 47:359-70; PMID:22742832; http://dx.doi.org/10.1016/j.molcel.2012.05.040 [80] Keni ﬁc CM, Thorburn A, Debnath J. Autophagy and metastasis: another double-edged sword.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Curr Opin Cell Biol 2010; 22:241-5;PMID:19945838; http://dx.doi.org/10.1016/j.ceb.2009.10.008 [81] Herranz D, Ambesi-Impiombato A, Sudderth J, Sanchez-Martin M, Belver L, Tosello V, Xu L, Wendorff AA, Castillo M, Haydu JE, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Med 2015; 21:1182-9; PMID:26390244; http://dx.doi.org/10.1038/nm.3955 [82] Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy.Cancer Res 2008; 68:1485-94; PMID:18316613; http://dx.doi.org/ 10.1158/0008-5472.CAN-07-0562 [83] Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"J Clin Invest 2009; 119:1109-23; PMID:19363292;http://dx.doi.org/10.1172/JCI35660 [84] Shingu T, Fujiwara K, Bogler O, Akiyama Y, Moritake K, Shinojima N, Tamada Y, Yokoyama T, Kondo S. Stage-speci ﬁc effect ofinhibition of autophagy on chemotherapy-induced cytotoxicity.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Autophagy 2009; 5:537-9; PMID:19270491; http://dx.doi.org/10.4161/auto.5.4.8164 [85] Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"PLoS One 2009; 4:e6251;PMID:19606230; http://dx.doi.org/10.1371/journal.pone.0006251 [86] Garrido-Laguna I, Uson M, Rajeshkumar NV, Tan AC, de Oliveira E, Karikari C, Villaroel MC, Salomon A, Taylor G, Sharma R, et al.Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemci- tabine in patients with pancreatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Clin Cancer Res 2011; 17:5793-800; PMID:21742805; http://dx.doi.org/10.1158/1078-0432.CCR-11-0341 [87] Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Clin Cancer Res 2007; 13:3989-98;PMID:17606733; http://dx.doi.org/10.1158/1078-0432.CCR-07-0078 [88] Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B, Strawn S, Wick MJ, Martell J, Sidran-sky D. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Mol Cancer Ther 2011; 10:1311-6; PMID:21673092; http://dx.doi.org/10.1158/1535-7163.MCT-11-0233 [89] Eritja N, Llobet D, Domingo M, Santacana M, Yeramian A, Matias- Guiu X, Dolcet X.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Am J Pathol2010; 176:2722-31; PMID:20395448; http://dx.doi.org/10.2353/ajpath.2010.090974 [90] Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095 [91] Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Sci Signal 2013; 6:pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088 [92] Hubbell E, Liu WM, Mei R. Robust estimators for expression analy- sis.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Bioinformatics 2002; 18:1585-92; PMID:12490442; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Nat Genet 2000; 25:25-9; PMID:10802651; http://dx.doi.org/10.1038/75556 [94] Burgess A, Vigneron S, Brioudes E, Labbe JC, Lorca T, Castro A.",OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
Proc NatlAcad Sci U S A 2010; 107:12564-9; PMID:20538976; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/ff/kaup-13-03-1271512.PMC5361596.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"3, 473 –485 http://dx.doi.org/10.1080/15548627.2016.1274596",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 2010; 41:S85-6; PMID:20876513; http://dx.doi.org/10.1161/STROKEAHA.110.598458 [2] Del Zoppo GJ, Saver JL, Jauch EC, Adams HP, Jr, American Heart Association Stroke C. Expansion of the time window for treatmentof acute ischemic stroke with intravenous tissue plasminogen activa-tor: a science advisory from the American Heart Association/Ameri- can Stroke Association.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 2009; 40:2945-8; PMID:19478221; http://dx.doi.org/10.1161/STROKEAHA.109.192535 [3] Zhao H, Sapolsky RM, Steinberg GK.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"J Cereb Blood Flow Metab 2006; 26:1114-21; PMID:16736038; http://dx.doi.org/10.1038/sj.jcbfm.9600233 [4] Leconte C, Tixier E, Freret T, Toutain J, Saulnier R, Boulouard M, Roussel S, Schumann-Bard P, Bernaudin M. Delayed hypoxic post- conditioning protects against cerebral ischemia in the mouse.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"2009; 40:3349-55; PMID:19628803; http://dx.doi.org/10.1161/ STROKEAHA.109.557314 [5] Fan YY, Zhang XN, He P, Shen Z, Shen Y, Wang XF, Hu WW, Chen Z.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"CNS Neuroscience Thera- peutics 2013; 19:30-7; http://dx.doi.org/10.1111/cns.12033 [6] Hess DC, Hoda MN, Bhatia K. Remote limb perconditioning [cor- rected] and postconditioning: will it translate into a promising treat- ment for acute stroke?",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 2013; 44:1191-7; PMID:23339961;http://dx.doi.org/10.1161/STROKEAHA.112.678482 [7] Esmaeeli-Nadimi A, Kennedy D, Allahtavakoli M. Opening the win- dow: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic timewindow in an embolic stroke model.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Eur J Pharmacol 2015; 764:55-62; PMID:26123846; http://dx.doi.org/10.1016/j.ejphar.2015.06.043 [8] Fan YY, Shen Z, He P, Jiang L, Hou WW, Shen Y, Zhang XN, Hu WW, Chen Z.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Neurosci Lett 2012; 523:3-8; PMID:22583767; http://dx.doi.org/10.1016/j.neulet.2012.05.015 [10] Wang YZ, Zeng WZ, Xiao X, Huang Y, Song XL, Yu Z, Tang D, Dong XP, Zhu MX, Xu TL.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Cell Death Differ 2013; 20:1359-69; PMID:23852371; http://dx.doi.org/10.1038/cdd.2013.90 [11] Khacho M, Tarabay M, Patten D, Khacho P, MacLaurin JG, Gua- dagno J, Bergeron R, Cregan SP, Harper ME, Park DS, et al.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Nat Commun 2014; 5:3550; PMID:24686499; http://dx.doi.org/10.1038/ncomms4550 [12] Nunnari J, Suomalainen A. Mitochondria: in sickness and in health.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Cell 2012; 148:1145-59; PMID:22424226; http://dx.doi.org/10.1016/j.cell.2012.02.035 [13] Youle RJ, van der Bliek AM.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Science 2012; 337:1062-5; PMID:22936770; http://dx.doi.org/10.1126/science.1219855 [14] Wei C, Li H, Han L, Zhang L, Yang X. Activation of autophagy in ischemic postconditioning contributes to cardioprotective effects against ischemia/reperfusion injury in rat hearts.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"J CardiovascularPharmacol 2013; 61:416-22; PMID:23364609; http://dx.doi.org/ 10.1097/FJC.0b013e318287d501 [15] Su J, Zhang T, Wang K, Zhu T, Li X. Autophagy activation contrib- utes to the neuroprotection of remote ischemic perconditioningagainst focal cerebral ischemia in rats.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Neurochem Res 2014; 39:2068-77; PMID:25082119; http://dx.doi.org/10.1007/s11064-014- 1396-x [16] Zhang X, Yan H, Yuan Y, Gao J, Shen Z, Cheng Y, Shen Y, Wang RR, Wang X, Hu WW, et al.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Autophagy 2013; 9:1321-33; PMID:23800795; http://dx.doi.org/10.4161/auto.25132 [17] Zhang X, Yuan Y, Jiang L, Zhang J, Gao J, Shen Z, Zheng Y, Deng T, Yan H, Li W, et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Autophagy 2014; 10:1801-13; PMID:25126734; http://dx.doi.org/10.4161/ auto.32136 [18] Yan H, Zhang X, Hu W, Ma J, Hou W, Wang X, Gao J, Shen Y, Lv J, Ohtsu H, et al.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"PLoS One 2012; 7:e46092; PMID:23029398; http://dx.doi.org/10.1371/journal.pone.0046092[20] Xie R, Wang P, Cheng M, Sapolsky R, Ji X, Zhao H. Mammalian target of rapamycin cell signaling pathway contributes to theprotective effects of ischemic postconditioning against stroke.Stroke 2014; 45:2769-76; PMID:25013017; http://dx.doi.org/ 10.1161/STROKEAHA.114.005406 [21] Wang J, Han D, Sun M, Feng J.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"J Mol Neurosci 2016; 58:424-31;PMID:26852332; http://dx.doi.org/10.1007/s12031-016-0724-9 [22] Qi ZF, Luo YM, Liu XR, Wang RL, Zhao HP, Yan F, Song ZJ, Luo M, Ji X. AKT/GSK3beta-dependent autophagy contributes to the neuro- protection of limb remote ischemic postconditioning in the transientcerebral ischemic rat model.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"CNS Neurosci Therapeutics 2012;18:965-73; http://dx.doi.org/10.1111/cns.12016 [23] Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Auto- phagy in acute brain injury.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Nat Rev Neurosci 2016; 17:467-84;PMID:27256553; http://dx.doi.org/10.1038/nrn.2016.51 [24] Baek SH, Noh AR, Kim KA, Akram M, Shin YJ, Kim ES, Yu SW, Majid A, Bae ON.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 2014; 45:2438-43; PMID:24938837; http://dx.doi.org/ 10.1161/STROKEAHA.114.005183 [25] Simon RP, Niro M, Gwinn R. Brain acidosis induced by hypercarbic ventilation attenuates focal ischemic injury.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 1971; 2:273-8;PMID:5111576; http://dx.doi.org/10.1161/01.STR.2.3.273 [27] Schips TG, Wietelmann A, Hohn K, Schimanski S, Walther P, Braun T, Wirth T, Maier HJ.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Cardiovasc Res 2011;91:587-97; PMID:21628326; http://dx.doi.org/10.1093/cvr/cvr144 [28] Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Ace- vedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al.Guidelines for the use and interpretation of assays for monitoringautophagy (3rd edition).",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Autophagy 2016; 12:1-222; PMID:26799652; http://dx.doi.org/10.1080/15548627.2015.1100356 [29] Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, et al.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Dev Cell 2008; 14:193-204; PMID:18267088; http://dx.doi.org/10.1016/j.devcel.2007.11.019 [30] Mizumura K, Cloonan SM, Nakahira K, Bhashyam AR, Cervo M, Kitada T, Glass K, Owen CA, Mahmood A, Washko GR, et al.Mitophagy-dependent necroptosis contributes to the pathogenesis ofCOPD.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Curr Biol 2012; 22:545-52; PMID:22342752; http://dx.doi.org/10.1016/j.cub.2012.02.005 [32] Connolly NM, Dussmann H, Anilkumar U, Huber HJ, Prehn JH.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"J Neurosci 2014; 34:10192- 205; PMID:25080581; http://dx.doi.org/10.1523/JNEUROSCI.3127- 13.2014 [33] Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, Harper JW, Youle RJ.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
Neuron 2015; 87:371-81; PMID:26182419;http://dx.doi.org/10.1016/j.neuron.2015.06.034 [34] Gidday JM.,OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Nat Rev Neurosci 2006; 7:437-48; PMID:16715053; http://dx.doi.org/10.1038/nrn1927 [35] Dezfulian C, Garrett M, Gonzalez NR.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
Transla- tional Stroke Res 2013; 4:19-24; PMID:24323188; http://dx.doi.org/10.1007/s12975-012-0224-3484 Z. SHEN ET AL.,OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"J Cereb Blood Flow Metab 2009;29:873-85; PMID:19240739; http://dx.doi.org/10.1038/jcbfm.2009.13 [37] Regli L, Anderson RE, Meyer FB.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Stroke 1995; 26:1444-51; discussion 51-2; PMID:7631351;http://dx.doi.org/10.1161/01.STR.26.8.1444 [38] Cutaia M, Kroczynski J, Tollefson K. pH-dependent oxidant produc- tion following inhibition of the mitochondrial electron transportchain in pulmonary endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Endothelium: J EndothelialCell Res 2002; 9:109-21; PMID:12200958; http://dx.doi.org/10.1080/ 10623320212007 [39] Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Huttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: piv-otal role of the mitochondrial membrane potential in reactive oxygen species generation.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Mol Neurobiol 2013; 47:9-23; PMID:23011809; http://dx.doi.org/10.1007/s12035-012-8344-z [40] Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord EN, Smith AC, et al.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Nature 2014; 515:431-5; PMID:25383517; http://dx.doi.org/10.1038/nature13909 [41] Lazarou M, Jin SM, Kane LA, Youle RJ.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Dev Cell 2012; 22:320-33;PMID:22280891; http://dx.doi.org/10.1016/j.devcel.2011.12.014 [42] Salabei JK, Hill BG.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Redox Biol 2013; 1:542-51;PMID:24273737; http://dx.doi.org/10.1016/j.redox.2013.10.011 [43] Liu JM, Yi Z, Liu SZ, Chang JH, Dang XB, Li QY, Zhang YL.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Brain Res 2015; 1619:155-65; PMID:25818100;http://dx.doi.org/10.1016/j.brainres.2015.03.033 [44] Zhou J, Li G, Zheng Y, Shen HM, Hu X, Ming QL, Huang C, Li P, Gao N. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediatedmitochondrial ﬁssion.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Autophagy 2015; 11:1259-79; PMID:26114658; http://dx.doi.org/10.1080/15548627.2015.1056970 [45] Song M, Gong G, Burelle Y, Gustafsson AB, Kitsis RN, Matkovich SJ, Dorn GW, 2nd.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Circulation Res 2015; 117:346-51; PMID:26038571; http://dx.doi.org/10.1161/ CIRCRESAHA.117.306859 [46] Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepul- veda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH.",OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Cir-culation 2011; 123:750-8; PMID:21311083; http://dx.doi.org/ 10.1161/CIRCULATIONAHA.110.974675 [47] Zhang L, Zhang ZG, Chopp M. The neurovascular unit and combi- nation treatment strategies for stroke.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
Trends Pharmacol Sci 2012; 33:415-22; PMID:22595494; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Free Radic Res 2009; 43:348-64; PMID:19241241; http://dx.doi.org/ 10.1080/10715760902751902 [49] Fan YY, Hu WW, Dai HB, Zhang JX, Zhang LY, He P, Shen Y, Ohtsu H, Wei EQ, Chen Z. Activation of the central histaminergic system isinvolved in hypoxia-induced stroke tolerance in adult mice.",Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
J Cereb Blood Flow Metab 2011; 31:305-14; PMID:20588322; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/be/kaup-13-03-1274596.PMC5361599.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"1, 46 –52 http://dx.doi.org/10.1080/19490976.2016.1256524",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"J Intern Med [Internet]2011; 270:327-38; PMID:21777306; http://dx.doi.org/10.1111/j.1365-2796.2011.02428.x [2] Flak MB, Neves JF, Blumberg RS.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Science (80-) 2013; 339:1044-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Science (80-) [Internet] 2013; 339:1084-8.Available from: http://www.sciencemag.org/content/339/ 6123/1084.abstract ; http://dx.doi.org/10.1126/science.123 3521 [4] Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, Antonopoulos D, Umesaki Y,Chervonsky AV.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"com.library.vu.edu.au/login.aspx?direct Dtrue&db Dedsel p&ANDS1074761313003415&site Deds-live ; PMID:2397 3225; http://dx.doi.org/10.1016/j.immuni.2013.08.013 [5] Yatsunenko T, Rey FE, Gordon JI, Manary MJ, Trehan I, Warner B, Dominguez-Bello MG, Contreras M, MagrisM, Hidalgo G, et al.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Available from:http://www.nature.com/articles/srep19171; http://dx.doi.org/10.1038/srep19171 [7] Hibbard JH, Pope CR.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Psychosom Med 2004; 66:559-63.Available from: http://0-search.ebscohost.com.library.vu.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Available from: http://0- search.ebscohost.com.library.vu.edu.au/login.aspx?direct Dtrue&db Dc8h&AN D104390401&site Deds-live ; PMID:22179096; http://dx.doi.org/10.1093/eurpub/ckr184 [10] Bergman EN.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Nature [Internet] 2010; 464:59-65;PMID:20203603; http://dx.doi.org/10.1038/nature08821 [12] Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Ken- nedy S, et al.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Nature [Internet] 2013;500:541-6; PMID:23985870; http://dx.doi.org/10.1038/nature12506 [13] Huttenhower C, Fah Sathirapongsasuti J, Segata N, Gevers D, Earl AM, Fitzgerald MG, Young SK, Zeng Q,Alm EJ, Alvarado L, et al.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Available from: http://0-search.ebsco host.com.library.vu.edu.au/login.aspx?direct Dtrue&db D edselc&AN Dedselc.2-52.0-84862276328&site Deds-live ; PMID:22699609; http://dx.doi.org/10.1038/nature11234 [14] Atarashi K, Tanoue T, Taniguchi T, Honda K, Shima T, Imaoka A, Umesaki Y, Kuwahara T, Momose Y, Itoh K,et al.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Available from: http://0-search.ebscohost.com.library.vu.edu.au/login.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
aspx?direct Dtrue&db Dedswsc&AN D000268869000012& siteDeds-live ; PMID:19235886; http://dx.doi.org/10.1002/ ibd.20903 [16] Hatheway CL.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"ncbi.nlm.nih.gov/pmc/articles/PMC358141/ ; PMID:2404569; http://dx.doi.org/10.1128/CMR.3.1.66 [17] Rajili /C19c–Stojanovi /C19c M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Availablefrom: http://www.gastrojournal.org/article/S0016-5085 (11)01076-6/abstract ; PMID:21820992; http://dx.doi.org/ 10.1053/j.gastro.2011.07.043 [18] Brown K, DeCoffe D, Molcan E, Gibson DL.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Nutrients 2012; 4:1095-119; PMID:23016134; http://dx.doi.org/10.3390/nu4081095 [19] Fremont M, Coomans D, Massart S, De Meirleir K. High- throughput 16S rRNA gene sequencing reveals altera-tions of intestinal microbiota in myalgic encephalomyeli- tis/chronic fatigue syndrome patients.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"ncbi.nlm.nih.gov/pubmed/23791918 ; PMID:23791918; http://dx.doi.org/10.1016/j.anaerobe.2013.06.002 [20] Dunlop RH, Hammond PB.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Ann N Y Acad Sci [Internet] 1965; 119:1109-32.Available from: http://0-search.ebscohost.com.library.vu.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
edu.au/login.aspx?direct=true&db=mnh&AN=5216443& site=ehost-live ; PMID:5216443; http://dx.doi.org/10.11 11/j.1749-6632.1965.tb47466.x [21] Tappenden KA.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Available from: http://0-search.ebscohost.com.library.vu.,Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Dig Dis Sci [Internet] 1995; 40:320-30.Available from: http://0-search.ebscohost.com.library.vu.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
edu.au/login.aspx?direct=true&db=mnh&AN=7851197& site=ehost-live ; PMID:7851197; http://dx.doi.org/10.100 7/BF02065417 [26] Petersen C. D-lactic acidosis.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"com.library.vu.edu.au/login.aspx?direct=true&db=mnh&AN=16306301&site=ehost-live ; http://dx.doi.org/ 10.1177/0115426505020006634 [27] Caldarini MI, Pons S, D ’Agostino D, DePaula JA, Greco G, Negri G, Ascione A, Bustos D. Abnormal fecal ﬂora in a patient with short bowel syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Available from: http://0- search.ebscohost.com.library.vu.edu.au/login.aspx?directDtrue &dbDmnh&AN D8769294&site Dehost-live ; PMID:8769294; http://dx.doi.org/10.1007/BF02087915 [28] Day AS, Abbott GD.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Available from: http://0-search.ebscohost.com.library.vu.edu.au/lo gin.aspx?direct Dtrue&db Dmnh&AN D10472893&site Deh ost-live ; PMID:10472893 [29] Kaneko T, Bando Y, Kurihara H, Satomi K, Nonoyama K, Matsuura N. Fecal micro ﬂora in a patient with short-bowel syndrome and identi ﬁcation of dominant lactobacilli.",OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
J Clin Microbiol [Internet] 1997; 35:3181-5.Available from: http://0-search.ebscohost.com.library.vu.,OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
"Physiol Rev 2010; 90:859-904; PMID:20664075; http://dx.doi.org/10.1152/physrev .00045.2009 [34] Preidis GA, Hotez PJ (2015) The Newest “Omics ”—Meta- genomics and Metabolomics —Enter the Battle against the Neglected Tropical Diseases.",Non-OADS,/arxiv_data1/oa_pdf/8f/ae/kgmi-08-01-1256524.PMC5361606.pdf
Available at: https://www.mathworks.com/.,Non-OADS,/arxiv_data1/oa_pdf/11/f1/i1552-5783-58-3-1751.PMC5361612.pdf
Available at: https://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/11/f1/i1552-5783-58-3-1751.PMC5361612.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.PEDIATRIC ALLERGY, IMMUNOLOGY, AND PULMONOLOGY Volume 30, Number 1, 2017Mary Ann Liebert, Inc.DOI: 10.1089/ped.2016.0662 222",Non-OADS,/arxiv_data1/oa_pdf/f8/9e/ped.2016.0662.PMC5361761.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 26, Number 3, 2017Mary Ann Liebert, Inc.DOI: 10.1089/jwh.2016.5832 249",Non-OADS,/arxiv_data1/oa_pdf/6f/d6/jwh.2016.5832.PMC5361762.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/6e/main.PMC5361768.pdf
The  disease  can  occur  at  any  site  or  tissue  of  the  body http://dx.doi.org/10.1016/j.ijscr.2017.02.036 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/6e/main.PMC5361768.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.008 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"43  (2016)  242–251,  Available  from  https://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"43  (2016)  252–263,  Available  from  https://www.ncbi.nlm.nih.gov/ pubmed/26945533 .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"30  (2016)  39–43,  Available  from  https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4759502/ .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"149 (5 (May))  (2013),  Available  from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809825/ .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"10  (2  (Jun))  (1994) 92–95, Available from  https://www.ncbi.nlm.nih.gov/pubmed/8086369 .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"134  (3)  (2002), Available from  https://www.ncbi.nlm.nih.gov/pubmed/12208260 .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"5  (4  (Apr)) (1946)  310–321,  Available  from  https://www.ncbi.nlm.nih.gov/pubmed/ 15417334 .",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"27 (6  (Nov-Dec))  (2011)  e155–e156,  Available  from  https://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
"34  (Oct)  (2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.",Non-OADS,/arxiv_data1/oa_pdf/8b/67/main.PMC5361770.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC5361854.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.016 138,OADS,/arxiv_data1/oa_pdf/e0/85/main.PMC5361854.pdf
http://dx.doi.org/10.1016/j.tranon.2017.02.001,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1056/NEJMra041842 [351/24/2519 (pii)].,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1586/14737140.4.4.639 [ERA040415 (pii)].,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1006/gyno.1998.5236 [S0090-8258(98)95236-2 (pii)].,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1200/JCO.,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
"JC l i nO n c o l 22(5), 900 –908.http://dx.doi.org/10.1200/JCO.2004.07.122 [JCO.2004.07.122 (pii)].",Non-OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1006/gyno.2002.6606 .,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1006/gyno.1993.1272 .,Non-OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1245/s10434-011-2153-x .,Non-OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1016/j.ijgo.2014.02.003 [S0020-7292(14)00076-9 (pii)].,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
"JC l i nO n c o l 21(14), 2651– 2657. http://dx.doi.org/10.1200/JCO.2003.12.004 [JCO.2003.12.004 (pii)].",Non-OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1016/j.ygyno.2014.03.016 [S0090-8258(14)00252-2 (pii)].,OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
http://dx.doi.org/10.1093/annonc/mdq628 [mdq628 (pii)].Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/37/81/main.PMC5361859.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/b2/main.PMC5361860.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.019 135,OADS,/arxiv_data1/oa_pdf/2f/b2/main.PMC5361860.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/22/a8/main.PMC5361867.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.011 131,OADS,/arxiv_data1/oa_pdf/22/a8/main.PMC5361867.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC5361868.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.02.001,OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC5361868.pdf
"Survival Analysis Publicly available clinical informa tion, including follow-up times and vital status data for patients across 11 cancer types were obtained from the TCGA viathe data portal ( https://tcga-data.nci.nih.gov /) on January 21, 2015.",OADS,/arxiv_data1/oa_pdf/3b/43/main.PMC5361868.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/78/main.PMC5361869.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.024 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/78/main.PMC5361869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/78/main.PMC5361869.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Parkinson's diseaseCognitive de ﬁcits Dense electroencephalographyBrain connectivityNetwork measures 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/d9/main.PMC5361870.pdf
http://dx.doi.org/10.1016/j.nicl.2017.03.002 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/d9/main.PMC5361870.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d9/main.PMC5361870.pdf
"An atlas-based approach was used to project EEG sen- sor signals onto an anatomical framework consisting of 68 cortical re- gions identi ﬁed by means of the Desikan-Killiany ( Desikan et al., 2006 ) atlas using Freesurfer ( Fischl, 2012 ),http://freesurfer.net /.",OADS,/arxiv_data1/oa_pdf/b7/d9/main.PMC5361870.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Event-relatedSensory-evoked Coherence GammaAlzheimer's diseaseEEGConnectivity 1.,Non-OADS,/arxiv_data1/oa_pdf/20/48/main.PMC5361871.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.021 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/48/main.PMC5361871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/48/main.PMC5361871.pdf
"Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND) ’ Marie-Lise Gougeona,*, Béatrice Poirier-Beaudouina, Jacques Durantb, Christine Lebrun-Frenayc, Héla Saïdia, Valérie Seffera, Michel Ticchionid, Stephane Chanalete, Helene Carsentib, Alexandra Harvey-Langtonb, Muriel Laffonc, Jacqueline Cottalordaf, Christian Pradierg, Pierre Dellamonicab, Matteo Vassallob,h aInstitut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France bUniversity of Nice, L ’Archet Hospital, Department of Infectious Diseases, Nice, France cUniversity of Nice, Pasteur Hospital, Department of Neurology, Nice, France dUniversity of Nice, L ’Archet Hospital, Immunology Laboratory Unit, Nice, France eUniversity of Nice, Pasteur Hospital, Department of Radiology, Nice, France fUniversity of Nice, L ’Archet Hospital, Virology Laboratory Unit, Nice, France gUniversity of Nice, Department of Public Health, L ’Archet Hospital, Nice, France hCannes General Hospital, Department of Internal Medicine, Cannes, France DOI of original article: http://dx.doi.org/10.1016/j.heliyon.2017.e00245 * Corresponding author at: Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France.",Non-OADS,/arxiv_data1/oa_pdf/c2/2c/main.PMC5361933.pdf
e00259 http://dx.doi.org/10.1016/j.heliyon.2017.e00259 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/2c/main.PMC5361933.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/2c/main.PMC5361933.pdf
"http://www2.mass- general.org (n.d., accessed 18 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/35/c8/10.1177_2055116915603077.PMC5361993.pdf
BMC Vet Res 2011; 7: 57. http://dx.doi.org/10.1186/1746- 6148-7-57  2 Helphrey M. Vascular ring anomalies.,Non-OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
"http://dx.doi.org/10.1111/j.1748-5827.2003.tb00164.x  6 Ketz CJ, Radlinsky M, Armbrust L, et al.",OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
"http://dx.doi.org/10.1638/1042-7260(2001)032[0268:praaaa] 2.0.co;2  7 Yarim M, Gültiken ME, Oztürk S, et al.",OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
"http://dx.doi.org/10.1111/j.1439-0442.1981.tb01228.x  11 Wheaton LG, Blevins WE and Weirich WE.",Non-OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
http://dx.doi.org/10.1007/s11748-015-0521-3  15 Washabau RJ.,Non-OADS,/arxiv_data1/oa_pdf/cf/70/10.1177_2055116915614590.PMC5361997.pdf
"http://www.ncbi.nlm.nih.gov/ books/NBK144013/ (2009, accessed ?",Non-OADS,/arxiv_data1/oa_pdf/1b/41/10.1177_2055116915621581.PMC5362001.pdf
"Available from: http://www.ncbi.nlm.nih.gov/books/ NBK2701/  4 Brown DL, Van Winkle T, Cecere T, et  al.",Non-OADS,/arxiv_data1/oa_pdf/30/de/10.1177_2055116915619191.PMC5362006.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602638/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/fe/b3/1602638.PMC5362009.pdf
"European Commission, “An analysis of the EU organic sector ”(European Commission, Directorate-General for Agriculture and Rural Development, 2010);http://ec.europa.eu/agriculture/sites/agriculture/files/markets-and-prices/more-reports/pdf/organic_2010_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fe/b3/1602638.PMC5362009.pdf
"A. Avery, Nature ’s Toxic Tools: The Organic Myth of Pesticide-free Farming (Center for Global Food Issues, 2001); http://www.biblelife.org/organic.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fe/b3/1602638.PMC5362009.pdf
http://www.cur-rentveterinarytherapy.com/references/webchapter_012.,Non-OADS,/arxiv_data1/oa_pdf/69/5e/10.1177_2055116915615370.PMC5362011.pdf
"5 The resulting 16s  rRNA gene sequence was compared with the GenBank database, using the Basic Local Alignment Search Tool  (http://blast.ncbi.nlm.nih.gov) to establish identifica- tion with a species (⩾99% sequence homology) or genus level (⩾97% sequence homology).",OADS,/arxiv_data1/oa_pdf/a4/fc/10.1177_2055116915597240.PMC5362016.pdf
"Proceedings of the Australian and New  Zealand College of Veterinary Scientists, Surgery   Chapter, Science Week, 2015. http://surgery.anzcvs.org.",Non-OADS,/arxiv_data1/oa_pdf/d3/6a/10.1177_2055116915613358.PMC5362017.pdf
"To address this, we performed comparative transcriptomics of macular and extramacular retinal pigmentedReceived: 20 October 2016 Revised: 6 March 2017 Accepted: 9 March 2017 Heliyon 3 (2017) e00266 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
We also demonstrated Article No~e00266 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
DEGs common to macular but not extramacular samples Article No~e00266 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
GO id Description q-value GO:0006695 cholesterol biosynthetic process 2.7E-22 GO:0016126 sterol biosynthetic process 2.7E-22 GO:0008203 cholesterol metabolic process 7.1E-18 GO:0016125 sterol metabolic process 4.3E-17 GO:0046165 alcohol biosynthetic process 8.5E-16 GO:0006694 steroid biosynthetic process 1.6E-15GO:1901617 organic hydroxy compound biosynthetic process 1.1E-14 GO:0008202 steroid metabolic process 3.7E-12 GO:0006066 alcohol metabolic process 1.6E-10 Article No~e00266 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
"GO id Description q-value GO:0016056 rhodopsin mediated signaling pathway 2.8E-28 GO:0007603 phototransduction, visible light 6.5E-27 GO:0022400 regulation of rhodopsin mediated signaling pathway 1.3E-26 GO:0009584 detection of visible light 2.0E-26 GO:0007602 phototransduction 3.3E-26GO:0009583 detection of light stimulus 8.9E-26 GO:0009581 detection of external stimulus 2.1E-24 GO:0009582 detection of abiotic stimulus 3.9E-24 GO:0071482 cellular response to light stimulus 2.6E-22 GO:0051606 detection of stimulus 3.6E-21GO:0097381 photoreceptor disc membrane 8.5E-21 GO:0071478 cellular response to radiation 2.6E-19 GO:0009416 response to light stimulus 3.5E-19 GO:0008277 regulation of G-protein coupled receptor protein signaling pathway 5.8E-18 GO:0071214 cellular response to abiotic stimulus 3.2E-17 GO:0009314 response to radiation 1.3E-16 GO:0060170 ciliary membrane 7.8E-16GO:0001750 photoreceptor outer segment 1.1E-15 GO:0098590 plasma membrane region 2.8E-13 GO:0031513 nonmotile primary cilium 6.6E-12 GO:0031253 cell projection membrane 8.8E-12 GO:0072372 primary cilium 1.5E-10GO:0097458 neuron part 5.0E-10 Article No~e00266 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
The PCR amplicons were cloned into a Article No~e00266 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
"Among these 55 and 128 genes, we found that 32 and 76 genes, respectively, had expression changes in the same Article No~e00266 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
"Although light-induced retinopathy isgenerally used as a model of neuroretinal degeneration [51], these results are Article No~e00266 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Supplementary content related to this article has been published online at http://dx.doi.org/10.1016/j.heliyon.2017.e00266 Acknowledgments We are grateful to Drs.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
"[8]S. Sasagawa, Y. Nishimura, H. Sawada, E. Zhang, S. Murakami, Y. Ashikawa, M. Yuge, S. Okabe, K. Kawaguchi, R. Kawase, et al., Article No~e00266 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
Article No~e00266 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00266 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/57/main.PMC5362043.pdf
The recent multicounty study of household health surveys revealed that the within- country economic-related inequality in the delivery of a vaccine was still high in Lao PDR.Received: 12 February 2017 Revised: 26 February 2017 Accepted: 9 March 2017 Heliyon 3 (2017) e00265 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Reasons related to the immunisation system can be addressed by immunisation Article No~e00265 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
"The sample size was calculatedbased on the expected measles and rubella IgG sero-prevalence, level of Article No~e00265 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
"For the analysis, 317 children aged between 12 and 35 months were eligible, after excluding those whose ages were Article No~e00265 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Fully immunised <N=187> (%)Partially immunised <N=130> (%)Crude OR (95% CI) p-value Source of information of vaccination From medical staff+0.31 yes 113 (61.08) 72 (55.38) 1.26 (0.80 –1.99) no 72 (38.92) 58 (44.62) Reference From village health volunteer++0.33 yes 61 (33.15) 50 (38.46) 0.79 (0.50 –1.27) no 123 (66.85) 80 (61.54) Reference From information written on the vaccination cards+++0.01 yes 56 (30.27) 23 (17.69) 2.02 (1.17 –3.50) no 129 (69.73) 107 (82.31) Reference From family member or friends#0.69 yes 4 (2.17) 2 (1.54) 1.42 (0.26 –7.88) no 180 (97.83) 128 (98.46) Reference From radio/TV##<0.01 yes 0 (0.00) 5 (3.85) no 184 (100.0) 125 (96.15) From poster###0.23 yes 0 (0.00) 1 (0.77)no 184 (100.0) 129 (99.23) From local authority x0.66 yes 68 (36.76) 51 (39.23) 0.90 (0.57 –1.43) no 117 (63.24) 79 (60.77) Reference From women ’s unionxx0.29 yes 16 (8.65) 16 (12.31) 0.67 (0.32 –1.40) no 169 (91.35) 114 (87.69) Reference Number of source of information of vacci- nationxxx0.66 1 104 (56.52) 78 (60.00) References 2 46 (25.00) 33 (25.38) 1.05 (0.61 –1.78) >=3 34 (18.48) 19 (14.62) 1.34 (0.71 –2.53) Source of information of vaccination date From medical staffa0.03 yes 101 (54.30) 54 (41.54) 1.67 (1.06 –2.63) no 85 (45.70) 76 (58.46) Reference From village health volunteerb0.93 yes 60 (32.61) 43 (33.08) 0.98 (0.61 –1.58) no 124 (67.39) 87 (66.92) Reference (Continued ) Article No~e00265 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Several Article No~e00265 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
"This study is the only nationwide study to identify factors associated with the vaccination status of children in Lao PDR, except for the Multiple Indicator Cluster Article No~e00265 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
"Ryman, P. Sandhu, A. Bo, K. Banerjee, Reasons related to non-vaccination and under-vaccination of children in low Article No~e00265 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
(cited 12.05.2015; accessed 29.06.2016) http://www.wpro.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
(cited 12.06.2015; accessed 29.06.2016) http://www.who.int/gho/countries/lao.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
(accessed 29.06.2016) http://www.unicef.org/immu- nization/files/EN-ImmSumm-2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
(accessed 30.12.2015) http://www.who.int/immunization/ sage/1_immunization_gender_reports_without_graphics.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
Article No~e00265 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00265 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ec/e8/main.PMC5362045.pdf
"22 The Los Alamos  HIV database provides an interactive map showing the global distri-bution of different clades and circulating recombinant forms, as they have been sampled and sequenced (http://www.hiv.lanl.gov/compo - nents/sequence/HIV/geo/geo.comp).",OADS,/arxiv_data1/oa_pdf/57/b2/IMR-275-230.PMC5362114.pdf
The treatment was complemented http://dx.doi.org/10.1016/j.gore.2017.03.008 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/17/f0/main.PMC5362132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/f0/main.PMC5362132.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Metagenome Pyrosequencing Great Salt PlainBacteriaSaltﬂat VegetationGSPGASGAB Speci ﬁcations Organism/cell line/tissueGreat salt plain sediment metagenome Sex Not applicable Sequencer Sequencer or array Type 454 GS FLX Titanium pyrosequencerData format Raw data FAST ﬁle Experimental factorsEnvironmental sample Experimental features16S rRNA genes ampli ﬁed from the metagenome using pyrosequencing followed by bacterial community analysisusing Mothur version 1.35.1 Consent Not applicableSample source locationSalty deposits, Vegetated soil, Great Salt Plains, Oklahoma, USA.",Non-OADS,/arxiv_data1/oa_pdf/32/a1/main.PMC5362135.pdf
"Direct link to deposited data http://www.ebi.ac.uk/ena/data/view/LT699840-LT700186North America harbors broadly terrestrial saline environments, in- cluding the Great Salt Plains district.",Non-OADS,/arxiv_data1/oa_pdf/32/a1/main.PMC5362135.pdf
http://dx.doi.org/10.1016/j.gdata.2017.03.002 2213-5960/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/32/a1/main.PMC5362135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/a1/main.PMC5362135.pdf
http://www.ebi.ac.uk/ena/data/view/LT699840-LT700186 Competing interests The author declares that there are no competing interests.,Non-OADS,/arxiv_data1/oa_pdf/32/a1/main.PMC5362135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/63/main.PMC5362136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/63/main.PMC5362136.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.002Urology Case Reports 12 (2017) 51 e53,Non-OADS,/arxiv_data1/oa_pdf/97/63/main.PMC5362136.pdf
Available at: https://www.rcpa.edu.au/Library/Practising-Pathology/RCPA-Manual/Items/ Pathology-Tests .,Non-OADS,/arxiv_data1/oa_pdf/97/63/main.PMC5362136.pdf
"Maturation http://dx.doi.org/10.1016/j.redox.2017.03.002 Received 28 February 2017; Accepted 3 March 2017☆This research was supported by the Intramural Research Program of the NIEHS, National Institute of Environmental Health Sciences/NIH.",OADS,/arxiv_data1/oa_pdf/61/6e/main.PMC5362137.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/61/6e/main.PMC5362137.pdf
Gene-speci ﬁc primers (Supplementary Data Table S2) were designed using the NCBI/ Primer BLAST Designing Tool ( https://www.ncbi.nlm.nih.gov/tools/ primer-blast/).,OADS,/arxiv_data1/oa_pdf/61/6e/main.PMC5362137.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.03.002 .,OADS,/arxiv_data1/oa_pdf/61/6e/main.PMC5362137.pdf
"Though a number of mechanisms have been proposed including neural and autonomic http://dx.doi.org/10.1016/j.redox.2017.03.010 Received 3 March 2017; Accepted 8 March 2017⁎Correspondence to: Vascular Medicine Institute, Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.",Non-OADS,/arxiv_data1/oa_pdf/f6/b7/main.PMC5362138.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f6/b7/main.PMC5362138.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.03.010 .,OADS,/arxiv_data1/oa_pdf/f6/b7/main.PMC5362138.pdf
http://dx.doi.org/10.1016/j.redox.2017.03.012 Received 23 February 2017; Received in revised form 7 March 2017; Accepted 9 March 2017⁎Corresponding authors.,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.03.012 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
208 (5) (2015) 501– 512. http://dx.doi.org/10.1083/jcb.201409063.,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
53 (2) (2012)227– 246. http://dx.doi.org/10.1194/jlr.R021089 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1007/s00125-016-4031-3 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
104 (2017) 129– 137. http://dx.doi.org/10.1016/j.freeradbiomed.2017.01.015 (Epub 2017 Jan 12).,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1172/JCI21625 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
442 (3) (2012) 453– 464. http://dx.doi.org/10.1042/BJ20111752 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.3109/10715762.2013.789136 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1021/jp3044219 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
92 (2013) 239– 247. http://dx.doi.org/10.1016/j.jprot.2013.02.004 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
6 (4)(2007) 624– 637. http://dx.doi.org/10.1074/mcp.M600120-MCP200 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
47 (1) (2013) 8–19.http://dx.doi.org/10.3109/10715762.2012.733003 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
44 (10) (2009) 625– 633. http://dx.doi.org/10.1016/j.ex- ger.2009.07.003 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1056/NEJM199602293340906 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
333 (9) (1995) 550– 554. http://dx.doi.org/10.1056/NEJM199508313330903 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1016/j.ejphar.2005.06.016 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
10 (8) (2008) 688– 690. http://dx.doi.org/10.1111/j.1463- 1326.2008.00890.x.,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
4 (4) (2012) 180– 184. http://dx.doi.org/10.4103/1947-2714.94944 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1074/jbc.M103382200 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
"Kahn, Developmental origin of fat: tracking obesity to its source, Cell 131 (2) (2007) 242– 256. http://dx.doi.org/10.1016/ j.cell.2007.10.004 .",Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
"Cleeman, S.C. Smith Jr., C. Lenfant, American Heart A, et al., De ﬁnition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scienti ﬁc issues related to de ﬁnition, Circulation 109 (3) (2004) 433– 438. http://dx.doi.org/ 10.1161/01.CIR.0000111245.75752.C6 .",Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
456 (2008) 155– 171. http://dx.doi.org/10.1007/978-1- 59745-245-8_12 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1038/oby.2012.116 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1016/j.tiv.2010.10.013 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
170 (2) (2012) 178– 185. http://dx.doi.org/ 10.1111/j.1365-2249.2012.04639.x .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.3109/ 10715762.2010.498476 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/ 10.2337/db08-0675 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1074/jbc.M500403200 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
"Hotamisligil, M. Rubinstein, FABP4 attenuates PPARgamma and adipogenesis and is inversely correlated with PPARgamma in adipose tissues, Diabetes 63 (3) (2014) 900– 911. http://dx.doi.org/10.2337/db13- 0436 .",Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
4 (4) (2003) 374– 380. http://dx.doi.org/10.1038/sj.embor.embor805 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1074/ jbc.M111.251926 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
40 (4) (2016) 272– 279. http://dx.doi.org/10.4093/ dmj.2016.40.4.272 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
"[44] L. Fang, F. Guo, L. Zhou, R. Stahl, J. Grams, The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetesmellitus in humans, Adipocyte 4 (4) (2015) 273– 279. http://dx.doi.org/10.1080/ 21623945.2015.1034920 .",Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
Acta 1781 (6 –7) (2008) 283– 287. http://dx.doi.org/10.1016/j.bbalip.2008.03.010 .,OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
12 (2) (1997) 131– 136. http://dx.doi.org/ 10.1089/cbr.1997.12.131 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
7(2014) 15 –24.http://dx.doi.org/10.2147/DMSO.S38753 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
199 (1) (2008) 33 –40.http://dx.doi.org/10.1677/JOE-08-0278 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.3109/10715762.2015.1112901 .,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
http://dx.doi.org/10.1089/ars.2015.6317 .M.,Non-OADS,/arxiv_data1/oa_pdf/a6/a3/main.PMC5362139.pdf
"In the present study, we have investigated the mechanism of cytostatic activity of two pentacyclic triterpenoids, namely ursolic acid (UA) and betulinic acid (BA) and sulforaphane (SFN), an isothiocya- nate, against phenotypically distinct breast cancer cells MCF-7 (ER +, PR+/-, HER2-, wild type p53), MDA-MB-231 (ER-,P R-, HER2-, mutant http://dx.doi.org/10.1016/j.redox.2017.03.014 Received 6 February 2017; Received in revised form 25 February 2017; Accepted 11 March 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/76/8e/main.PMC5362140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/76/8e/main.PMC5362140.pdf
http://dx.doi.org/10.1007/s10495-017-1353-7 .,Non-OADS,/arxiv_data1/oa_pdf/76/8e/main.PMC5362140.pdf
"Kidney Int Rep (2017) 2,239 –247; http://dx.doi.org/10.1016/j.ekir.2016.11.004 KEYWORDS: chronic kidney disease; renal function; suPAR ª2016 International Society of Nephrology.",Non-OADS,/arxiv_data1/oa_pdf/df/a2/main.PMC5362148.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/a2/main.PMC5362148.pdf
We calculated the Net Reclassi ﬁcation Improvement (NRI)26using the nriSTATA command for the package idi from http://personalpages.manchester.,OADS,/arxiv_data1/oa_pdf/df/a2/main.PMC5362148.pdf
"As a consequence, the molecular weight profile of silicone lubricants should be established prior to thepreparation of prefilled syringes.Received: 1 November 2016 Revised: 8 February 2017 Accepted: 9 March 2017 Heliyon 3 (2017) e00264 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
"Octamethylcyclote- trasiloxane (D 4) (Aldrich), 100 and 1000 cSt trimethylsiloxy-terminated poly- dimethylsiloxane (PDMS-TMS) (Gelest), 200, 5000, 60,000 cSt PDMS-TMS (HulsAmerica), as well as 3225C Formulation Aid (Dow Corning) were also used as Article No~e00264 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Component viscosity/Blend Name Silicone oil Concentration of silicone (wt%) Concentration of insulin Shear Mixing Time (s) Series 1 D4 0.001 0.6 mM Low 360 D4 0.010 0.6 mM Low 360 D4 0.100 0.6 mM Low 360 D4 1.000 0.6 mM Low 360 Series 1 D4 0.001 0.6 mM High 50 D4 0.010 0.6 mM High 50 D4 0.100 0.6 mM High 50 D4 1.000 0.6 mM High 50 Series 2 D4 0.001 0.05 μM Low 360 D4 0.010 0.05 μM Low 360 D4 0.100 0.05 μM Low 360 D4 1.000 0.05 μM Low 360 Series 2 D4 0.001 0.05 μM High 50 D4 0.010 0.05 μM High 50 D4 0.100 0.05 μM High 50 D4 1.000 0.05 μM High 50 D4 0.100 0.6 mM High 20 0.100 0.6 mM High 300.100 0.6 mM High 40 0.100 0.6 mM High 50 D 4 0.100 0.05 μM High 20 0.100 0.05 μM High 30 0.100 0.05 μM High 40 0.100 0.05 μM High 50 (Continued ) Article No~e00264 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
The final 3D conformation orients the polar and hydrophobic sides Article No~e00264 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
"For example, fibrinogen and fibronectin have been shown to aggregate inthe presence of D 4; both show increased aggregation with an increasing D 4to Article No~e00264 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
The net rate Article No~e00264 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
"[9] Silicone fluids: property profile guide, Gelest, 2013. http://www.gelest.com/ wp-content/uploads/Goods-PDF-brochures-inert_silicones_2013.pdf .",Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
"Randolph, Flow cytometry: A promising technique for the study of silicone oil-induced Article No~e00264 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
Article No~e00264 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00264 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/main.PMC5362151.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.01.011,OADS,/arxiv_data1/oa_pdf/97/09/main.PMC5362152.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602244/DC1text S1.,Non-OADS,/arxiv_data1/oa_pdf/06/56/1602244.PMC5362170.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1501645/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/38/71/1501645.PMC5362183.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1603131/DC1 note S1.,Non-OADS,/arxiv_data1/oa_pdf/b1/e9/1603131.PMC5362184.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601990/DC1 information S1.,Non-OADS,/arxiv_data1/oa_pdf/9f/61/1601990.PMC5362185.pdf
Quantification of fluorescence intensity Fluorescence intensity was measured using ImageJ (http://rsbweb.nih.,OADS,/arxiv_data1/oa_pdf/38/28/1601528.PMC5362186.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601528/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/38/28/1601528.PMC5362186.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.02.003 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/main.PMC5362271.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2, 173e185",Non-OADS,/arxiv_data1/oa_pdf/15/d8/main.PMC5362271.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/d8/main.PMC5362271.pdf
126All HPAs result in a single amino acid substitution except for HPA-14w where the antigen is a result of a one amino acid deletion.127The database of all immunizingHPAs that have caused at least one case of FNAIT can be found at http://www.ebi.ac.uk/ipd/hpa/table2.html .T o date there are 36 HPAs on six platelet surface proteins thathave been discovered and may lead to FNAIT.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/main.PMC5362271.pdf
"Only KS_0600 and KS_0601 showed clear disease progression in OCT B-scan over 32 months and 30 months, respectively (See Figure, Supplemental Dig- ital Content 1 http://links.lww.com/IAE/A496, which shows longitudinal OCTs for all subjects).",Non-OADS,/arxiv_data1/oa_pdf/e0/bd/retina-37-741.PMC5362286.pdf
"Compared with confocal imaging, nonconfocal split- detector AOSLO allows for a more accurate assessment of photoreceptor structure in BVMD, especially in areas of the photoreceptor mosaic overlying subretinal pathology (Figures 1 –3a n ds e e Figure, Supplemental Digital Content 2 , http://links.lww.com/IAE/A497, which shows split-detector and OCT imaging within and outside vitelliform lesions).",Non-OADS,/arxiv_data1/oa_pdf/e0/bd/retina-37-741.PMC5362286.pdf
"In agreement with previous AOSLO studies,21immediately adjacent to the lesions, both den- sity and appearance of cone inner segments return to normal (Figure 4 and see Figure, Supplemental Digi- tal Content 2 , http://links.lww.com/IAE/A497, which shows split-detector and OCT imaging within and out- side vitelliform lesions), lending support to BVMD causing focal photoreceptor lesions.",Non-OADS,/arxiv_data1/oa_pdf/e0/bd/retina-37-741.PMC5362286.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/main.PMC5362382.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 54 e58 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.09.001 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c4/e4/main.PMC5362382.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/e4/main.PMC5362382.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/42/main.PMC5362383.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 69 e71 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.12.002 2452-2325/Copyright ©2016, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a1/42/main.PMC5362383.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/42/main.PMC5362383.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/d0/main.PMC5362384.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 28 e32 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.10.006 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/10/d0/main.PMC5362384.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/d0/main.PMC5362384.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/99/main.PMC5362385.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 63 e65 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.08.009 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/07/99/main.PMC5362385.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/99/main.PMC5362385.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 1 e4 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2017.02.005 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
2017 Jan 16. http://dx.doi.org/10.1097/IAE.0000000000001471 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
2016 Sep 30. http://dx.doi.org/ 10.1097/IAE.0000000000001344 .,Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
2016 Sep 14. http://dx.doi.org/10.1136/bjophthalmol-2016- 308869 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
2016. http://dx.doi.org/10.1136/bjophthalmol-2016-309104 .,OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
2016. http://dx.doi.org/10.1136/bjoph- thalmol-2016-309678 .,Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
"2016. http://dx.doi.org/10.1097/IAE.0000000000001414 .Khalil Ghasemi Falavarjani * Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Sattarkhan-Niaiesh St, Tehran, Iran David Sarraf Stein Eye Institute, University of California Los Angeles, Los Angeles, CA, USA Greater Los Angeles VA Healthcare Center, Los Angeles, CA, USA *Corresponding author .",Non-OADS,/arxiv_data1/oa_pdf/27/22/main.PMC5362386.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/5e/main.PMC5362387.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 45 e49 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.08.005 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2c/5e/main.PMC5362387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/5e/main.PMC5362387.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/0c/main.PMC5362388.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 66 e68 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.11.003 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/81/0c/main.PMC5362388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/0c/main.PMC5362388.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/48/main.PMC5362389.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 17 e22 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.09.003 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/41/48/main.PMC5362389.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/48/main.PMC5362389.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5362390.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 33 e38 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.05.006 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5362390.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/main.PMC5362390.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/3b/main.PMC5362391.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 50 e53 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.09.004 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/30/3b/main.PMC5362391.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/3b/main.PMC5362391.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/0f/main.PMC5362392.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 39 e44 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.08.003 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a2/0f/main.PMC5362392.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/0f/main.PMC5362392.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/1e/main.PMC5362393.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 23 e27 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.09.005 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/15/1e/main.PMC5362393.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/1e/main.PMC5362393.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 5 e6 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2017.02.006 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/74/dd/main.PMC5362394.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/dd/main.PMC5362394.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/dc/main.PMC5362395.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 7 e16 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.09.009 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9e/dc/main.PMC5362395.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/dc/main.PMC5362395.pdf
http://www.who.int/blindness/Vision2020_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/dc/main.PMC5362395.pdf
http://dx.doi.org/10.1371/ journal.pone.0141137 .,Non-OADS,/arxiv_data1/oa_pdf/9e/dc/main.PMC5362395.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/95/main.PMC5362396.pdf
"Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 29 (2017) 59 e62 http://www.journals.elsevier.com/journal-of-current-ophthalmology http://dx.doi.org/10.1016/j.joco.2016.11.001 2452-2325/Copyright ©2017, Iranian Society of Ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0b/95/main.PMC5362396.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/95/main.PMC5362396.pdf
"This collaborative effort is provided via the WEB- RADR project ( http://www.web-radr.eu ), which is supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) underGrant Agreement No.",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
"115632, resources of which are composed of ﬁnancial contributions from the EU’s Seventh Framework Pro- gramme (FP7/2007-2013) and European Federation of Pharmaceuti-cal Industries and Associations (EFPIA) companies’ in-kind contribution ( http://www.imi.europa.eu ).",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
"Development of thesocial listening platform, research conducted, and manuscript devel- opment was funded by the US FDA ( http://www.fda.gov ) under contract with Epidemico, Inc (HHSF223201210217C).",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
2012. http://dannybrown.me/2012/06/06/52-cool- facts-social-media-2012 .,Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
2012. http://temp.beevolve.,Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
"Pew Internet: Pew Research Center, 2013. http://www.pewinternet.org/2013/01/15/ health-online-2013 .",Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
DailyMed: National Institutes of Health; 2016. https://dailymed.nlm.nih.gov .,Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
2015. http://www.meddra.org .,Non-OADS,/arxiv_data1/oa_pdf/d5/cc/40264_2016_Article_491.PMC5362648.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/10/1d/40264_2017_Article_505.PMC5362649.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/61/1e/40264_2016_Article_493.PMC5362651.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0b/4f/40264_2016_Article_501.PMC5362654.pdf
http://seer.cancer.gov/csr/1975_2011/ .,Non-OADS,/arxiv_data1/oa_pdf/0b/4f/40264_2016_Article_501.PMC5362654.pdf
REVLIMID [lenalidomide] full prescribing information 2015. http://www.revlimid.com/wp-content/uploads/ 2013/11/PI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/4f/40264_2016_Article_501.PMC5362654.pdf
https://www.celgenerisk management.com .Effectiveness of REMS for Lenalidomide and Thalidomide 341,Non-OADS,/arxiv_data1/oa_pdf/0b/4f/40264_2016_Article_501.PMC5362654.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
2013. http://www.patientsacademy.eu/ .,Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
2016. http://www.invo.org.,Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
2015. http://www.arthritispatient.ca/research .,Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
2016. http://www.omeract.org/ .,Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
2015. http://www.pcori.,Non-OADS,/arxiv_data1/oa_pdf/95/7d/40271_2016_Article_198.PMC5362656.pdf
"R Foundation for Statistical Computing, 2014 (http://www.R-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/c5/0a/bjporcpsych003889.PMC5362727.pdf
"Crime Statistics, Recidivism, Recidivism among All Men by Age 2004 –2008 (http://www.bra.se/bra/bra-in-english/home/crime- and-statistics/crime-statistics.html).Hofvander et al 84",Non-OADS,/arxiv_data1/oa_pdf/c5/0a/bjporcpsych003889.PMC5362727.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/jgenv05p0016.PMC5362762.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/cd/bd/jgenv05p0016.PMC5362762.pdf
miRNAs were annotated  from miRBase version 21 (http://www.mirbase.,OADS,/arxiv_data1/oa_pdf/cd/bd/jgenv05p0016.PMC5362762.pdf
"lncRNAs  were quantified using reference annotation LNCipedia (http://www.lncipedia.org) version 3.1, downloaded from all c oordinates relative to the hg19  reference genome [16].",OADS,/arxiv_data1/oa_pdf/cd/bd/jgenv05p0016.PMC5362762.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/49/19/jgenv05p0032.PMC5362763.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/49/19/jgenv05p0032.PMC5362763.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
jgenomics.com  38  [21] and also by comparing the same to t he NCBI  non- redundant protein database (ftp://ftp.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"Six metagenomes were classified (PS1,  PS2, 1 Km, 5 Km, DS(Dumpsite) and SolexaDS)  against the nr database (ftp://ftp.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
A set of 107 essential single -copy gene HMMs (24)  were searched against the predicted ORFs of pond sediment associated genomes using HMMER3  (http://hmmer.janelia.org/).,OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
All -versus -all BLASTP  (default parameters) followed by MCL cluster ing  (http://micans.org/mcl/) was used t o determine  clusters of homologs in order to validate the  pathways.,OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"Taxonomical classification across PS1 and PS2 was determined using the Environmental Gene Tag analysis (EGT: a  compositional based binning) as well as BLASTP of  contigs against NCBI’s non- redundant protein  database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/nr,  June, 2015).",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"a)  Phylogenetic reassignment of metagenomic reads of PS1, PS2 and HCH gradient (1 Km, 5 Km, DS and  SolexaDS) against the nr -database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/nr, June, 2015) (BLASTX, E -value = 1e –10), b) Stack area plot of the most abundant phyla present among PS1  and PS2 samples which were statistically computed using METASTATS (P value ≤ 0.05 and 1000 permutations), c) Depiction of genomic variation in pond sediment by principal  component analysis of tetranucleotide frequency of essential single copy genes  using R v. 3.2.2 via the ace function of ape.",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"The first step  was to annotate the six metagenomes (PS1, PS2, 1 Km, 5 Km, DS and SolexaDS) against nr -database  (ftp://ftp.ncbi.nlm.nih.gov/blast/db/nr, June, 2015).",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"Then the annotation was performed against the nr-database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/nr,  June, 2015) with the isolates (Table S4)  that were  obtained from the HCH contaminated site or the pond  sediment.",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
"The dominant bacterial phyla in pond sediment  were identified and these, along with other unknown phyla, were subjected to METASTATS  ( http://metastats.cbcb.umd.edu ) in order to  compute differential abundance.",OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/a8/77/jgenv05p0036.PMC5362764.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f7/79/jgenv05p0048.PMC5362765.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/f7/79/jgenv05p0048.PMC5362765.pdf
1 https://jgc-online.orgABSTRACT Gastric cancer (GC) has high mortality owing to its aggressive nature.,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
"2017 Mar;17(1):1-10 https://doi.org/10.5230/jgc.2017.17.e1 pISSN 2093-582X·eISSN 2093-5641 Review Article Received:  Jan 29, 2017 Revised:  Mar 3, 2017 Accepted:  Mar 3, 2017 Correspondence to Sandra F. Martins Life and Health Sciences Research Institute,  School of Health Sciences, University of Minho,  Campus de Gualtar, 4710-057 Braga, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
"Four articles were subsequently excluded  from this review: one was excluded because the subject of the study was neuroendocrine  carcinomas, and no GCs were examined; another paper was excluded because it was a letter  to the editor; another because the article was written in Romanian; and another was excluded  2 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis",Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
3 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
4 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis Table 1.,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
5 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
[ 30] concluded that serum ANGPTL2 was significantly higher  6 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
7 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
PUBMED  | CROSSREF 8 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
PUBMED  | CROSSREF 9 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
PUBMED  | CROSSREF 10 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e1Gastric Cancer and Angiogenesis,Non-OADS,/arxiv_data1/oa_pdf/62/ba/jgc-17-1.PMC5362829.pdf
11 https://jgc-online.orgABSTRACT Purpose:  Acupuncture has recently been accepted as a treatment option for managing  postoperative ileus (POI) and various functional gastrointestinal disorders.,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
"2017 Mar;17(1):11-20 https://doi.org/10.5230/jgc.2017.17.e2 pISSN 2093-582X·eISSN 2093-5641 Original Article Received:  Sep 2, 2016 Revised:  Sep 27, 2016 Accepted:  Oct 5, 2016 Correspondence to In Hwan Kim Department of Surgery, Catholic University of  Daegu School of Medicine, 33 Duryugongwon- ro 17-gil, Nam-gu, Daegu 42472, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
"Study design Patients potentially eligible for the study were informed by the principal investigator,  regarding the study details on the day before their scheduled surgery, and a standard  12 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus",Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
13 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
Two patients in each group were withdrawn due to discontinued intervention or  14 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus C D A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
15 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
Postoperative WBC counts increased gradually and were significantly lower on postoperative  16 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus Table 4.,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
17 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
18 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
PUBMED  | CROSSREF 19 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
PUBMED  | CROSSREF 20 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e2Effect of Acupuncture on Postoperative Ileus,Non-OADS,/arxiv_data1/oa_pdf/7d/38/jgc-17-11.PMC5362830.pdf
21 https://jgc-online.orgABSTRACT Purpose:  Perioperative chemotherapy improves survival outcomes in locally advanced (LA)  gastric cancer.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
"2017 Mar;17(1):21-32 https://doi.org/10.5230/jgc.2017.17.e3 pISSN 2093-582X·eISSN 2093-5641 Original Article Vikas Ostwal1, Arvind Sahu2, Anant Ramaswamy1, Bhawna Sirohi3,   Subhadeep Bose1, Vikas Talreja1, Mahesh Goel4, Shraddha Patkar4,   Ashwin Desouza4, Shailesh V. Shrikhande4 1Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India 2Department of Medicine, H.M. Patel Center for Medical Care and Education, Karamsad, Anand, Gujarat, India 3Department of Medical Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK 4Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, IndiaPerioperative Epirubicin, Oxaliplatin,  and Capecitabine Chemotherapy in  Locally Advanced Gastric Cancer:  Safety and Feasibility in an Interim  Survival Analysis Received:  Oct 12, 2016 Revised:  Dec 13, 2016 Accepted:  Dec 24, 2016 Correspondence to Vikas Ostwal Department of Medical Oncology, Tata  Memorial Hospital, Dr Ernest Borges Rd, Parel,  Mumbai, Maharashtra 400012, India.",Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
Eastern Cooperative Oncology Group performance status 0–2 22 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
23 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
The tumors in 22 of  24 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer Completed NACT (n=/two.LP/six.LP/zero.LP) Subtotal or total gastrectomy (n=/two.LP/zero.LP/zero.LP) Progression on NACT (n=/two.LP/nine.LP)  Refused surgery (n=/nine.LP)  Intraoperatively inoperable (n=/two.LP/two.LP) Palliative chemotherapy (n=/five.LP/one.LP) Best supportive care (n=/nine.LP) Adjuvant chemotherapy completed (n=/one.LP/seven.LP/eight.LP)On adjuvant chemotherapy (n=/one.LP/two.LP)Adjuvant chemotherapy stopped owing to toxicity (n=/four.LP)Death due to postoperative complications (n=/three.LP)Recurrence while on adjuvant chemotherapy (n=/three.LP) NACT stopped owing to toxicity (n=/eight.LP) Death due to NACT toxicity (n=/six.LP)Lost to follow-up (n=/two.LP) Locally advanced gastric cancer May /two.LP/zero.LP/one.LP/three.LP to December /two.LP/zero.LP/one.LP/five.LP (n=/two.LP/six.LP/eight.LP/parenright.cap NACT with the EOX regimen for /three.LP/endash.cap/four.LP cycles Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
One hundred seventy-eight patients  25 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer Table 2.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
Patients without features of gastric outlet obstruction at  26 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer Time (mo)0.6 0.4 0.2 0 10 20 30 40Cumulative survival0.81.0 Surgical status group No surgery Surgery No surgery-censored Surgery-censored Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
Doses were modified during adjuvant chemotherapy in 20 of the patients  27 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer Table 4.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
28 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer Time (mo)0.6 0.4 0.2 0 10 20 30 40Cumulative survival0.81.0 Pathological T stage /three.LP&/four.LP /one.LP&/two.LP /three.LP&/four.LP-censored /one.LP&/two.LP-censored Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
29 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
"The prognostic factors identified in our analysis (ypT and  ypN stage, delay in adjuvant chemotherapy, symptoms of obstruction) are hypothesis- 30 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer",Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
PUBMED  | CROSSREF 31 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
PUBMED  | CROSSREF 32 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e3Perioperative EOX in Locally Advanced Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/37/6b/jgc-17-21.PMC5362831.pdf
33 https://jgc-online.orgABSTRACT Purpose:  Endoscopic submucosal dissection (ESD) in early gastric cancer causes an artificial  gastric ulcer and local inflammation that has a negative intraprocedural impact on additional  laparoscopic gastrectomy in patients with noncurative ESD.,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
"2017 Mar;17(1):33-42 https://doi.org/10.5230/jgc.2017.17.e4 pISSN 2093-582X·eISSN 2093-5641 Original Article Received:  Oct 4, 2016 Revised:  Oct 30, 2016 Accepted:  Nov 10, 2016 Correspondence to Keun Won Ryu Gastric Cancer Branch, Division of  Translational & Clinical Research I, Research  Institute, National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 10408, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
The absolute  34 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
35 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
36 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
In the surgery-only  37 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
38 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD Table 4.,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
"Therefore, the most common  39 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD Table 5.",Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
40 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
PUBMED  | CROSSREF 41 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
PUBMED  | CROSSREF 42 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e4Laparoscopic Gastrectomy after ESD,Non-OADS,/arxiv_data1/oa_pdf/b4/ef/jgc-17-33.PMC5362832.pdf
"43 https://jgc-online.orgABSTRACT Purpose:  This study aimed to analyze G3BP1  and VEZT  expression profiles in patients with  gastric cancer, and examine the possible relationship between the expressions of each gene  and clinicopathological factors.",Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
"2017 Mar;17(1):43-51 https://doi.org/10.5230/jgc.2017.17.e5 pISSN 2093-582X·eISSN 2093-5641 Original Article Received:  Dec 1, 2016 Revised:  Mar 4, 2017 Accepted:  Mar 4, 2017 Correspondence to Elham Moslemi Department of Biology, East Tehran Branch,  Islamic Azad University, Qiam Dasht, Tehran,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
With the collaboration  44 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes,Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
"Furthermore,  45 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes Table 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
46 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes,Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
"Similarly, there was a significant  47 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes Derivative Reporter (−Rn) Derivative Reporter (−Rn) Derivative Reporter (−Rn) Temperature (°C) Temperature (°C) Temperature (°C)A B C 65.0 75.0 80.0 70.0 85.0 90.5 95.0 65.0 75.0 80.0 70.0 85.0 95.0 90.0 65.0 75.0 80.0 70.0 85.0 95.0 90.00.5 0 0 01.02.02.5 0.51.5 1.02.02.53.0 0.51.01.52.02.5 Fig.",OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
48 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes 00.20.40.6 IV III II IVEZT expression in TNM classiﬁcationMean RQ 00.40.61.0 0.20.8 IV III II IG3BP1 expression in TNM classiﬁcationMean RQ Fig.,OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
49 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes,Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
PUBMED  | CROSSREF 50 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes,Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
PUBMED  | CROSSREF 51 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e5VEZT  and G3BP1  Genes,Non-OADS,/arxiv_data1/oa_pdf/8b/be/jgc-17-43.PMC5362833.pdf
52 https://jgc-online.orgABSTRACT Purpose:  The Trastuzumab for gastric cancer (GC) trial identified human epidermal  growth factor receptor 2 (HER2) as a predictor of successful treatment with trastuzumab  (HER2 receptor targeting agent) among patients with advanced/metastatic GC.,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"2017 Mar;17(1):52-62 https://doi.org/10.5230/jgc.2017.17.e6 pISSN 2093-582X·eISSN 2093-5641 Original Article Kyung Won Seo1,*, Taeyong Jeon2, Sewon Kim3, Sung Soo Kim4, Kwanghee Kim5,  Byoung-Jo Suh6, Sunhwi Hwang7, SeongHee Choi8, Seungwan Ryu9, Jae Seok Min10,  Young-Joon Lee11, Ye Seob Jee12, Hyeondong Chae13, Doo Hyun Yang14,*, Sang Ho Lee1,*   1Department of Surgery, Kosin University College of Medicine, Busan, Korea   2Pusan National University Hospital, Busan, Korea   3Yeungnam University Medical Center, Daegu, Korea   4Chosun University Hospital, Gwangju, Korea   5Inje University Busan Paik Hospital, Busan, Korea   6Inje University Haeundae Paik Hospital, Busan, Korea   7Pusan National University Yangsan Hospital, Yangsan, Korea   8Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Changwon, Korea   9Keimyung University Dongsan Medical Center, Daegu, Korea 10Dongnam Institute of Radiological and Medical Sciences, Busan, Korea 11Gyeongsang National University Hospital, Jinju, Korea 12Dankook University Hospital, Cheonan, Korea 13Daegu Catholic University Medical Center, Daegu, Korea 14Chonbuk National University Medical School, Jeonju, KoreaEpidemiologic Study of Human  Epidermal Growth Factor Receptor 2  Expression in Advanced/Metastatic  Gastric Cancer: an Assessment of  Human Epidermal Growth Factor  Receptor 2 Status in Tumor Tissue  Samples of Gastric and Gastro- Esophageal Junction Cancer Received:  Nov 22, 2016 Revised:  Dec 29, 2016 Accepted:  Jan 9, 2017 Correspondence to Sang Ho Lee Department of Surgery, Kosin University  College of Medicine, 262 Gamcheon-ro,   Seo-gu, Busan 49267, Korea.",Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
53 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"SISH Three central laboratories performed automated SISH analyses using the PathVysion HER2  DNA Probe Kit (Abbott/Vysis, Des Plaines, IL, USA) and Ventana INFORM HER2 DNA dual- 54 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients Eligible for trastuzumab Patient tumor sample IHC /zero.LP  /one.LP/plus.cap  /two.LP/plus.cap  /three.LP/plus.cap FISH/SISH /plus.cap  /minus.cap Fig.",OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"This sample size was expected  55 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients HER/two.LP-positive (n=/one.LP/eight.LP/two.LP) HER/two.LP-negative (n=/one.LP,/five.LP/zero.LP/five.LP) Not evaluable (n=/two.LP) No.",Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"Furthermore,  198 of 1,689 samples were subjected to IHC re-testing, one sample was withdrawn, and 64  56 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients Table 1.",Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"Among 768 samples  diagnosed as tumor stage 3, T4N3M0 was most prevalent (264 samples, 34.4%), followed by  57 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients Table 2.",Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
"First, inter-study variability can largely be attributed  58 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients",Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
59 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
60 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
PUBMED 61 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
PUBMED  | CROSSREF 62 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e6HER2 Status in Korean Advanced Gastric Cancer Patients,Non-OADS,/arxiv_data1/oa_pdf/93/78/jgc-17-52.PMC5362834.pdf
63 https://jgc-online.orgABSTRACT Purpose: Data on operable gastric cancer from India is sparse.,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
"2017 Mar;17(1):63-73 https://doi.org/10.5230/jgc.2017.17.e7pISSN 2093-582X·eISSN 2093-5641 Original Article Received:  Nov 28, 2016 Revised: Feb 9, 2017 Accepted: Feb 20, 2017 Correspondence to Joshua FranklynUpper GI Surgery Unit, Department of General Surgery, Unit 3, Christian Medical College, Paul Brand building, Vellore, Tamil Nadu 632004, India.Tel: +91-948-634-2627Fax: +91-416-223-2035E-mail: Joshua_franklyn@yahoo.com Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
64 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
"Surgical details such as the extent of lymphadenectomy, R0/R1/R2 resection, multi-organ  resection, the length of hospital stays, the details of postoperative complications, early post- 65 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital Table 1.",Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
"However, for the multi-variable analysis, only stage of the tumor (P=0.049)  66 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital Table 2.",Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
Most information  67 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital Table 3.,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
"68 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital A Time (mo)0.6 0.4 0.2 0DFS0.81.0B Time (mo)0.6 0.4 0.2 0OS0.81.0 TNM staging Stage I(IA, IB) Stage IIA Stage IIBStage IIIA Stage IIIB Stage IIICStage I(IA, IB)-censored Stage IIA-censored Stage IIB-censoredStage IIIA-censored Stage IIIB-censored Stage IIIC-censored12 24 36 48 60 72 84 96 108 120 132 144 12 24 36 48 60 72 84 96 108 120 132 144 Fig.",Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
69 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital Table 4.,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
70 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital Table 6.,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
71 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
PUBMED | CROSSREF 72 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
Available from: http://www.cancer.org/cancer/ stomachcancer/detailedguide/stomach-cancer-key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
PUBMED | CROSSREF 73 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e7Surgical Outcomes in Indian Hospital,Non-OADS,/arxiv_data1/oa_pdf/6b/0a/jgc-17-63.PMC5362835.pdf
"74 https://jgc-online.orgABSTRACT Purpose:  Neoadjuvant chemotherapy has been shown to improve survival in locally advanced  gastric cancer, but it is associated with significant toxicity.",Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
"2017 Mar;17(1):74-87 https://doi.org/10.5230/jgc.2017.17.e8 pISSN 2093-582X·eISSN 2093-5641 Original Article Received:  Jan 29, 2017 Revised:  Mar 3, 2017 Accepted:  Mar 3, 2017  Correspondence to Carolina Palmela Division of Gastroenterology, Surgical  Department, Hospital Beatriz Ângelo, Avenida  Carlos Teixeira, nº3, Loures 2674-514, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
"Locally advanced gastric/GEJ  cancer was defined as tumor stage greater than cT2 or positive locoregional lymph nodes  (cN+), according to the tumor, node, and metastasis (TNM) staging classification (American  75 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer",Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
Mean muscle radiation attenuation (MA) was calculated for muscle area and was also  76 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Fig.,OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
Body composition data at diagnosis are shown  77 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
"However, patients with sarcopenic obesity showed reduced survival  78 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Table 1.",Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
79 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Table 2.,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
"In our population, a quarter of  80 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Table 3.",Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
81 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer A Time (mo)0.6 0.4 0.2 0 10 20 30 40 50Cumulative survival0.81.0 10 20 30 40 50B Time (mo)0.6 0.4 0.2 0Cumulative survival0.81.0 P=/zero.LP./zero.LP/zero.LP/zero.LP P=/zero.LP./four.LP/one.LP/four.LPSarcopenia Yes No Yes-censoredNo-censoredSarcopenia obesity YesNo Yes-censored No-censored Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
82 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Table 4.,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
83 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer Table 5.,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
84 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
PUBMED 85 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
PUBMED  | CROSSREF 86 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
PUBMED 87 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e8Body Composition in Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/fa/87/jgc-17-74.PMC5362836.pdf
88 https://jgc-online.orgABSTRACT Early detection and treatment decrease the mortality rate associated with gastric cancer (GC).,Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
"2017 Mar;17(1):88-92 https://doi.org/10.5230/jgc.2017.17.e9 pISSN 2093-582X·eISSN 2093-5641 Case Report Received:  Sep 19, 2016 Revised:  Nov 2, 2016 Accepted:  Nov 10, 2016 Correspondence to Naomi Kakushima Division of Endoscopy, Shizuoka Cancer  Center, 1007 Shimonagakubo, Nagaizumi,  Suntogun, Shizuoka 411-8777, Japan.",Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
"Six months later, the patient  89 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e9Natural History of Early Gastric Cancer A B C July /two.LP/zero.LP/zero.LP/seven.LP July /two.LP/zero.LP/zero.LP/seven.LP April /two.LP/zero.LP/one.LP/zero.LP D E F G May /two.LP/zero.LP/one.LP/one.LP May /two.LP/zero.LP/one.LP/two.LP November /two.LP/zero.LP/one.LP/two.LP May /two.LP/zero.LP/one.LP/three.LP Fig.",Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
The outcome may  90 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e9Natural History of Early Gastric Cancer A B C D/two.LP/zero.LP/zero.LP/seven.LP /two.LP/zero.LP/zero.LP/seven.LP /two.LP/zero.LP/zero.LP/nine.LP /two.LP/zero.LP/zero.LP/nine.LP Fig.,Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
91 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e9Natural History of Early Gastric Cancer Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
PUBMED  | CROSSREF 92 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e9Natural History of Early Gastric Cancer,Non-OADS,/arxiv_data1/oa_pdf/f2/0f/jgc-17-88.PMC5362837.pdf
"93 https://jgc-online.orgABSTRACT An 84-year-old man was diagnosed with two synchronous adenocarcinomas, a Borrmann  type IV advanced gastric adenocarcinoma in his antrum and a well-differentiated Borrmann type I carcinoma on the anterior wall of the higher body of his stomach.",Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
"2017 Mar;17(1):93-97 https://doi.org/10.5230/jgc.2017.17.e10pISSN 2093-582X·eISSN 2093-5641 Case Report Received:  Oct 10, 2016 Revised: Nov 14, 2016 Accepted: Nov 22, 2016 Correspondence to Sang-Ho JeongDepartment of Surgery, Gyeongsang National University Changwon Hospital, 11 Samjeongja-ro, Seongsan-gu, Changwon 51472, Korea.Tel: +82-55-214-3771Fax: +82-55-214-3251E-mail: jshgnu@gmail.com Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
94 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e10AGC with Para-Aortic Prostate Cancer Meta A B C D Fig.,Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
"However, he refused a  95 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e10AGC with Para-Aortic Prostate Cancer Meta A BB C D E/one.LP/zero.LP/zero.LP µm /one.LP/zero.LP/zero.LP µm C Fig.",Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
The pathologist  96 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e10AGC with Para-Aortic Prostate Cancer Meta,Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
PUBMED | CROSSREF 97 https://jgc-online.org https://doi.org/10.5230/jgc.2017.17.e10AGC with Para-Aortic Prostate Cancer Meta,Non-OADS,/arxiv_data1/oa_pdf/6e/f5/jgc-17-93.PMC5362838.pdf
"http://www.capcvet.org/ capc-recommendations/lungworms (2007, accessed 4 May  2016).",Non-OADS,/arxiv_data1/oa_pdf/38/44/10.1177_2055116916675801.PMC5362839.pdf
"https://doi.org/10.1177/2055116917691175 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917691175 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed  by the European Editorial Office (ISFM) for  publication in JFMS Open Reports Introduction Proliferative and necrotising otitis externa (PNOE) has  been described as a condition affecting kittens,1 although  Mauldin et al documented the condition in four cats ranging in age from 6 months to 5 years.",Non-OADS,/arxiv_data1/oa_pdf/b0/55/10.1177_2055116917691175.PMC5362840.pdf
"http://www.wsava.org/sites/default/files/Body%20 condition%20score%20chart%20cats.pdf (2013, accessed  August 2, 2015).",Non-OADS,/arxiv_data1/oa_pdf/10/dd/10.1177_2055116916630002.PMC5362848.pdf
"https://doi.org/10.1177/2055116917691403 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1  © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917691403 journals.sagepub.com/home/jfmsopenreports JFMS Open Reports reviewers in 2016 Carl Adagra, Australia Elena Addison, UKNuno Alexandre, Portugal Barbara Ambros, Canada Randolph Baral, AustraliaEsther Barrett, UKVanessa Barrs, Australia Joe Bartges, USA Julia Beatty, AustraliaDavid Bennett, UKMatthew Best, Australia Nicholas Bexfield, UK Laura Blackwood, UKDanielle Bowles, AustraliaDwight Bowman, USA David Bruyette, USA Marie Cadiergues, FranceL Miguel Carreira, PortugalSheila Carrera-Justiz, USADomingo Casamian, UK Ke Chow, Australia Louise Clark, UKRoger Clemmons, USALeah Cohn, USA Katia Corgozinho, BrazilSandra Corr, UK P Cynda Crawford, USASmita Das, UK Gigi Davidson, USA Augusto de Matos, PortugalSimon Dennis, USAFabienne Dethioux, France Jennifer Devey, Canada Robin Downing, USAMark Dunning, UKSue Duran, USA Amara Estrada, USA Janean Fidel, USAAiden Foster, UKJonathan Foster, USA Sue Foster, Australia Valerie Freiche, FranceBarbara Gallagher, IrelandLaurent Garosi, UKFernanda Gonsales, Brazil Danielle Gunn-Moore, UK Greg Harasen, CanadaRoss Harley, UKChristine Heinrich, UK Paul Higgs, UKXander Huizing, The  Netherlands Matthew Kornya, CanadaMerja Laitinen, Finland Stephanie Lalor, UKSorrel Langley-Hobbs, UKCathy Langston, USA Sally Lester, USA Annette Litster, USAAlbert Lloret, SpainRemo Lobetti, South Africa Amy MacKay, USA David Maggs, USARichard Malik, AustraliaFrancesca Mancianti, Italy Marian Matas Riera, UK Glenna Mauldin, CanadaShannon McLeland, USAKaren Moriello, USARalf Mueller, Germany Richard Nelson, USA Shila Nordone, USAJacqueline Norris,   Australia Mark Papich, USAPeter Pascoe, USAAlessandro Poli, ItalyBarrak Pressler, USA Martí Pumarola, Spain Rosama Pusoonthornthum,  Thailand Jessica Quimby, USA Nicola Reed, UK Carol Reinero, USAElise Robertson, UKSheila Robertson, USA Ken Smith, UK Valeria Sousa, BrazilTim Spotswood, CanadaKelly St Denis, Canada Ann Strom, USA Donato Traversa, ItalyLauren Trepanier, USAAndrew Vince, CanadaKaren Walsh, UK Robert Washabau, USA Scott Weese, CanadaKerstin Wildermuth,  Germany Mike Willard, USA Thank you to our reviewers The Editors – Andy and Margie – and the JFMS Open Reports editorial team (Margaret and Abi) would like to extend  their sincere thanks to all of the following people who have been so helpful in reviewing papers for JFMS Open  Reports in 2016.",Non-OADS,/arxiv_data1/oa_pdf/88/1f/10.1177_2055116917691403.PMC5362852.pdf
"The two-sample z-test was used to compare FIV sero-prevalence between ‘healthy’ and ‘sick’ cats in cohort 2, using an online calculator (http://epitools.ausvet.com.",Non-OADS,/arxiv_data1/oa_pdf/77/a3/10.1177_2055116916646388.PMC5362860.pdf
"http://www.pathology outlines.com/topic/softtissuefibromatosisdeep.html (2015,  accessed 26 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/23/53/10.1177_2055116915626166.PMC5362861.pdf
The molecular identity of the isolate was determined  by PCR and comparative gene sequence analysis of the 16S recombinant DNA (rDNA) region (primers BF – 5′ AGAGTTGGATCCTGGCTCAG 3′ and R2 – 5′ CCTAGAGCTCTTTACG 3′) and Basic Local Alignment  Search Tool (BLAST) search (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/bf/0d/10.1177_2055116915589836.PMC5362864.pdf
"https://doi.org/10.1177/2055116917695053 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1 –6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917695053 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed  by the American Editorial Office (AAFP) for  publication in JFMS Open Reports Introduction Radiographic and histologic evidence of medial humeral  epicondylitis (MHE) has been reported in up to 10% of cats, based on post-mortem examination.",Non-OADS,/arxiv_data1/oa_pdf/ad/da/10.1177_2055116917695053.PMC5362866.pdf
"Picking just one exam- ple of each indicates the breadth of scope and the truly  international nature of the journal: ••First report of Cylicospirura felineus in a feral domestic  shorthair cat in North America (Crossland NA, et al, case  report, published July 1 2015, Baton Rouge, LA, USA) ••A survey of feline leukaemia virus antigenaemia among cats in eastern Austria: a retrospective   analysis of serum samples routinely tested between 1996 and 2011 (Firth CL, et al, case series, published July 29 2015, University of Vienna, Austria) ••Effect of age and surgical approach on perioperative wound complication following ovariohysterectomy  in shelter-housed cats in Australia (Roberts ML, et al,  short communication, published October 29 2015, University of Sydney, Australia) All clinical reports in JFMS Open Reports are freely acces- sible to any reader and are published under liberal creative  commons licences (https://uk.sagepub.com/en-gb/eur/re- use-of-open-access-content).",Non-OADS,/arxiv_data1/oa_pdf/5c/c5/10.1177_2055116915627096.PMC5362869.pdf
"Compensation in patients with NSHP is typically adequate for the maintenance of  blood calcium and phosphorus levels within reference Table 2 Analysis of the kitten’s past diet Nutrient content NRC recommended allowance for kitten growth1 Raw chicken* Protein 5.6 g/100 kcal ME 18.62 g/100 kcal ME Fat 2.25 g/100 kcal ME 2.27 g/100 kcal ME Carbohydrate (NFE) N/A 0 g/100 kcal ME Crude fiber N/A 0 g/100 kcal ME Calcium 200 mg/100 kcal ME 4.39 mg/100 kcal ME Phosphorus 180 mg/100 kcal ME 184.21 mg/100 kcal ME Sodium 35 mg/100 kcal ME 101.75 mg/100 kcal ME Potassium 100 mg/100 kcal ME 324.56 mg/100 kcal ME Magnesium 10 mg/100 kcal ME 22.81 mg/100 kcal ME Taurine 10 mg/100 kcal ME 13.96 mg/100 kcal ME Vitamin D 5.6 IU cholecalciferol/100 kcal ME 4.38 IU/100 kcal ME Vitamin C N/A 1.05 mg/100 kcal ME Copper 0.21 mg/100 kcal ME NR Zinc 1.85 mg/100 kcal ME 0.51 mg/100 kcal ME EPA + DHA 2.5 mg/100 kcal ME NR *Raw chicken: from Spitze et al (taurine content, using average content, converted to caloric content basis)2 and the US Department of  Agriculture’s Food Composition Database (http://www.nal.usda.gov/fnic/foodcomp/search/) searched for ‘chicken, broilers or fryers, breast,  meat only, raw’, accessed 28 July 2013, and converted to caloric content basis (all other nutrients)   NRC = National Research Council; NFE = nitrogen-free extract; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid;  ME = metabolizable energy; N/A = not applicable; NR = not reported",Non-OADS,/arxiv_data1/oa_pdf/bb/c9/10.1177_2055116915579682.PMC5362880.pdf
"According to the USDA’s National Nutrient  Database (http://www.nal.usda.gov/fnic/foodcomp/search/ searched for ‘chicken, broilers or fryers, breast, meat only, raw’ on 28 July 2013), 100 g raw chicken breast  contains 5 mg calcium and 210 mg phosphorus, making  the Ca:P ratio 0.024:1.",Non-OADS,/arxiv_data1/oa_pdf/bb/c9/10.1177_2055116915579682.PMC5362880.pdf
"How to deter-mine a cat’s or dog’s age, http://www.ruralareavet.org/PDF/Physical_Exam-How_to_Determine_Age.pdf (1996,  accessed March 1st 2016).",Non-OADS,/arxiv_data1/oa_pdf/bf/b7/10.1177_2055116916655174.PMC5362915.pdf
"https://doi.org/10.1177/2055116917693491 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons   Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial  use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Feline Medicine and Surgery Open  Reports  1 –5 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2055116917693491 journals.sagepub.com/home/jfmsopenreports This paper was handled and processed  by the European Editorial Office (ISFM) for  publication in JFMS Open Reports Introduction Primary renal tumours are uncommon and make up  about 1.5–2.5% of all feline neoplasms.1 In 1999,  Henry et al reported 19 primary feline renal tumours  that consisted of tubulopapillary or tubular carci- noma (n =  13), transitional cell carcinoma (n =  3),  adenoma (n =  1), haemangiosarcoma (n =  1) and  nephroblastoma (n =  1).2 Feline renal leiomyosar - coma, squamous cell carcinoma and sarcomatoid  renal cell carcinoma have also been sporadically  reported.3–5 However, feline renal oncocytoma has not  yet been reported.",Non-OADS,/arxiv_data1/oa_pdf/1a/8e/10.1177_2055116917693491.PMC5362917.pdf
"[http://dx.doi.org/10.1054/bjom.2000.0500 ] [PMID: 11010781 ] [2] Martin B, Ghosh A.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
[http://dx.doi.org/10.1136/emj.20.1.66-a ] [PMID: 12533379 ],Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"Available  at: http://news.nationalgeographic.com/news/2014/05/140501-superbugs-antibiotics-resistance-disease-medicine/?sf2792698=1 [4] Westfall CT, Shore JW.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.1055/s-0034-1378187 ] [PMID: 25709755 ] [7] Beigi B, Khandwala M, Gupta D. Management of pure orbital floor fractures: a proposed protocol to prevent unnecessary or early surgery.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.3109/01676830.2014.902475 ] [PMID: 24987818 ] [8] Yadav K, Cowan E, Wall S, Gennis P. Orbital fracture clinical decision rule development: burden of disease and use of a mandatory electronic survey instrument.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.1111/j.1553-2712.2011.01017.x ] [PMID: 21352401 ] [9] Ben Simon GJ, Bush S, Selva D, McNab AA.",OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2005.06.012 ] [PMID: 16157384 ] [10] Silver HS, Fucci MJ, Flanagan JC, Lowry LD.",OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.1001/archotol.1992.01880080067015 ] [PMID: 1642837 ] [11] Dhariwal DK, Kittur MA, Farrier JN, Sugar AW, Aird DW, Laws DE.",OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"[http://dx.doi.org/10.1016/S0266-4356(02)00259-0 ] [PMID: 12576036 ] [12] Citrome L, Ketter TA.",OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
[http://dx.doi.org/10.1111/ijcp.12142 ] [PMID: 23574101 ] © Reiss et al.,OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/TOOPHTJ-11-11.PMC5362967.pdf
[http://dx.doi.org/10.1016/0022-3913(87)90065-5 ] [PMID: 3305906 ],OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0022-3913(89)90014-0 ] [PMID: 2657009 ] [3] Vergani CE, Giampaolo ET, Cucci AL.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0022-3913(97)70193-8 ] [PMID: 9069091 ] [4] Yanikoglu DN, Duymus DZ, Bayindir DF.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1111/j.1875-595X.2002.tb00592.x ] [PMID: 11931217 ] [5] Kawara M, Carter JM, Ogle RE, Johnson RR.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
[http://dx.doi.org/10.1016/0022-3913(91)90525-2 ] [PMID: 1791572 ] [6] Cunningham JL.,OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0300-5712(93)90106-Z ] [PMID: 8227688 ] [7] Stameisen AE, Ruffino A.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0022-3913(87)80155-5 ] [PMID: 3302215 ] [8] Turner CW, Meiers JC.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0022-3913(87)90318-0 ] [PMID: 3553559 ] [13] Johnson T, Wood DJ.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0022-3913(99)70056-9 ] [PMID: 10559729 ] [17] Vergani CE, Machado AL, Giampaolo ET, Pavarina AC.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0109-5641(92)90020-D ] [PMID: 1303383 ] [19] Caswell CW, Norling BK.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0022-3913(86)90447-6 ] [PMID: 3522865 ] [20] Chatterjee N, Gupta TK, Banerjee A.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1007/s13191-011-0053-1 ] [PMID: 22379301 ] [21] Suzuki S, Sakoh M, Shiba A. Adhesive bonding of denture base resins to plastic denture teeth.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1002/jbm.820240811 ] [PMID: 2203795 ] [22] Clancy JM, Hawkins LF, Keller JC, Boyer DB.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/0022-3913(91)90182-V ] [PMID: 2051372 ] [23] Hayakawa I, Hirano S, Nagao M, Matsumoto T, Masuhara E. Adhesion of a new light-polymerized denture base resin to resin teeth and denture base materials.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"64   The Open Dentistry Journal, 2017, Volume 11 Saja Ali Muhsin [http://dx.doi.org/10.1016/0022-3913(93)90075-Y ] [PMID: 8254541 ] [25] Chung RW, Clark RK, Darvell BW.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.1995.tb04804.x ] [PMID: 7575280 ] [26] Lastumäki TM, Kallio TT, Vallittu PK.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0142-9612(02)00197-7 ] [PMID: 12322973 ] [27] Rupp N, Bowen R, Paffenbarger G. Bonding cold-curing denture base acrylic resin to acrylic resin teeth.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.14219/jada.archive.1971.0355 ] [PMID: 4397863 ] [28] Shen C, Colaizzi FA, Birns B.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0022-3913(84)80016-5 ] [PMID: 6392516 ] [29] Vallittu PK, Ruyter IE, Nat R. The swelling phenomenon of acrylic resin polymer teeth at the interface with denture base polymers.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1016/S0022-3913(97)70125-2 ] [PMID: 9260138 ] [30] Guzman A, Moore BK.",OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[PMID: 8941837 ] © Saja Ali Muhsin; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/50/TODENTJ-11-57.PMC5362969.pdf
"[http://dx.doi.org/10.1083/jcb.201208152 ] [PMID: 23185029 ] [2] Xu M, Motabar O, Ferrer M, Marugan JJ, Zheng W, Ottinger EA.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1111/nyas.13052 ] [PMID: 27144735 ] [3] Vanier MT.,OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1186/1750-1172-5-16 ] [PMID: 20525256 ] [4] Toscano A, Schoser B.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/s00415-012-6636-x ] [PMID: 22926164 ] [5] Meikle PJ, Hopwood JJ, Clague AE, Carey WF.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1001/jama.281.3.249 ] [PMID: 9918480 ] [6] Brady RO.,OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1074/jbc.X110.197954 ] [PMID: 21030589 ] [7] Pastores  GM.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.2174/157488906775245282 ] [PMID: 18221193 ] [8] Abramov A, Schorr S, Wolman M. Generalized xanthomatosis with calcified adrenals.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1136/adc.45.243.664 ] [PMID: 5477680 ] [10] Maehira F, Nakada F, Hokama T. Characteristics of acid esterase in Wolmans disease.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1016/0006-2944(84)90037-1 ] [PMID: 6517876 ] [11] Porto AF.,OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1177/000992289503400406 ] [PMID: 7789014 ] [13] Wolman Disease.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1089/gtmb.2010.0203 ] [PMID: 21291321 ] [15] Muntoni S, Wiebusch H, Jansen-Rust M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1161/ATVBAHA.107.146639 ] [PMID: 17634524 ] [16] Bernstein DL, Hülkova H, Bialer MG, Desnick RJ.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.jhep.2013.02.014 ] [PMID: 23485521 ] [17] Burton BK, Deegan PB, Enns GM, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/MPG.0000000000000935 ] [PMID: 26252914 ] [18] Coates PM, Cortner JA, Mennuti MT, Wheeler JE.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/ajmg.1320020409 ] [PMID: 122435 ] [19] Patrick AD, Willcox P, Stephens R, Kenyon VG.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1136/jmg.13.1.49 ] [PMID: 1271426 ],OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.cradex.2004.05.002 ] [23] Sadhukhan M, Saha A, Vara R, Bhaduri B.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1136/bcr-2013-202652 ] [PMID: 24832708 ] [24] Shenoy P, Karegowda L, Sripathi S, Mohammed N. Wolman disease in an infant.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1148/104.2.357 ] [PMID: 5044990 ] [26] Schaub J, Janka GE, Christomanou H, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/BF00445892 ] [PMID: 7449788 ] [27] Hill SC, Hoeg JM, Dwyer AJ, Vucich JJ, Doppman JL.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/00004728-198310000-00011 ] [PMID: 6886132 ] [28] Du H, Schiavi S, Levine M, Mishra J, Heur M, Grabowski GA.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1093/hmg/10.16.1639 ] [PMID: 11487567 ] [29] Lake BD, Patrick AD.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0022-3476(70)80172-X ] [PMID: 5410174 ] [30] Boldrini R, Devito R, Biselli R, Filocamo M, Bosman C. Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.prp.2003.11.001 ] [PMID: 15200275 ] [31] Wolman M, Sterk VV, Gatt S, Frenkel M. Primary familial xanthomatosis with involvement and calcification of the adrenals.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1111/j.1399-0004.1992.tb03125.x ] [PMID: 1516222 ] [33] Kikuchi M, Igarashi K, Noro T, Igarashi Y, Hirooka M, Tada K. Evaluation of jejunal function in Wolmans disease.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/00005176-199101000-00014 ] [PMID: 2061782 ] [34] Grabowski G, Du H, Charnas L. Lysosomal acid lipase deficiencies: the wolman disease/cholesteryl ester storage disease spectrum the online metabolic & molecular bases of inherited disease.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/s10620-008-0310-2 ] [PMID: 18478331 ] [36] Hůlková H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1111/j.1365-2559.2011.04164.x ] [PMID: 22621222 ] [37] Kwiterovich PO Jr.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0002-9149(00)01461-2 ] [PMID: 11374859 ] [38] Drebber U, Andersen M, Kasper HU, Lohse P, Stolte M, Dienes HP.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.3748/wjg.v11.i15.2364 ] [PMID: 15818756 ] [39] Groener JE, Bax W, Stuani C, Pagani F. Difference in substrate specificity between human and mouse lysosomal acid lipase: low affinity for cholesteryl ester in mouse lysosomal acid lipase.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S1388-1981(00)00091-3 ] [PMID: 11018468 ] [40] Beaudet AL, Ferry GD, Nichols BL Jr, Rosenberg HS.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1016/S0022-3476(77)80557-X ] [PMID: 859064 ],OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.cca.2012.03.019 ] [PMID: 22483793 ] [43] Dairaku T, Iwamoto T, Nishimura M, Endo M, Ohashi T, Eto Y.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.ymgme.2013.11.003 ] [PMID: 24295952 ] [44] Christomanou H, Cáp C. Prenatal monitoring for Wolmans disease in a pregnancy at risk: first case in the Federal Republic of Germany.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/BF00281702 ] [PMID: 7286988 ] [45] Desai PK, Astrin KH, Thung SN, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/ajmg.1320260324 ] [PMID: 3565483 ] [46] Anderson RA, Bryson GM, Parks JS.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1006/mgme.1999.2904 ] [PMID: 10562460 ] [47] Scott SA, Liu B, Nazarenko I, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/hep.26327 ] [PMID: 23424026 ] [48] Lohse  P,  Chahrokh-Zadeh  S,  Lohse  P,  Seidel  D.  Human  lysosomal  acid  lipase/cholesteryl  ester  hydrolase  and  human  gastric  lipase: identification of the catalytically active serine, aspartic acid, and histidine residues.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1194/jlr.R016675 ] [PMID: 21976778 ] [51] Salvayre R, Negre A, Maret A, Radom J, Douste-Blazy L. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolmans disease.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1111/j.1432-1033.1987.tb13721.x ] [PMID: 3691534 ] [52] Reiner Ž, Guardamagna O, Nair D, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.atherosclerosis.2014.04.003 ] [PMID: 24792990 ] [53] Zschenker O, Jung N, Rethmeier J, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1006/geno.1996.0162 ] [PMID: 8617513 ] [55] Pagani F, Pariyarath R, Garcia R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1172/JCI116888 ] [PMID: 8254026 ] [57] Ameis D, Brockmann G, Knoblich R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1074/jbc.274.24.16995 ] [PMID: 10358049 ] [59] Pagani F, Garcia R, Pariyarath R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1093/hmg/5.10.1611 ] [PMID: 8894696 ] [60] Eto Y, Kitagawa T. Wolmans disease with hypolipoproteinemia and acanthocytosis: clinical and biochemical observations.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0022-3476(70)80248-7 ] [PMID: 5504079 ] [61] Rao RH, Mansbach CM II.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/0005-2760(90)90027-U ] [PMID: 2322572 ] [62] Meyers W, Hoeg J, Demosky S, Herbst J, Brewer H. The use of parenteral hyperalimentation and elemental formula feeding in the treatment of wolman disease.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0271-5317(85)80226-8 ] [63] Assmann G, Fredrickson DS, Sloan HR, Fales HM, Highet RJ.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1042/bj3010267 ] [PMID: 8037680 ] [65] Nègre-Salvayre A, Salvayre R. UV-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/0005-2760(92)90113-A ] [PMID: 1739749 ] [66] Marshall WC, Ockenden BG, Fosbrooke AS, Cumings JN.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1136/adc.44.235.331 ] [PMID: 5785183 ] [67] Lowden JA, Barson AJ, Wentworth P. Wolmans disease: a microscopic and biochemical study showing accumulation of ceroid and esterified cholesterol.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/BF00691802 ] [PMID: 216225 ] [70] Kamoshita S, Landing BH.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1093/ajcp/49.3.312 ] [PMID: 5645093 ] [71] Stein  J,  Garty  BZ,  Dror  Y,  Fenig  E,  Zeigler  M,  Yaniv  I.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/s00431-006-0298-6 ] [PMID: 17033804 ] [72] Osellame LD, Duchen MR. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1111/bph.12453 ] [PMID: 24116849 ] [73] Guazzi GC, Martin JJ, Philippart M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1159/000113673 ] [PMID: 5711398 ] [74] Gasche C, Aslanidis C, Kain R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0168-8278(97)80092-X ] [PMID: 9365051 ] [75] Bindu PS, Taly AB, Christopher R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1177/0883073807307104 ] [PMID: 18174560 ] [76] Tolar J, Petryk A, Khan K, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/bmt.2008.273 ] [PMID: 18776925 ] [77] Krivit W, Peters C, Dusenbery K, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/sj.bmt.1702557 ] [PMID: 11019848 ] [78] Yanir A, Allatif MA, Weintraub M, Stepensky P. Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.ymgme.2013.03.007 ] [PMID: 23583223 ] [79] Gramatges  MM,  Dvorak  CC,  Regula  DP,  Enns  GM,  Weinberg  K,  Agarwal  R.  Pathological  evidence  of  Wolmans  disease  following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1038/bmt.2009.57 ] [PMID: 19308038 ],Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1111/j.1600-0676.1994.tb00002.x ] [PMID: 8177025 ] [81] Krivit W, Freese D, Chan KW, Kulkarni R. Wolmans disease: a review of treatment with bone marrow transplantation and considerations for the future.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/00004836-199108000-00028 ] [PMID: 1918862 ] [83] Ferry GD, Whisennand HH, Finegold MJ, Alpert E, Glombicki A. Liver transplantation for cholesteryl ester storage disease.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/00005176-199104000-00016 ] [PMID: 2072231 ] [84] Kale AS, Ferry GD, Hawkins EP.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/00005176-199501000-00016 ] [PMID: 7884624 ] [85] Barton NW, Brady RO, Dambrosia JM, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1056/NEJM199105233242104 ] [PMID: 2023606 ] [86] Braulke T, Bonifacino J.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1016/j.bbamcr.2008.10.016 ] [87] Lachmann RH.,OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1097/MOP.0b013e32834c20d9 ] [PMID: 21946346 ] [88] Poznansky MJ, Hutchison SK, Davis PJ.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1016/S0140-6736(96)04451-0 ] [PMID: 8950883 ] [91] FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1056/NEJMoa1501365 ] [PMID: 26352813 ] [93] Valyannopoulos V, Plantaz D, Vara R, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.ymgme.2013.12.268 ] [94] Maron DJ, Fazio S, Linton MF.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1161/01.CIR.101.2.207 ] [PMID: 10637210 ] [95] Ginsberg HN, Le NA, Short MP, Ramakrishnan R, Desnick RJ.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1172/JCI113259 ] [PMID: 3680522 ] [96] Dalgiç B, Sari S, Gündüz M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/S0022-3476(05)81866-9 ] [PMID: 1986080 ] [98] Glueck CJ, Lichtenstein P, Tracy T, Speirs J.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1203/00006450-199211000-00015 ] [PMID: 1480458 ] [99] Di Bisceglie AM, Ishak KG, Rabin L, Hoeg JM.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1002/hep.1840110509 ] [PMID: 2347551 ],Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1186/1476-511X-4-26 ] [PMID: 16255772 ] [101] Yokoyama  S,  McCoy  E.  Long-term  treatment  of  a  homozygous  cholesteryl  ester  storage  disease  with  combined  cholestyramine  and lovastatin.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/BF01799650 ] [PMID: 1528002 ] [102] Levy R, Ostlund RE Jr, Schonfeld G, Wong P, Semenkovich CF.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1177/000456329703400418 ] [PMID: 9247680 ] [104] Macarron R, Banks MN, Bojanic D, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/nrd3368 ] [PMID: 21358738 ] [105] Huang H-P, Chuang C-Y, Kuo H-C.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1186/scrt125 ] [PMID: 22925465 ] [106] Xu M, Liu K, Swaroop M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1177/1087057113501197 ] [PMID: 23983233 ] [107] Xu M, Liu K, Swaroop M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1074/jbc.M112.357707 ] [PMID: 23035117 ] [108] Du H, Duanmu M, Witte D, Grabowski GA.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1093/hmg/7.9.1347 ] [PMID: 9700186 ] [109] Lemonnier T, Blanchard S, Toli D, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1093/hmg/ddr285 ] [PMID: 21685203 ] [110] Zhang J, Lian Q, Zhu G, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.stem.2010.12.002 ] [PMID: 21185252 ] [111] Yu D, Swaroop M, Wang M, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1177/1087057114537378 ] [PMID: 24907126 ] [112] Kuriyama M, Yoshida H, Suzuki M, Fujiyama J, Igata A. Lysosomal acid lipase deficiency in rats: lipid analyses and lipase activities in liver and spleen.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.cell.2006.07.024 ] [PMID: 16904174 ] [114] Dimos JT, Rodolfa KT, Niakan KK, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1126/science.1158799 ] [PMID: 18669821 ] [115] Spence J, Mayhew C, Rankin S, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/nature09691 ] [116] Chen Y-F, Tseng C-Y, Wang H-W, Kuo H-C, Yang VW, Lee OK.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/hep.24790 ] [PMID: 22095466 ] [117] Meng X-L, Shen J-S, Kawagoe S, Ohashi T, Brady RO, Eto Y.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1093/hmg/ddr424 ] [PMID: 21926084 ],Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.stemcr.2014.03.014 ] [PMID: 24936472 ] [120] Swaroop M, Thorne N, Rao MS, Austin CP, McKew JC, Zheng W. Evaluation of cholesterol reduction activity of methyl-β-cyclodextrin using differentiated human neurons and astrocytes.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1177/1087057112456877 ] [PMID: 22923786 ] [121] Smid BE, Aerts JM, Boot RG, Linthorst GE, Hollak CE.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1517/13543784.2010.524205 ] [PMID: 20942596 ] [122] Mistry PK, Lukina E, Ben Turkia H, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1001/jama.2015.459 ] [PMID: 25688781 ] [123] Ellgaard L, Helenius A.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/nrm1052 ] [PMID: 12612637 ] [124] Valenzano KJ, Khanna R, Powe AC, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1089/adt.2011.0370 ] [PMID: 21612550 ] [125] Harris H, Rubinsztein DC.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1038/nrneurol.2011.200 ] [PMID: 22187000 ] [126] Appelqvist H, Wäster P, Kågedal K, Öllinger K. The lysosome: from waste bag to potential therapeutic target.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1093/jmcb/mjt022 ] [PMID: 23918283 ] [127] Wraith JE.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1007/s10545-006-0239-6 ] [PMID: 16763916 ] [128] Lohse  P,  Maas  S,  Sewell  AC,  Seidel  D,  van  Diggelen  O,  Seidel  D.  Molecular  defects  underlying  Wolman  disease  appear  to  be  more heterogeneous than those resulting in cholesteryl ester storage disease.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/(SICI)1098-1004(1996)8:4<377::AID-HUMU15>3.0.CO;2-# ] [PMID: 8956047 ] [130] Anderson RA, Byrum RS, Coates PM, Sando GN.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1155/2015/347342 ] [133] Hooper AJ, Tran HA, Formby MR, Burnett JR. A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.cca.2008.08.007 ] [PMID: 18775687 ] [134] Ries S, Büchler C, Schindler G, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O ] [PMID: 9633819 ] [135] Kojima S, Watanabe N, Takashimizu S, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1111/hepr.12087 ] [PMID: 23675960 ] [136] Kuranobu N, Murakami J, Okamoto K, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1006/bmme.1997.2626 ] [PMID: 9367797 ] [138] Lohse P, Maas S, Lohse P, et al.",OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
[http://dx.doi.org/10.1161/01.ATV.15.6.773 ] [PMID: 7773732 ] © Aguisanda et al.,Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/21/CCGTM-11-1.PMC5362971.pdf
"[http://dx.doi.org/10.1016/j.bmcl.2009.02.045 ] [PMID: 19251412 ] [2] Warashina T, Noro T. 8, 14-Secopregnane glycosides from the aerial parts of Asclepias tuberosa.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1016/j.phytochem.2009.07.033 ] [PMID: 19703695 ] [3] Amiran MD, Lang Y, Yeung SN.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1038/eye.2011.59 ] [PMID: 21423142 ] [4] Chakraborty S, Siegenthaler J, Büchi ER.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
[http://dx.doi.org/10.1001/archopht.1995.01100080024013 ] [PMID: 7639668 ] [5] Bonanno JA.,Non-OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1016/j.exer.2011.06.004 ] [PMID: 21693119 ] [6] Agrawal AA, Petschenka G, Bingham RA, Weber MG, Rasmann S. Toxic cardenolides: chemical ecology and coevolution of specialized plant-herbivore interactions.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1111/j.1469-8137.2011.04049.x ] [PMID: 22292897 ] [7] Hämäläinen KM, Kananen K, Auriola S, Kontturi K, Urtti A.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1002/jps.2600770103 ] [PMID: 3126290 ] [9] Hatou S, Yamada M, Mochizuki H, Shiraishi A, Joko T, Nishida T. The effects of dexamethasone on the Na, K-ATPase activity and pump function of corneal endothelial cells.",OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
[http://dx.doi.org/10.1080/02713680902829624 ] [PMID: 19401877 ] © Mikkelsen et al.,Non-OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/5b/TOOPHTJ-11-1.PMC5362972.pdf
"[http://dx.doi.org/10.1016/S0889-5406(98)70260-4 ] [PMID: 9598607 ] [2] Björk A, Skieller V. Normal and abnormal growth of the mandible.",OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1093/ejo/5.1.1 ] [PMID: 6572593 ],OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/S0889-5406(96)70172-5 ] [PMID: 8638557 ] [4] Houston WJ.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1093/ejo/10.4.369 ] [PMID: 3061834 ] [5] Karlsen AT.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/0889-5406(91)70076-9 ] [PMID: 1927988 ] [7] Nanda SK.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/0889-5406(88)90287-9 ] [PMID: 3422525 ] [8] Nielsen IL.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1016/0002-9416(78)90240-3 ] [PMID: 277066 ] [10] Pollard D, Akyalcin S, Wiltshire WA, Rody WJ Jr. Relapse of orthodontically corrected deepbites in accordance with growth pattern.",Non-OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/j.ajodo.2011.11.013 ] [PMID: 22464530 ] [11] Turley PK.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1016/S1073-8746(96)80049-1 ] [PMID: 9161276 ] [12] Wessberg GA, Fish LC, Epker BN.",OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/j.ajodo.2009.10.039 ] [PMID: 21435546 ] [15] Kiliaridis S. Masticatory muscle influence on craniofacial growth.,Non-OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.3109/00016359509005972 ] [PMID: 7572097 ] [16] Rowlerson A, Raoul G, Daniel Y, et al.",OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
[http://dx.doi.org/10.1016/j.ajodo.2004.03.025 ] [PMID: 15643413 ] [17] Jago JD.,OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1111/j.1752-7325.1974.tb00682.x ] [PMID: 4275506 ] [18] Dandajena TC, Chung KW, Nanda RS.",OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2004.11.039 ] [PMID: 16905064 ] [19] Capelozza Filho L, Cardoso MA, An TL, Lauris JR. Proposal for classification of individuals with long face pattern malocclusions according to severity.",Non-OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1590/1678-7757201302270 ] [PMID: 23739865 ] [21] Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD.",Non-OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/4d/TODENTJ-11-1.PMC5362973.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.109.551226 ] [PMID: 19478214 ] [2] Secades S, Martín M, Corros C, et al.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.nrl.2012.03.002 ] [PMID: 22608679 ] [3] Herm J, Konieczny M, Jungehulsing GJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.jocn.2012.03.049 ] [PMID: 23384509 ] [4] Zhang L, Harrison JK, Goldstein LB.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2011.01.005 ] [PMID: 21367623 ] [5] Young KC, Benesch CG.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.03.001 ] [PMID: 20813548 ] [6] Pepi M, Evangelista A, Nihoyannopoulos P, et al.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1093/ejechocard/jeq045 ] [PMID: 20702884 ] [7] Stöllberger  C,  Blazek  G,  Wegner  C,  Finsterer  J.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.hrtlng.2012.03.002 ] [PMID: 22515930 ] [8] Stöllberger  C,  Blazek  G,  Dobias  C,  Hanafin  A,  Wegner  C,  Finsterer  J.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2011.05.039 ] [PMID: 21784395 ] [9] Evangelista A, Flachskampf F, Lancellotti P, et al.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
[http://dx.doi.org/10.1093/ejechocard/jen174 ] [PMID: 18579482 ] [10] A language and environment for statistical computing.,Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
[http://dx.doi.org/10.1038/jhh.2011.104 ] [PMID: 22113443 ] [12] Galderisi M. Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient.,Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1038/ajh.2010.235 ] [PMID: 21164497 ] [13] Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population- based estimates.",Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1016/S0002-9149(98)00583-9 ] [PMID: 9809895 ] [14] Furie KL, Goldstein LB, Albers GW, et al.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1161/STR.0b013e318266722a ] [PMID: 22858728 ] [15] Calvet D, Mas JL.",OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1097/WCO.0000000000000052 ] [PMID: 24300793 ] [16] Finsterer J, Stöllberger C. Juvenile cryptogenic stroke from noncompaction in a neuromuscular disease.",Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
[http://dx.doi.org/10.1159/000356555 ] [PMID: 24481414 ],Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/74/TOCMJ-11-14.PMC5362974.pdf
"[http://dx.doi.org/10.1136/bjo.58.12.955 ] [PMID: 4376415 ] [2] İbrahimov E, Selver OB, Ozturk AT, et al.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1167/iovs.14-15314 ] [PMID: 25587057 ] [5] Papchenko T, Grainger BT, Savino PJ, Gamble GD, Danesh-Meyer HV.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2012.02467.x ] [PMID: 22690753 ] [6] Hedges TR III, Vuong LN, Gonzalez-Garcia AO, Mendoza-Santiesteban CE, Amaro-Quierza ML.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
[http://dx.doi.org/10.1001/archopht.126.6.812 ] [PMID: 18541844 ] [7] Galvez-Ruiz A. Macular star formation in diabetic patients with non-arteritic anterior ischemic optic neuropathy (NA-AION).,Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
[http://dx.doi.org/10.1016/j.sjopt.2014.09.002 ] [PMID: 25859144 ] [8] Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic optic neuropathy decompression trial.,Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1001/archopht.1996.01100140566007 ] [PMID: 8906027 ] [9] Coscas G, De Benedetto U, Coscas F, et al.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1159/000342159 ] [PMID: 23006969 ] [10] Larrea BA, Iztueta MG, Indart LM, Alday NM.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1007/s00417-014-2697-0 ] [PMID: 25107540 ] [11] Dreyer RF, Hopen G, Gass JD, Smith JL.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1001/archopht.1984.01040030918013 ] [PMID: 6466174 ] [12] Soylev MF, Saatci O, Memisoglu B. Non-arteritic ischemic optic neuropathy and macula.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1038/eye.2014.144 ] [PMID: 24993324 ] [15] Tawse KL, Hedges TR III, Gobuty M, Mendoza-Santiesteban C. Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2013-304301 ] [PMID: 24627251 ] [16] Bajin MS, Selver OB, Taskin O, Yaman A, Saatci AO.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1111/j.1444-0938.2010.00570.x ] [PMID: 21255078 ] [17] Saatci AO, Taskin O, Selver OB, Yaman A, Bajin MS. Efficacy of intravitreal ranibizumab injection in acute nonarteritic ischemic optic neuropathy: a long-term follow up.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.2174/1874364101307010058 ] [PMID: 24133556 ] [18] Ayhan Z, Kocaoğlu G, Yaman A, et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1155/2015/783241 ] [19] Rootman  DB,  Gill  HS,  Margolin  EA.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1038/eye.2012.296 ] [PMID: 23370417 ] [20] Bolz  M,  Schmidt-Erfurth  U,  Deak  G,  Mylonas  G,  Kriechbaum  K,  Scholda  C.  Optical  coherence  tomographic  hyperreflective  foci:  a morphologic sign of lipid extravasation in diabetic macular edema.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2008.12.039 ] [PMID: 19410950 ] [21] Deák  GG,  Bolz  M,  Kriechbaum  K,  et  al.",OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"Macular Evaluation wıth Spectral Domain Type Optic Coherence The Open Ophthalmology Journal, 2017, Volume 11    23 [http://dx.doi.org/10.1016/j.ophtha.2009.09.027 ] [PMID: 20079541 ] [22] Gelman SK, Freund KB, Shah VP, Sarraf D. The pearl necklace sign: a novel spectral domain optical coherence tomography finding in exudative macular disease.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
[http://dx.doi.org/10.1097/IAE.0000000000000207 ] [PMID: 25020214 ] © Donmez et al.,Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/55/TOOPHTJ-11-17.PMC5362975.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2006.00430.x ] [PMID: 17635356 ] [2] Koyuturk AE, Kusgoz A.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2008.00579.x ] [PMID: 18557754 ] [3] Lam R, Abbott P, Lloyd C, Lloyd C, Kruger E, Tennant M. Dental trauma in an Australian rural centre.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
[http://dx.doi.org/10.1111/j.1600-9657.2008.00689.x ] [PMID: 19021660 ] [4] Glendor U.,Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2008.00696.x ] [PMID: 19021651 ] [5] Borssén E, Holm A-K. Traumatic dental injuries in a cohort of 16-year-olds in northern Sweden.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.1997.tb00055.x ] [PMID: 9558509 ] [6] Olsburgh S, Jacoby T, Krejci I.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1034/j.1600-9657.2002.00004.x ] [PMID: 12110103 ] [7] Calişkan MK, Türkün M. Clinical investigation of traumatic injuries of permanent incisors in Izmir, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.1995.tb00490.x ] [PMID: 8625933 ] [8] Majorana A, Pasini S, Bardellini E, Keller E. Clinical and epidemiological study of traumatic root fractures.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1034/j.1600-9657.2002.180206.x ] [PMID: 12184216 ] [9] Bastone EB, Freer TJ, McNamara JR.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2000.tb00234.x ] [PMID: 10846265 ] [10] Flores MT, Andersson L, Andreasen JO, et al.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2007.00592.x ] [PMID: 17367451 ] [11] Flores MT, Andersson L, Andreasen JO, et al.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2007.00605.x ] [PMID: 17511833 ] [12] Berrezouga L, Kammoun D, Bhouri L, Alaya BT, Belkhir MS.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2010.00967.x ] [PMID: 21281442 ] [13] Berman LH, Blanco L, Cohen S. Alveolar fractures.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.1990.tb00414.x ] [PMID: 1983466 ] [16] Kamboozia AH, Punnia-Moorthy A.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1016/S0901-5027(05)80811-2 ] [PMID: 8320457 ] [17] Berman LH, Blanco L, Cohen S. Patient assessment.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2006.00509.x ] [PMID: 17367457 ] [19] Berman LH, Blanco L, Cohen S. Alveolar fractures.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.1995.tb00464.x ] [PMID: 7641622 ] [21] Nasjleti CE, Castelli WA, Caffesse RG.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1016/0030-4220(82)90340-1 ] [PMID: 6954434 ] [22] Berman LH, Blanco L, Cohen S. A clinical guide to dental traumatology.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
[http://dx.doi.org/10.1016/0030-4220(55)90101-8 ] [PMID: 14370759 ] [24] Ravn JJ.,OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
[http://dx.doi.org/10.1111/j.1600-0528.1974.tb01658.x ] [PMID: 4154162 ] [25] Andreasen  JO.,OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1053/joms.2003.50049 ] [PMID: 12524610 ] [27] Iida S, Matsuya T. Paediatric maxillofacial fractures: their aetiological characters and fracture patterns.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1054/jcms.2002.0295 ] [PMID: 12231205 ] [28] Gassner R, Tuli T, Hächl O, Rudisch A, Ulmer H. Cranio-maxillofacial trauma: a 10 year review of 9,543 cases with 21,067 injuries.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1016/S1010-5182(02)00168-3 ] [PMID: 12553928 ] [29] Lin S, Levin L, Goldman S, Peled M. Dento-alveolar and maxillofacial injuries - a retrospective study from a level 1 trauma center in Israel.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2005.00418.x ] [PMID: 17355291 ] [30] Lin S, Levin L, Goldman S, Sela G. Dento-alveolar and maxillofacial injuries: a 5-year multi-center study.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1111/j.1600-9657.2006.00511.x ] [PMID: 18173667 ] [31] Olson RA, Fonseca RJ, Zeitler DL, Osbon DB.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.1016/S0278-2391(82)80011-6 ] [PMID: 6950035 ] [32] Levin L, Friedlander LD, Geiger SB.",OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
[http://dx.doi.org/10.1034/j.1600-9657.2003.00196.x ] [PMID: 14708646 ] [33] Järvinen S. Incisal overjet and traumatic injuries to upper permanent incisors.,Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"[http://dx.doi.org/10.3109/00016357809029088 ] [PMID: 281861 ] [34] Berman CL, Berman LG.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/68/TODENTJ-11-8.PMC5362980.pdf
"The use of self-inactivating(SIN) lentiviruses (LVs) for gene transfer is one critical improvement,combining a safer integration pro ﬁle (less af ﬁnity for insertions near promoters than g-retroviruses 16–18) with the ability to select internal promoters that optimize transgene expression and safety.19Because of the association between internal promoter strength and transfor-mation potential, 19internal promoters are selected for their ability to recapitulate endogenous expression levels and regulation, as wellas for the lack of transactivation potential both in vitro and in vivo.These considerations are particularly important for treating WASbased on the following ﬁndings: sub-endogenous levels of WASp Received 30 July 2016; accepted 15 November 2016; http://dx.doi.org/10.1016/j.omtm.2016.11.001 .",Non-OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC5363182.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC5363182.pdf
62 Genomic sequences were mapped to the rhesus macaque genome(rheMac3) using a stand-alone version of BLAT available from theUCSC Genome Browser ( http://genome.ucsc.edu/ ).,OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC5363182.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes nine ﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/main.PMC5363182.pdf
"Additional problems may emerge from the production of toxic homopolymeric polypeptides, which areformed by decoding of the normally untranslated (CUG)n repeattract in DMPK mRNA by repeat-associated non-ATG (RAN) Received 9 August 2016; accepted 11 October 2016; http://dx.doi.org/10.1016/j.ymthe.2016.10.014 .",Non-OADS,/arxiv_data1/oa_pdf/63/f6/main.PMC5363205.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/f6/main.PMC5363205.pdf
"Target sitesfor CRISPR/Cas9 across the trinucleotide repeat in exon 15 ofDMPK (NCBI, Gene Database, GeneID: 1760, nucleotides 45,770,345 –45,770,148) were selected using four CRISPR gRNA design web tools ( http://omictools.com ,http://crispr.mit.edu ,https://chopchop.rc.fas.harvard.edu , and https://www.dna20.com ).",OADS,/arxiv_data1/oa_pdf/63/f6/main.PMC5363205.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/63/f6/main.PMC5363205.pdf
Received 16 October 2016; accepted 11 November 2016; http://dx.doi.org/10.1016/j.ymthe.2016.11.010 .,Non-OADS,/arxiv_data1/oa_pdf/74/28/main.PMC5363210.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/28/main.PMC5363210.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/74/28/main.PMC5363210.pdf
"Genet., Published online September 15, 2016. http://dx.doi.org/10.1093/hmg/ddw286 .40.Hendel, A., Bak, R.O., Clark, J.T., Kennedy, A.B., Ryan, D.E., Roy, S., Steinfeld, I., Lunstad, B.D., Kaiser, R.J., Wilkens, A.B., et al.",OADS,/arxiv_data1/oa_pdf/74/28/main.PMC5363210.pdf
"[16]Thevastmajority of13C-satellites remain overlapped bythelarge body ofredundant resonances that populate 1D-1H-NMR spectra ofbiological cellextracts .1D[*]Dr.M.Vinaixa, Dr.O.Yanes Department ofElectron icEngineeri ng-Universita tRovira iVirgili, Spanish Biomedic alResearch Center inDiabetes andAssociated Metabolic Disorder s(CIBERDE M) 43204 Reus (Spain ) E-mail :maria.vinaix a@urv .cat oscar .yanes@urv .cat Dr.M.A.Rodr/C237guez, J.Capellades Universit atRovira iVirgili, Spanish Biomedical Research Center in Diabetes andAssociated Metabolic Disorde rs(CIBERDEM) 43204 Reus (Spain ) Dr.S.Aivio, Dr.T.H.Stracker Institute forResearch inBiomedic ine(IRB Barcelona), TheBarcelona Institute ofScience andTechnology 08028 Barcelona (Spain) Dr.J.G/C243mez, Dr.N.Canyellas Department ofElectron icEngineeri ng-Universita tRovira iVirgili 43007 Tarragona (Spain) Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016113 47.",Non-OADS,/arxiv_data1/oa_pdf/73/b6/ANIE-56-3531.PMC5363230.pdf
Supportin ginforma tionandtheORCID identifica tionnumber(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016120 37.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/ANIE-56-3299.PMC5363232.pdf
URL http://www.nccn.org/professionals/physycian_gls/pdf/melanoma.pdf (lastaccessed: 21 August 2014).,OADS,/arxiv_data1/oa_pdf/92/76/JDV-31-450.PMC5363235.pdf
"wileyonlinelibrary.com/journal/cdr 	 | 	1 of 8 https://doi.org/10.1111/1755-5922.12250 Received:	27	June	2016  | Revised:	20	December 	2016  | Accepted:	2	 January	2017 DOI:	10.1111/1755-5922.12250 ORIGINAL RESEARCH ARTICLE Epoetin beta pegol ameliorates flow- mediated dilation with  improving endothelial nitric oxide synthase coupling state in  nonobese diabetic rats Kenichi Serizawa1 | Kenji Yogo1 | Yoshihito Tashiro2 | Ryohei Kawasaki2 |   Koichi Endo3 | Yasushi Shimonaka2 | Michinori Hirata2 1Product	Research	Department,	Chugai	 Pharmaceutical	Co.,	Ltd,	Shizuoka,	 Japan 2Product	Research	Department,	Chugai	 Pharmaceutical	Co.,	Ltd,	Kanagawa,	 Japan 3Medical	Science	Department,	Chugai	 Pharmaceutical	Co.,	Ltd,	 Tokyo,	Japan Correspondence M.	Hirata,	Product	Research	Department,	 Chugai	Pharmaceutical	Co.,	Ltd,	Kamakura,	Kanagawa,	Japan.",Non-OADS,/arxiv_data1/oa_pdf/dd/9e/CDR-35-na.PMC5363236.pdf
https://doi.org/10.1111/1755-5922.12250,Non-OADS,/arxiv_data1/oa_pdf/dd/9e/CDR-35-na.PMC5363236.pdf
MethPrimer (http://www.urogene.org/methprimer/) was utilized to design combined bisul ﬁte and restriction anal- ysis (COBRA) and methylation-speci ﬁc polymerase chain reaction (MSP) primers (Table 2).,OADS,/arxiv_data1/oa_pdf/cf/2d/HON-35-25.PMC5363240.pdf
The results shown here are based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/cf/2d/HON-35-25.PMC5363240.pdf
"[*]M.Jaegle, Prof. Dr.J.Rademann Institute ofPharmacy ,Medicinal Chemistry FreieUniversit /C228tBerlin Kçnigin-L uise-Strasse 2+4,14195 Berlin (Germany) E-mail :joerg.radem ann@fu-be rlin.de Homepag e:http://www .bcp.fu-berlin .de/ag-rad emann Prof. Dr.T.Steinmetze r Philipps-U niversit /C228tMarburg Fachbereich Pharmazie Institut f/C252rPharmaze utische Chemie Marbache rWeg6,35037 Marburg (Germany ) Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016115 47.",Non-OADS,/arxiv_data1/oa_pdf/87/40/ANIE-56-3718.PMC5363247.pdf
"U.S. Department of Health and Human Services, Healthy People  2020 topics & objectives, 2016, https://www.healthypeople.gov/2020/topics-objectives.",Non-OADS,/arxiv_data1/oa_pdf/7f/ea/PSRH-49-7.PMC5363251.pdf
"62, http://www.cdc.gov/nchs/data/nhsr/ nhsr062.pdf.",OADS,/arxiv_data1/oa_pdf/7f/ea/PSRH-49-7.PMC5363251.pdf
"60, http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/7f/ea/PSRH-49-7.PMC5363251.pdf
"17 To evaluate the functionality of pExu plasmid, we cloned the eGFP(egfp) open reading frame (ORF) into its multiple cloning site, and Received 9 November 2016; accepted 15 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.005 .",OADS,/arxiv_data1/oa_pdf/47/5a/main.PMC5363290.pdf
83 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/5a/main.PMC5363290.pdf
"22 During the activation process, the T cells are incubated with theviral vector encoding the CAR, and, after several days, the vector Received 28 September 2016; accepted 21 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.006 .",OADS,/arxiv_data1/oa_pdf/af/6a/main.PMC5363291.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/6a/main.PMC5363291.pdf
"To bring harmonization in the emerging area of cell andgene therapies, on October 11, 2012, nine members of the global reg-ulatory community, including Brazil ANVISA; European MedicinesAgency (EMA); Health Canada; India National Institute of Biologi-cals (NIB); Japan Ministry of Health, Welfare and Labour/Pharma-ceutical and Medical Devices Agency; South Korea Ministry ofFood and Drug Safety (previously known as Food and Drug Admin-istration [KFDA]); Singapore Health Sciences Authority (HSA);Swissmedic; and the U.S. Food and Drug Administration, convenedto form an integrated group with a goal to discuss best practices in the regulation of cell/gene-based therapies and support harmoniza-tion ( https://www.i-p-r-f.org/en/workin g-groups/gene-therapy-working- group/ ).",Non-OADS,/arxiv_data1/oa_pdf/af/6a/main.PMC5363291.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM232592.pdf .,Non-OADS,/arxiv_data1/oa_pdf/af/6a/main.PMC5363291.pdf
Two patients experienced adverse Received 1 September 2016; accepted 11 October 2016; http://dx.doi.org/10.1016/j.ymthe.2016.10.020 8These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/7b/5d/main.PMC5363293.pdf
285 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/5d/main.PMC5363293.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods, three ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.ymthe.2016.10.020 .www.moleculartherapy.org Molecular Therapy Vol.",Non-OADS,/arxiv_data1/oa_pdf/7b/5d/main.PMC5363293.pdf
"Because nullmutations within the gene encoding an HIV-1 co-receptor, CCR5,render T cells resistant to infection by the most prevalent strains ofHIV-1, 23–25disruption of CCR5 by HDR delivery of anti-CD19- or anti-BCMA-CAR expression cassettes into the CCR5 locus could be Received 30 September 2016; accepted 28 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.008 .",Non-OADS,/arxiv_data1/oa_pdf/09/1c/main.PMC5363294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/1c/main.PMC5363294.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.2016.12.008 .,Non-OADS,/arxiv_data1/oa_pdf/09/1c/main.PMC5363294.pdf
Received 1 October 2016; accepted 28 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.009 .,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/main.PMC5363298.pdf
137 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/main.PMC5363298.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7d/c4/main.PMC5363298.pdf
"Previous studies suggested that the ef ﬁcacy of this rAAV8 vector at a low dose12(2/C21010vector genomes [vg], Received 21 October 2016; accepted 30 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.010 .",OADS,/arxiv_data1/oa_pdf/76/3f/main.PMC5363303.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/3f/main.PMC5363303.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.,Non-OADS,/arxiv_data1/oa_pdf/76/3f/main.PMC5363303.pdf
RD114-TR-pseudotyped retroviral vectors are suitable forboth ex vivo and in vivo gene therapy applications because they Received 29 November 2016; accepted 4 January 2017; http://dx.doi.org/10.1016/j.omtm.2017.01.002 .,Non-OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
Images were acquired using the Leica Application Suite (LAS) Advanced Fluorescence (AF) software (Leica Microsystems) and processedby the public domain ImageJ image processing and analysissoftware ( http://rsb.info.nih.gov/ij/ ) (Image Processing and Analysis in Java).,OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
RNA Splicing and Structure Prediction Web Servers Prediction of RNA splice sites was generated by the software madeavailable by the NetGene2 Server ( http://www.cbs.dtu.dk/services/ NetGene2/ ) and prediction of mRNA structure by the software MFOLD ( http://mfold.rit.albany.edu/?q=mfold/RNA-Folding-Form ) using the following parameters: linear RNA sequence; 37 /C14C folding temperature; 1 M NaCl ionic condition: number of calculated folding;differences between the calculated foldings = default parameters;maximum extension of the calculated loops = 30; maximum asymme-try between the calculated loops = 30; and no limit in base pairing dis-tance.,OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
The comparison between different structures was obtained bythe SimTree software ( http://bioinfo.cs.technion.ac.il/SimTree/ ).,OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5363313.pdf
"Several clinical trials have taken different approaches tothis problem in LINCL, including the use of stem cells ( https:// ClinicalTrials.gov : NCT00337636), gene therapy to the parenchyma of the brain ( https://ClinicalTrials.gov : NCT00151216), and cerebro- spinal ﬂuid (CSF)-mediated delivery of enzyme via intracerebroven- tricular (ICV) injection ( https://ClinicalTrials.gov : NCT01907087).",Non-OADS,/arxiv_data1/oa_pdf/72/25/main.PMC5363315.pdf
administration of K16ApoE and TPP1 stems Received 28 November 2016; accepted 23 January 2017; http://dx.doi.org/10.1016/j.omtm.2017.01.004 .,OADS,/arxiv_data1/oa_pdf/72/25/main.PMC5363315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/25/main.PMC5363315.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes nine movies and can be found withthis article online at http://dx.doi.org/10.1016/j.omtm.2017.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/72/25/main.PMC5363315.pdf
http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/72/25/main.PMC5363315.pdf
Software is available at https://github.com/BushmanLab/ INSPIIRED .,Non-OADS,/arxiv_data1/oa_pdf/21/47/main.PMC5363316.pdf
"Perfor- mance was then tested over several datasets ranging from experi-mental infections to human gene therapy samples, allowing analysis Received 18 August 2016; accepted 15 November 2016; http://dx.doi.org/10.1016/j.omtm.2016.11.002 .",OADS,/arxiv_data1/oa_pdf/21/47/main.PMC5363316.pdf
39 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/47/main.PMC5363316.pdf
"The virtual machine, software, instructions, and a walkthrough that processes provided sample data are available at https://github.com/BushmanLab/INSPIIRED .",OADS,/arxiv_data1/oa_pdf/21/47/main.PMC5363316.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods and fourteen tables and can be found with this article onlineathttp://dx.doi.org/10.1016/j.omtm.2016.11.002 .,Non-OADS,/arxiv_data1/oa_pdf/21/47/main.PMC5363316.pdf
"Inorder to disrupt the endogenous TCR, we generated 12 TALENsandﬁve CRISPR/Cas9 gRNAs speci ﬁc for the constant regions of Received 11 January 2017; accepted 25 January 2017; http://dx.doi.org/10.1016/j.omtm.2017.01.005 .",OADS,/arxiv_data1/oa_pdf/5d/c3/main.PMC5363317.pdf
213 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/c3/main.PMC5363317.pdf
MATERIALS AND METHODS TALEN and CRISPR/Cas9 gRNA Design and Generation TALEN target sites were chosen using two versions of the online toolTAL Effector-Nucleotide Targeter (TALE-NT; https://tale-nt.cac.,OADS,/arxiv_data1/oa_pdf/5d/c3/main.PMC5363317.pdf
"10For TRBC CRISPR/Cas9 gRNA design and in silico off-target prediction, the gRNA design tool ( http://crispr.mit.edu/ ) was applied.38Chosen gRNA sequences were ordered as 50phosphorylated oligonucleotides and cloned into the pX330-U6-Chimeric_BB-CBh-hSpCas9 vector.10 Cell Culture Cells were cultured with 5% CO 2at 37/C14C.",OADS,/arxiv_data1/oa_pdf/5d/c3/main.PMC5363317.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures, ﬁve tables, and a list of primers and can be found with this article online at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5d/c3/main.PMC5363317.pdf
Software is available at https://github.com/BushmanLab/ INSPIIRED .,Non-OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
We have Received 20 August 2016; accepted 15 November 2016; http://dx.doi.org/10.1016/j.omtm.2016.11.003 .,Non-OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
Inte-gration sites are annotated with the hiAnnotator R software package(http://bioconductor.org/packages/release/bioc/html/hiAnnotator.,OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
All such values are calculated for a data-set of integration sites and averaged to obtain the overall ROC area for the feature measured ( https://github.com/BushmanLab/hotROCs ).,OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
"For annotating gene therapy results, we have thus generated multiple lists of cancer-associatedgenes that can be queried as appropriate for integration site analysis(http://www.bushmanlab.org/links/genelists ).",OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
"Pipeline Utilization INSPIIRED is distributed online as a downloadable virtual ma-chine executable on the Windows, Mac, and Linux operatingsystems, as well as a GitHub source code repository supported by aConda software environment (see https://github.com/BushmanLab/ INSPIIRED , which also includes detailed instructions for use and test datasets).",OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials andMethods, one ﬁgure, one table, and two data ﬁles and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.2016.",OADS,/arxiv_data1/oa_pdf/08/be/main.PMC5363318.pdf
"7,8The increased regulatory burden on such direct fetal transplantations has made them more dif ﬁcult to perform, Received 7 October 2016; accepted 15 November 2016; http://dx.doi.org/10.1016/j.omtm.2016.11.005 .",Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
"38The study initially planned to transplant 13 patients but is now seeking approval to transplant 40(http://asteriasbiotherapeutics.com ).“Low level ”immunosuppres- sion was used for 60 days to help cells resist rejection, although weare unaware of any post-mortem analysis showing survival and integration in patients to date.",Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
http://ir.geron.,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
http://asteriasbiotherapeutics.com/wp- content/uploads/2016/09/Wirth-ISCoS-14SEP2016-talk-FINAL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
"Cell Transplant., Published online May 20, 2016. http://dx.doi.org/10.3727/ 096368916X691682 .",Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
http://investors.interna tionalstemcell.com/pro ﬁles/investor/ ResLibraryView.asp?ResLibraryID=82118&GoTopage=1&Category=958&BzID= 1468&G=583 .,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/ Quality/Q6A/Step4/Q6Astep4.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070273 .,Non-OADS,/arxiv_data1/oa_pdf/a8/ae/main.PMC5363320.pdf
We found that the deletion spans 5.6 Mb and is remarkably similar to that of patient Received 27 October 2016; accepted 7 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.001 .,Non-OADS,/arxiv_data1/oa_pdf/bb/78/main.PMC5363321.pdf
4 March 2017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/78/main.PMC5363321.pdf
"48SUPPLEMENTAL INFORMATION Supplemental Information includes nine ﬁgures, one table, and two data ﬁles and can be found with this article online at http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bb/78/main.PMC5363321.pdf
"Endogenous expres- sion of CD8 epitopes by a variety of major histocompatibility complexclass I (MHC-I) +cells can effectively mediate deletion of autoreactive CD8+T cells.14–17Moreover, endogenous CD4 epitopes can be re- directed to endosomes or lysosomes18–22and may contribute to in- duction of tolerance.21,22Co-expression of multiple CD4 and CD8 epitopes offers the unique possibility of bridging potentiallypathogenic T cells and regulatory T cells (Tregs) to enable linked Received 1 September 2016; accepted 13 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.002 .",Non-OADS,/arxiv_data1/oa_pdf/21/28/main.PMC5363322.pdf
27 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/28/main.PMC5363322.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seventeen ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/28/main.PMC5363322.pdf
12One of the most potent interventions to date employed the combinationtherapy of autologous nonmyeloablative stem cell transplant plus Received 11 October 2016; accepted 16 December 2016; http://dx.doi.org/10.1016/j.omtm.2016.12.003 .,Non-OADS,/arxiv_data1/oa_pdf/d4/35/main.PMC5363324.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/35/main.PMC5363324.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtm.,Non-OADS,/arxiv_data1/oa_pdf/d4/35/main.PMC5363324.pdf
Long noncoding RNA ( lncRNA ) gene annotations were obtained from GENCODE.31ToppCluster was used to cluster differentially expressed genes from different time points based on phenotype enrichment32and Cytoscape was used for cluster visualization.33Mouse phenotype data was obtained from MGI database (http://www.informatics.jax.org/).,OADS,/arxiv_data1/oa_pdf/ec/2e/JOR-35-474.PMC5363336.pdf
"Morristown, NJ: Actavis Pharma Inc; 2014. http://www.allergan.com/assets/pdf/kadian_pi.",Non-OADS,/arxiv_data1/oa_pdf/47/a5/JCPH-57-500.PMC5363337.pdf
http://www.fda.gov/downloads/RegulatoryInformation/ Guidances/UCM126833.pdf.,Non-OADS,/arxiv_data1/oa_pdf/47/a5/JCPH-57-500.PMC5363337.pdf
"Box207, 7500 AEEnschede (The Netherlands ) S.P.Fletcher Department ofChemist ry Chemist ryResearch Laboratory ,Universi tyofOxford 12Mansfield Road, Oxford OX1 3TA(UK) E-mail :stephen.fletch er@chem.ox .ac.uk Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016113 25.",Non-OADS,/arxiv_data1/oa_pdf/1c/ea/ANIE-56-3261.PMC5363340.pdf
"[*]T.Scherpf, K.-S. Feichtner ,Prof.Dr.V.H.Gessne r Chair ofInorganic Chemistry II Faculty ofChemist ryandBiochemistr y Ruhr University Bochum Universit /C228tsstraße 150, 44780 Bochum (Germany ) E-mail :viktoria.gess ner@rub.de Homepag e:http://www .ruhr-uni-bo chum.de/ac2 / Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016116 77.",Non-OADS,/arxiv_data1/oa_pdf/8b/b9/ANIE-56-3275.PMC5363341.pdf
Available at:http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/00/95/JMRI-45-1013.PMC5363344.pdf
Available at http://cancercontrol.cancer.gov/brp/research/the ories_project/cameron.pdf Last accessed 1 March 2016.,Non-OADS,/arxiv_data1/oa_pdf/c1/17/DME-34-467.PMC5363347.pdf
Available from: http://www.casp-uk.net/wp-content/uploads/2011/11/casp_qualitative_appraisal_ checklist_14oct10.pdf#!casp-tools-checklists/ c18f8 [Accessed 30 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/14/d3/PON-26-291.PMC5363350.pdf
Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016117 87.,Non-OADS,/arxiv_data1/oa_pdf/39/f3/ANIE-56-3285.PMC5363351.pdf
A tutorial for pAMR learning is now available at http://scvp.net/amr/index.html.,Non-OADS,/arxiv_data1/oa_pdf/a2/2a/AJT-17-42.PMC5363364.pdf
"These include increased tobacco and alcohol use,2,3higher body mass index (BMI),4–6and reduced uptake of cervical cytology screening.7–9Lesbians are also said to have fewer reproductive behaviours that are associated with protection from various reproductive sys- tem cancers than heterosexual women, including use of oral contraceptives, childbirth and breastfeeding.10,11This article includes Author Insights, a video abstract available at https://vimeo.com/rcog/authorinsights14414.",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/BJO-124-381.PMC5363366.pdf
NHS Cerv Screen Prog 2009; http://www.glhv.org.au/ﬁles/screening-lesbians-bisexual- women.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/BJO-124-381.PMC5363366.pdf
"(2016), which were taken by Marco Anelli in his excellent series ‘portrait in the presence of Marina Abrahamovi /C19c’ (http://www.mar coanelli.com/portraits-in-the-presence-of-marina-abramovic/).",Non-OADS,/arxiv_data1/oa_pdf/93/6a/BJSO-56-146.PMC5363367.pdf
The 1Study materials and data can be found at http://hdl.handle.net/10411/20818.Perceived warmth and competence of tearful individuals 149,Non-OADS,/arxiv_data1/oa_pdf/93/6a/BJSO-56-146.PMC5363367.pdf
"[a]J.Kiebist, Dr.K.-U.Schm idtke, J.Zimmermann ,Prof.Dr.K.Scheib ner Faculty ofEnvironment and Natura lSciences Brandenb urgUniv ersity ofTechnolo gyCottbu s-Senfte nber g Universi t/C228tsplatz 1,01968 Senftenberg(Germ any) E-mail :jan.ki ebist@b-tu.d e [b]Dr.H.Kellner ,Dr.R.Ullrich, Prof. Dr.M.Hofrichter Depar tment ofBio- and Environmenta lSciences TUDres den, Inter nation alInstit uteZittau Markt 23,02763 Zittau (Germany) [c]Dr.N.Jehmlich Depar tment ofMole cularSystems Biology Helmho ltz-Centre forEnvironmenta lResearch, UFZ Permose rstrasse 15,04318 Leipzig(Germany ) [d]D.Z/C228nder JenaBio sGmbH Lçbsted terStrasse 80,0774 9Jena (Germ any) Supportin ginformat ionforthisarticle canbefound under : http://dx.doi.or g/10.10 02/cbic.201 600677.",Non-OADS,/arxiv_data1/oa_pdf/9b/60/CBIC-18-563.PMC5363369.pdf
2003. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRe gulatoryInformation/Guidances/ucm072123.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/2d/JCPH-57-513.PMC5363371.pdf
"Reads were mapped to the human referencegenome sequence (UCSC hg19) using the Burrows-Wheeler Align-ment Tool (http://bio-bwa.sourceforge.net) [Li and Durbin, 2009].Duplicate read removal, local sequence realignment, and basequality recalibration were performed by Picard (http://picard.sourceforge.net) and Genome analysis Tool Kit (GATK, (https:// www.broadinstitute.org/gatk/) [McKenna et al., 2010].",OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
Variants were annotated and analyzed with Cartagenia (http://www.cartagenia.com/) ﬁlter tree speciﬁcally designed to detectvariants causative for a trait with an autosomal dominant inheri- tance pattern.,OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
"In the described family, variants were selected if (i) absent in the following databases: dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP, build 138), the 1.000 genome project(www.1000genomes.org) or the National Heart Lung Blood Insti-tute Exome Variant Server (EVS) (https://evs.gs.washing ton.edu/EVS); (ii) prevalent /C205% in the 363 patients of the Amsterdam Dementia Cohort [van der Flier et al., 2014]; (iii) heterozygote inall three affected individuals; (iv) potential causative based on the possible effects of the variants on the expression or function of the protein and in a morbid OMIM gene.",Non-OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
Variants in the CCM genes were analyzed by using the Combined Annotation DependentDeletion (CADD) scoring tool (http://cadd.gs.washington.edu/)v1.2.We used Sanger sequencing to conﬁrm the novel variant wefound with exome sequencing.,OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
The vari-ant has not been reported before in literature or in the Dutchgenetic biobank GoNL (http://www.nlgenome.nl/) and was notfound in 363 patients with early onset Alzheimer’s disease and/or multiple microbleeds.,Non-OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
"http://www.ncbi.nlm.nih.gov/ books/NBK1293/ Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM.",Non-OADS,/arxiv_data1/oa_pdf/a1/47/AJMG-174-220.PMC5363380.pdf
"The ﬁrst reason is embryologic, namely that only the maxillary and ethmoid sinuses are present at birth and relatively prema- ture compared to an adult.2During childhood, progres- sive expansion and pneumatization occurs with subsequent Public clinical trial registration: http://clinicaltrials.gov/show/NCT02278484.",Non-OADS,/arxiv_data1/oa_pdf/6a/81/ALR-7-221.PMC5363383.pdf
"13MicroRNA-134 (miR-134) was identi ﬁed as a brain- enriched, neuronally expressed miRNA that controls dendrite spine Received 24 June 2016; accepted 29 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.002 .",OADS,/arxiv_data1/oa_pdf/2b/96/main.PMC5363384.pdf
45 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/96/main.PMC5363384.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two tables and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2016.11.002 .,OADS,/arxiv_data1/oa_pdf/2b/96/main.PMC5363384.pdf
"Epilepsia Open, Published online November9, 2016. http://dx.doi.org/10.1002/epi4.12023 .",Non-OADS,/arxiv_data1/oa_pdf/2b/96/main.PMC5363384.pdf
"Neurobiol., Published online May 10, 2016. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/2b/96/main.PMC5363384.pdf
"Methods 2.1 The participants 36 healthy participants, 21 women, 15 men ( M [mean] age =25 years, SD [standard deviation] =7, range =18–48 years) were recruited through an aca- demic study website (http://www.studentkaninen.se) or via ads on university message boards.",Non-OADS,/arxiv_data1/oa_pdf/3e/61/EJP-21-594.PMC5363385.pdf
"Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19486/2014-8-2.pdf(accessed on October 30, 2016).",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/APA-106-579.PMC5363386.pdf
"Available at: http://www.socialstyrelsen.se/Lists/Artikelka talog/Attachments/20009/2015-12-27.pdf (accessed onOctober 30, 2016).",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/APA-106-579.PMC5363386.pdf
"Plant Phys 2017; In press; http://dx.doi.org/1 0.1104/pp.16.01628 © 2017 Francisco Figueroa-Martinez, Aurora M. Nedelcu, Adrian Reyes-Prieto, and David R. Smith.",Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.COMMUNICATIVE & INTEGRATIVE BIOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"1, e1283080 (3 pages)http://dx.doi.org/10.1080/19420889.2017.1283080",Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"ORCID David R. Smith http://orcid.org/0000-0001-9560-5210 References [1] Krause K, Scharff LB.",Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
USA 2015; 112:10200-7; PMID:25717057; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"BMC Biol 2006; 4:12; PMID:16630350; http://dx.doi.org/10.1186/1741-7007-4-12 [4] Wilson RJ, Denny PW, Preiser PR, Rangachari K, Rob- erts K, Roy A, Whyte A, Strath M, Moore DJ, Moore PW, et al.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"J Mol Biol 1996; 261:155-72; PMID:8757284; http://dx.doi.org/ 10.1006/jmbi.1996.0449 [5] Cai X, Fuller AL, McDougald LR, Zhu G. Apicoplast genome of the coccidian Eimeria tenella .",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Gene 2003; 321:39-46; PMID:14636990; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Genome Biol Evol 2015; 7:1179-91; PMID:25635040; http://dx.doi.org/10.1093/gbe/evv019 [7] Bellot S, Renner SS.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Genome Biol Evol 2016; 8:189-201; http://dx.doi.org/10.1093/gbe/evv251 [8] Molina J, Hazzouri KM, Nickrent D, Geisler M, Meyer RS, Pentony MM, Flowers JM, Pelser P, Barcelona J, Ino-vejas SA, et al.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Mol Biol Evol 2014; 31:793-803; PMID:24458431;http://dx.doi.org/10.1093/molbev/msu051 [9] Smith DR, Lee RW.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Plant Phys 2014; 164:1812-9; http://dx.doi.org/ 10.1104/pp.113.233718 [10] Figueroa /C0Martinez F, Nedelcu AM, Smith DR, Reyes /C0; Prieto A.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"New Phytologist 2015; 206:972-82; PMID:26042246; http://dx.doi.org/10.1111/ nph.13279 [11] Ohta N, Matsuzaki M, Misumi O, Miyagishima SY, Nozaki H, Tanaka K, Shin T, Kohara Y, Kuroiwa T. Complete sequence and analysis of the plastid genome of the unicellular red alga Cyanidioschyzon merolae .",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"DNA Res 2003; 10:67-77; PMID:12755171; http://dx.doi.org/ 10.1093/dnares/10.2.67 [12] Robbens S, Derelle E, Ferraz C, Wuyts J, Moreau H, Van de Peer Y.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Plant Phys 2017; In press; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Trends Plant Sci 2010; 15:227-35; PMID:20153240; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Science 2010; 330:1543-6; PMID:21148392; http://dx.doi.org/10.1126/science.1194573 [17] Nakjang S, Williams TA, Heinz E, Watson AK, Foster PG, Sendra KM, Heaps SE, Hirt RP, Embley TM.",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Genome BiolEvol 2013; 5:2285-303; PMID:24259309; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Parasitology 2015; 142:S6-15; PMID:24229807; http://dx.doi.org/ 10.1017/S0031182013001674 [19] McCutcheon JP, Moran NA.",Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Genome Biol Evol 2009; 1:439-48; PMID:20333213; http://dx.doi.org/10.1093/ gbe/evp047 [21] Gockel G, Hachtel W. Complete gene map of the plastid genome of the nonphotosynthetic euglenoid ﬂagellate Astasia longa .",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Protist 2000; 151:347-51; PMID:11212895; http://dx.doi.org/10.1078/S1434-4610(04)70033-4 [22] Krause K. From chloroplasts to “cryptic ”plastids: evolu- tion of plastid genomes in parasitic plants.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
"Curr Genet 2008; 54:111-121; PMID:18696071; http://dx.doi.org/10.1007/s00294-008-0208-8 [23] Del Vasto M, Figueroa-Martinez F, Featherston J, Gonza- lez MA, Reyes-Prieto A, Durand PM, Smith DR. Massiveand widespread organelle genomic expansion in the green algal genus Dunaliella .",OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Genome Biol Evol 2015; 7:656-63; PMID:25663488; http://dx.doi.org/10.1093/gbe/evv027 [24] Smith DR.,OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Mol Ecol 2016; 25:3769-75;PMID:27357487; http://dx.doi.org/10.1111/mec.13742COMMUNICATIVE & INTEGRATIVE BIOLOGY e1283080-3,Non-OADS,/arxiv_data1/oa_pdf/91/50/kcib-10-01-1283080.PMC5363391.pdf
Received 19 September 2016; accepted 21 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.003 .,Non-OADS,/arxiv_data1/oa_pdf/e2/35/main.PMC5363400.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/35/main.PMC5363400.pdf
"injections of mouse laminin-111 pro-tected the mdx muscles during eccentric contractions and signi ﬁ- cantly increased the strength, 31independently con ﬁrming the results published by Burkin ’s group.29Laminin-111 makes links between Received 17 June 2016; accepted 21 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.004 .",Non-OADS,/arxiv_data1/oa_pdf/29/10/main.PMC5363410.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/10/main.PMC5363410.pdf
"Possible off-target sequences of the best gRNAs (i.e., gRNA3 and gRNA4) were identi-ﬁed with the Benchling software ( https://benchling.com/editor ).",OADS,/arxiv_data1/oa_pdf/29/10/main.PMC5363410.pdf
"41–44 Lama1 is not expressed in adult muscles, but laminin subunit alpha 2 (Lama2), laminin subunit beta 1 (Lamb1), and laminin subunit gamma 1 (Lamc1) are still expressed ( http://www.genecards.org/ )forming laminin-211.",Non-OADS,/arxiv_data1/oa_pdf/29/10/main.PMC5363410.pdf
"Construction and Oligonucleotide Synthesis The 20 nucleotide sequences, which will be targeted by the guideRNAs (gRNAs) in the Lama1 promoter, were identi ﬁed through the Leiden Muscular Dystrophy Pages Web Site ( http://www.dmd.nl/ seqs/murefDMD.html ) (GenBank NM004006.1).",OADS,/arxiv_data1/oa_pdf/29/10/main.PMC5363410.pdf
"Then, the DERs were Received 30 July 2016; accepted 1 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.005 .",OADS,/arxiv_data1/oa_pdf/78/67/main.PMC5363412.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/67/main.PMC5363412.pdf
"Selection of Candidate Biomarkers Based on Network Analysis of DERs To identify the molecular network of the selected DERs, the Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com ) was used.",OADS,/arxiv_data1/oa_pdf/78/67/main.PMC5363412.pdf
The analysis was performed using the Ingenuity Pathway Analysis (IPA) program at http://www.ingenuity.com .,OADS,/arxiv_data1/oa_pdf/78/67/main.PMC5363412.pdf
"Pathway analysis was performed to determine the most relevant signaling pathways associated with DERs, using the IPA ( http://www.ingenuity.com ) database.",OADS,/arxiv_data1/oa_pdf/78/67/main.PMC5363412.pdf
GENE-IS is available at https://github.com/G100DKFZ/ gene-is .,OADS,/arxiv_data1/oa_pdf/b8/d2/main.PMC5363413.pdf
Received 29 August 2016; accepted 1 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.001 .,Non-OADS,/arxiv_data1/oa_pdf/b8/d2/main.PMC5363413.pdf
133 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d2/main.PMC5363413.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods, seven ﬁgures, one table, and four data ﬁles and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.",OADS,/arxiv_data1/oa_pdf/b8/d2/main.PMC5363413.pdf
[ http://hadoop.apache.org ].,OADS,/arxiv_data1/oa_pdf/b8/d2/main.PMC5363413.pdf
Received 21 August 2016; accepted 21 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.006 .,Non-OADS,/arxiv_data1/oa_pdf/5a/02/main.PMC5363415.pdf
89 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/02/main.PMC5363415.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes fourteen ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/02/main.PMC5363415.pdf
"The relatively new agents monomethyl auristatin E (MMAE), a synthetic analog of the natural product dolastatin, 11and the Received 19 September 2016; accepted 2 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.008 .",Non-OADS,/arxiv_data1/oa_pdf/ad/9b/main.PMC5363417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/9b/main.PMC5363417.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ad/9b/main.PMC5363417.pdf
"New gene-editing tools, such as Received 9 October 2016; accepted 20 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.010 .",OADS,/arxiv_data1/oa_pdf/bd/16/main.PMC5363452.pdf
57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/16/main.PMC5363452.pdf
Guide RNAs were designed using a web tool ( http://crispr.mit.edu ) and followed the rule 50-GN (18 –20) NGG-30.,OADS,/arxiv_data1/oa_pdf/bd/16/main.PMC5363452.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two tables and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2016.11.010 .Molecular Therapy: Nucleic Acids 66 Molecular Therapy: Nucleic Acids Vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/16/main.PMC5363452.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fe/0c/10.1177_2325967117695788.PMC5363455.pdf
The gene therapy Received 16 November 2016; accepted 21 November 2016; http://dx.doi.org/10.1016/j.omtn.2016.11.011 .,OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
"Of the 407 mouse orthologs contained in the Sanger cancer consensus genesdatabase ( http://cancer.sanger.ac.uk/census/ ), 14 (3.4%) displayed expression levels that were altered >2-fold when compared to wild-type thymocytes ( Brca2 ,Card11 ,Ccnd1 ,Gnaq ,Hmga1 ,Il21r,Itk, Jazf1 ,Notch1 ,Nr4a3 ,Pdgfrb ,Recql4 ,Rel, and Tfrc).",Non-OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
bioinformatics pipeline was applied for sequencing analysis and variation detection ( http://www.bgitechsolutions.com/ ).,OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
BAM ﬁles and associated metadata in XML format have been uploaded to the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena ) under the study identi ﬁcation number PRJEB8006.,OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
Microar-ray data have been deposited at ArrayExpress ( http://www.ebi.ac.,OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
Statistical Analysis Results were analyzed by the Wilcoxon rank-sum (Mann-Whitney) (http://www.socscistatistics.com/t ests/mannwhitney /default2.aspx ) or Fisher ’s exact test ( http://www.graphpad.com/quickcalcs/ contingency1.cfm ).,OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,Non-OADS,/arxiv_data1/oa_pdf/6a/e2/main.PMC5363493.pdf
"24,27,28The presence of Ca2+ions is required for proper recognition and binding of the li- gands to the carbohydrate recognition domain of the receptor.29,30 Received 19 September 2016; accepted 4 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.003 .",OADS,/arxiv_data1/oa_pdf/ef/9e/main.PMC5363494.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/9e/main.PMC5363494.pdf
http://www.alnylam.,Non-OADS,/arxiv_data1/oa_pdf/ef/9e/main.PMC5363494.pdf
http://www.themedicinescompany.com/sites/ default/ ﬁles/pdf/ALNY-MDCO_PCSsc_AnalystCallSlides_30Aug2015.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ef/9e/main.PMC5363494.pdf
http://www.alnylam.com/ web/assets/ALN-TTRsc02_OTS_101415.pdf .117.,OADS,/arxiv_data1/oa_pdf/ef/9e/main.PMC5363494.pdf
"These data suggest that care shouldbe taken when using shRNA-expressing vectors in either basicresearch or clinical gene therapy, since they can induce type I IFN Received 24 April 2016; accepted 16 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.007 .",Non-OADS,/arxiv_data1/oa_pdf/10/23/main.PMC5363498.pdf
173 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/23/main.PMC5363498.pdf
"(PEGINTRON, MSD) reported that /C24103U/mL of IFN- awas de- tected in the serum following repetitive administration of PEG-IFNin patients with HBV, HCV, or melanoma ( http://database.japic.or.",OADS,/arxiv_data1/oa_pdf/10/23/main.PMC5363498.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes eight ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/10/23/main.PMC5363498.pdf
"CHST15 was puri ﬁed to homogeneity from squid cartilage containing large amounts of CS-E,8and human cDNAs were cloned.9CHST15 is responsible for bone marrow-derived mast cell and pulmonary metastasis.10–12The effect of CHST15 Received 6 September 2016; accepted 20 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.008 .",OADS,/arxiv_data1/oa_pdf/60/47/main.PMC5363499.pdf
163 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/47/main.PMC5363499.pdf
"Kyiv, Ukraine: Ukraine Ministry of Health; 2015. http://ucdc.gov.ua/uploads/documents/c21991/ 2b413308855aa209c676da62a8f 562e9.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1e/75/10.1177_2325957416686194.PMC5363501.pdf
http://www.unaids.org/site s/default/files/country/docu ments/UKR_narrative_repor t_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/75/10.1177_2325957416686194.PMC5363501.pdf
"UNAIDS, 2014. http://www.unaids.org/sites/default/files/media_ asset/90-90-90_en_0.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1e/75/10.1177_2325957416686194.PMC5363501.pdf
"Kyiv, Ukraine, 2011. http://autta.org.ua/ files/Inform_bullet_35.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1e/75/10.1177_2325957416686194.PMC5363501.pdf
"CDC, 2007 https://stacks.cdc.gov/view/c dc/5518.",OADS,/arxiv_data1/oa_pdf/1e/75/10.1177_2325957416686194.PMC5363501.pdf
"Mathematical models for educational simula- tion of cardiovascular pathophysiology, 2009, https://repositorio-aberto.up.pt/bitstream/10216/60409/1/000137145.pdf 6.",Non-OADS,/arxiv_data1/oa_pdf/0f/be/10.1177_0954411917691555.PMC5363502.pdf
21–23We hypothesized that our hybrid nanoparticles would ef ﬁ- ciently deliver loaded anti-mutant K- rassiRNA into the cytosol of Received 25 August 2016; accepted 9 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.009 .,OADS,/arxiv_data1/oa_pdf/1a/1c/main.PMC5363504.pdf
259 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/1c/main.PMC5363504.pdf
A p value of 0.05 was taken as statisti- cally signi ﬁcant.SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2016.12.,OADS,/arxiv_data1/oa_pdf/1a/1c/main.PMC5363504.pdf
"Based on RNA resistant to nucleases, we designed conjugates Received 13 October 2016; accepted 23 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.011 .",OADS,/arxiv_data1/oa_pdf/c0/ee/main.PMC5363506.pdf
209 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/ee/main.PMC5363506.pdf
"Mutations in IDH1/2 genes occur frequently in AML patients, and IDH2 R140Q has been shown to be the most frequent IDH mutation in AML.6IDH mutants pro- mote signi ﬁcant increases in repressive histone methylation marks, inducing a block in cell differentiation and aberrant self-renewal.7 Moreover, IDH2 R140Q has been identi ﬁed as a key driver mutation in a transgenic mouse model, supporting its relevance as a therapeutic target for the treatment of human AML.8 Using the IDH2 R140Q mutation as a model, we present a new effec- tive methodology here using the RNA-guided CRISPR-Cas9 systemto reproduce or remove AML-associated mutations in or from human Received 14 December 2016; accepted 30 December 2016; http://dx.doi.org/10.1016/j.omtn.2016.12.012 .",Non-OADS,/arxiv_data1/oa_pdf/f4/4d/main.PMC5363507.pdf
243 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/4d/main.PMC5363507.pdf
"CRISPR Vectors, sgRNA, and DNA Template Cloning sgRNAs were designed using the website http://crispr.mit.edu/ .",OADS,/arxiv_data1/oa_pdf/f4/4d/main.PMC5363507.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,Non-OADS,/arxiv_data1/oa_pdf/f4/4d/main.PMC5363507.pdf
"35However, the N-terminal domain of the HIV integrase enzyme is not conservativeand thus may cause great concerns on the safety of this approach for Received 17 July 2016; accepted 9 January 2017; http://dx.doi.org/10.1016/j.omtn.2017.01.002 .",Non-OADS,/arxiv_data1/oa_pdf/68/7d/main.PMC5363508.pdf
233 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/7d/main.PMC5363508.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.,Non-OADS,/arxiv_data1/oa_pdf/68/7d/main.PMC5363508.pdf
Received 30 August 2016; accepted 11 January 2017; http://dx.doi.org/10.1016/j.omtn.2017.01.003 .,Non-OADS,/arxiv_data1/oa_pdf/f8/83/main.PMC5363509.pdf
269 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/83/main.PMC5363509.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f8/83/main.PMC5363509.pdf
Received 4 June 2016; accepted 21 January 2017; http://dx.doi.org/10.1016/j.omtn.2017.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/main.PMC5363510.pdf
6 March 2017 ª2017 279 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/main.PMC5363510.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.2017.01.004 .,Non-OADS,/arxiv_data1/oa_pdf/4b/2d/main.PMC5363510.pdf
"We then outline the potential therapeutic utility of fusion genes, their relevance in murine models, and we Received 2 November 2016; accepted 24 January 2017; http://dx.doi.org/10.1016/j.omtn.2017.01.005 .",OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
315 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
"Syndromes of Genetic Predisposition Found among Children with Cancer and the Corresponding Affected Genes Genetic Predisposition Affected Genea Li-Fraumeni syndrome TP53/CHK2/SNF5 Familial Wilms tumor FTW1/2Familial retinoblastoma RB1 Fanconi anemia FANCA IgA de ﬁciency IGAD1 Blood syndrome BLM Wiskott-Aldrich syndrome WAS Ataxia telangiectasia ATM Familial adenomatous polyposis APC Hereditary non-polyposis colon cancer MSH2/MLH1/PMS2 Tuberous sclerosis TSC1/2Beckwith-Wiedemann syndrome Complex Xeroderma pigmentosum ERCC2 aChildren ’s Health and the Environment, WHO Training Package for the Health Sector (World Health Organization, http://www.who.int/ceh ).",Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
aMost of the fusions are listed in the Mitelman database ( http://cgap.nci.nih.gov/Chromosomes/RecurrentAberrations ).,OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
"73–77 An increased number of new fusion genes are expected to be discov- ered, owing to worldwide projects (The Cancer Genome Atlas[TCGA], https://tcga-data.nci.nih.gov/docs/publications/tcga/? )",Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
"and to data-sharing platforms (e.g., the International Cancer GenomeConsortium [ICGC] platform, https://icgc.org/ ; and the European Genome-phenome Archive [EGA], https://ega.crg.eu/ ).",OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
https://apps.health.state.mn.us/mndata/cancer_child#childbraincancer_year .,Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
http://emedicine.medscape.com/article/989841-overview .,Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
https://www.cancer.gov/types/ childhood-cancers/research/childhood-genomics-workshop-summary.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/f8/main.PMC5363511.pdf
This leads to so-called RNAi: mRNA Received 4 August 2016; accepted 31 January 2017; http://dx.doi.org/10.1016/j.omtn.2017.01.006 .,OADS,/arxiv_data1/oa_pdf/f6/c9/main.PMC5363512.pdf
6 March 2017 ª2017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/c9/main.PMC5363512.pdf
"To meet such treatmentmodality, in 2006, Campochiaro and colleagues delivered the gene en-coding PEDF to the retina of nvAMD patients using adenoviral (Ad)delivery and reported signi ﬁcant improvement in 25% of patients Received 24 October 2016; accepted 2 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.002 .",OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
"Currently, three additional gene therapy clinical trials are ongoing ( https://clinicaltrials.gov/ ): trial NCT01494805 is based on the use of an adeno-associated viral(AAV) vector encoding sFlt-1, a splice variant of VEGF receptor 1;trials NCT01301443 and NCT01678872 are based on the use of a len-tiviral vector expressing endostatin and angiostatin (RetinoStat).Aside from the results reported by Campochiaro et al., 8the only other available data are from two Association for Research in Vision andOphthalmology abstracts in 2014 and 2016 (M. Davies et al., 2014,Invest.",Non-OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
"Proteins bands were visualized by chemiluminescence usingthe LAS-3000 imaging system (Fuji ﬁlm) or the Omega Lum G Imaging System (Aplegen) and evaluated by the open source imageprocessing program ImageJ (Rasband, W.S., ImageJ, U.S. NIH,http://imagej.nih.gov/ij/ , 1997 –2014).",OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
"Computational Analysis The raw reads were processed for mapping using R (R: A languageand environment for statistical computing; R Foundation for Statis-tical Computing, https://www.r-project.org/ ) as follows: primer-, transposon-, and right Illumina adaptor-related sequences weretrimmed and the resulting reads were quality ﬁltered by omitting reads containing “N”bases and by trimming reads as soon as two ofﬁve bases have quality encoding less than a phred score of 20.",OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
"The sequence logos for thenucleotide composition around the integration sites were generatedwith the seqLogo package in R. To compute the representation ofthe insertion sites in various annotated segments of the humangenome, databases for various genomic features were downloadedfrom the UCSC database ( http://genome.ucsc.edu ), and the repre- sentation of the insertion sites were counted in the feature intervals using the BEDTools suite.",OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6b/e5/main.PMC5363513.pdf
"FRNA is an RNA-analog adopting a C3 0-endo conformation, whereas FANA adopts an unusual O40-endo Received 7 October 2016; accepted 2 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.001 .",OADS,/arxiv_data1/oa_pdf/97/2c/main.PMC5363678.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/2c/main.PMC5363678.pdf
17 SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,OADS,/arxiv_data1/oa_pdf/97/2c/main.PMC5363678.pdf
"However,two drugs have recently obtained conditional approval in Europe Received 12 November 2016; accepted 6 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.004 .",Non-OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
11 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
A graphical representation of the duplications was produced by creating a custom track and displaying it in UCSC Genome Browser GRCh37/hg19 assembly ( http://genome.ucsc.edu ).,OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
Percentage of DNA modi ﬁcation was calculated using the formula %DNA modi ﬁca- tion = 100*(1-(1-fraction cleaved)1/2) reported on the NEB website (https://www.neb.com/protocols/2014/08/11/determining-genome- targeting-ef ﬁciency-using-t7-endonuclease-i ).,OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
RT-PCR of the exon 2 duplication was performed with Platinum Taq DNA Polymerase High Fidelity (Thermo Scienti ﬁc) and oligos 21F and 448R (designed complementary to exon 1 and 4 of the DMD muscle isoform and taken from http://dmd.nl/ ) and resolved on 2% agarose gel.,Non-OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/04/28/main.PMC5363679.pdf
23 Received 18 November 2016; accepted 2 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.003 .,Non-OADS,/arxiv_data1/oa_pdf/57/31/main.PMC5363680.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/31/main.PMC5363680.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/57/31/main.PMC5363680.pdf
22–26ECO contains a protonable Received 12 November 2016; accepted 11 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.005 .,OADS,/arxiv_data1/oa_pdf/ff/7a/main.PMC5363681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/7a/main.PMC5363681.pdf
"However, report on their effective application in regenerative and reparative therapeu-tics was rare except for human intestinal stem cells, which canbe expanded in culture over long time periods as genetically and Received 11 December 2016; accepted 16 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.007 .",Non-OADS,/arxiv_data1/oa_pdf/35/07/main.PMC5363682.pdf
31 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/07/main.PMC5363682.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes one ﬁgure and one table and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,Non-OADS,/arxiv_data1/oa_pdf/35/07/main.PMC5363682.pdf
"Stem Cells Transl Med., Published online February 28, 2017. http://dx.doi.org/10.1002/sctm.16-0427 .",OADS,/arxiv_data1/oa_pdf/35/07/main.PMC5363682.pdf
Received 31 August 2016; accepted 14 February 2017; http://dx.doi.org/10.1016/j.omtn.2017.02.006 .,Non-OADS,/arxiv_data1/oa_pdf/68/73/main.PMC5363683.pdf
53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/73/main.PMC5363683.pdf
"23TURBOMOLE V6.1 2009, a development of University of Karlsruhe and Forschungszentrum Karlsruhe GmbH , TURBOMOLE GmbH, 1989 –2007, since 2007; available from http://www.turbomole.com.",Non-OADS,/arxiv_data1/oa_pdf/c9/4e/SC-007-C6SC01810F.PMC5363685.pdf
"15–17Regarding prior knowledge about the re- combinant proteins, IL-2 has been widely used in treating malignantmelanoma and renal cell carcinoma 18and it stimulates T cell prolif- eration and differentiation.9,19,20Like IL-2, TNF- acan activate im- mune cells,21but it also induces antitumor in ﬂammation and the pro- duction of other cytokines and chemokines.22,23Moreover, it directly causes cancer cell necrosis and apoptosis.23 In this study, we constructed and characterized new oncolytic adeno-viruses built on a backbone of Ad5/3-E2F-d24 (OAd) carrying human Received 29 November 2016; accepted 20 December 2016; http://dx.doi.org/10.1016/j.omto.2016.12.004 .",Non-OADS,/arxiv_data1/oa_pdf/de/62/main.PMC5363700.pdf
77 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/62/main.PMC5363700.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials and Methods, three ﬁgures, and one appendix and can be found with this article online at http://dx.doi.org/10.1016/j.omto.2016.12.004 .",Non-OADS,/arxiv_data1/oa_pdf/de/62/main.PMC5363700.pdf
"1521-0111/91/4/403 –415$25.00 http://dx.doi.org/10.1124/mol.116.106013 MOLECULAR PHARMACOLOGY Mol Pharmacol 91:403 –415, April 2017 Copyright ª2017 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/2d/39/mol.116.106013.PMC5363712.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: Merlin G Butler, MD, PhD, Departments of Psychiatry, Behavioral Sciences and Pediatrics, University of Kansas  Medical Center, 3901 Rainbow Blvd, MS 4015, Kansas City, KS 66160, United States.",Non-OADS,/arxiv_data1/oa_pdf/c1/60/nihms814447.PMC5363719.pdf
10Irinotecan is currently being used in Received 29 November 2016; accepted 29 November 2016; http://dx.doi.org/10.1016/j.omto.2016.11.004 .,OADS,/arxiv_data1/oa_pdf/f5/28/main.PMC5363723.pdf
67 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/28/main.PMC5363723.pdf
"Toxicol., Published online April 5, 2016.http://dx.doi.org/10.1002/tox.22268 .",OADS,/arxiv_data1/oa_pdf/f5/28/main.PMC5363723.pdf
"Clin Cancer Res., Published online December 15, 2016. http://dx.doi.org/10.1158/1078- 0432.CCR-16-1518 .",Non-OADS,/arxiv_data1/oa_pdf/f5/28/main.PMC5363723.pdf
29–31One Received 21 June 2016; accepted 29 November 2016; http://dx.doi.org/10.1016/j.omto.2016.11.005 .,OADS,/arxiv_data1/oa_pdf/a0/29/main.PMC5363727.pdf
41 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/29/main.PMC5363727.pdf
"DISCUSSION CAR T cell therapy for hematologic malignancies has shown some remarkable success in recent years.29,30,39,57,58We focused on hPSMA targeting in prostate tumors using human anti-hPSMA CAR T cells,because of an existing clinical trial at our institution (MSKCC) (clin- ical trial #NCT01140373, https://clinicaltrials.gov ) (Slovin et al., 2013,J.",Non-OADS,/arxiv_data1/oa_pdf/a0/29/main.PMC5363727.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Materials andMethods and ﬁveﬁgures and can be found with this article online athttp://dx.doi.org/10.1016/j.omto.2016.11.005 .,Non-OADS,/arxiv_data1/oa_pdf/a0/29/main.PMC5363727.pdf
Seminal Received 23 August 2016; accepted 1 December 2016; http://dx.doi.org/10.1016/j.omto.2016.12.001 .,OADS,/arxiv_data1/oa_pdf/37/f7/main.PMC5363728.pdf
55 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/f7/main.PMC5363728.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omto.2016.,Non-OADS,/arxiv_data1/oa_pdf/37/f7/main.PMC5363728.pdf
We Received 3 November 2016; accepted 19 February 2017; http://dx.doi.org/10.1016/j.omto.2017.02.001 .,Non-OADS,/arxiv_data1/oa_pdf/9a/8a/main.PMC5363760.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/8a/main.PMC5363760.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes seven ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omto.2017.02.001 .,Non-OADS,/arxiv_data1/oa_pdf/9a/8a/main.PMC5363760.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/main.PMC5363781.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.002 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/main.PMC5363781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 89 e97,Non-OADS,/arxiv_data1/oa_pdf/ab/d6/main.PMC5363781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/12/main.PMC5363783.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.005 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/12/main.PMC5363783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 112 e116,Non-OADS,/arxiv_data1/oa_pdf/a7/12/main.PMC5363783.pdf
"Acknowledgements This work was supported by the Ministry of Health, Labour and Welfare of Japan, Jisedai-Ippan (H25-002, http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo- h25/gaiyo/08.html )t oZ Y .",Non-OADS,/arxiv_data1/oa_pdf/a7/12/main.PMC5363783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/41/main.PMC5363784.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.003 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/41/main.PMC5363784.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 98 e106,Non-OADS,/arxiv_data1/oa_pdf/a3/41/main.PMC5363784.pdf
The number of disease-free women after 1992 was approximated based on the population statistics in Sweden ( http://www.scb.se ).,OADS,/arxiv_data1/oa_pdf/a3/41/main.PMC5363784.pdf
"Acknowledgements We are grateful to EPSRC (grant EP/K022792/1) for funding,Simon Colebrooke for helpful discussions and Dr Soumya S.Roy for the thermal measurement of the I zSzstates lifetime in 2.Notes and references ‡Data created during this research are available by request from the University of York Data Catalogue (http://dx.doi.org/10.15124 /282717d1-d7d9-428f-8b77-b98b6a8b6f80).",Non-OADS,/arxiv_data1/oa_pdf/ff/36/SC-007-C6SC01956K.PMC5363785.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.03.001 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 135 e142,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
"We have publicly disclosed the information of the survey, including the signi ﬁcance, objectives, and methods on the Tohoku University School of Medicine website ( http://www.med.tohoku.ac.",Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.bousai.go.,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.jst.go.jp/pr/pdf/great_east_japan_earthquake.pdf .,OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from http://nsdl.niscair.res.in/jspui/bitstream/123456789/243/1/PDF%205.5CHAPTER%20ON%20HUMAN%20GROWTH% 20FOR%20CSIR.pdf .,OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.niph.go.jp/ soshiki/07shougai/hatsuiku/index.,OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.childrenshealthfund.org/sites/default/ ﬁles/Legacy-of-Shame-BR- White-Paper-Dec-2009.pdf.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
http://dx.doi.org/10.2188/jea.JE20150073 (Epub 2015 Oct 10).,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.lifescience.mext.go.jp/ ﬁles/pdf/n796_01.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.pref.iwate.jp/hokenfukushi/toukei/ (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.pref.fukushima.lg.,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Available from: http://www.mhlw.go.jp/ ﬁle/04-Houdouhappyou- 11901000-Koyoukintoujidoukateikyoku-Soumuka/gaiyou.pdf (in Japanese).H.,Non-OADS,/arxiv_data1/oa_pdf/93/36/main.PMC5363786.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.006 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S22 eS28,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
https://biobankjp.org/work/ public.html ; Updated 30.06.16.,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
http://ganjoho.jp/reg_stat/statistics/qa_words/ cohort01.html (in Japanese); Updated 11.03.16.,OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
Abridged Life Tables for Japan ; 2014 (in Japanese) http://www.mhlw.go.jp/toukei/saikin/hw/seimei/list54-57- 02.html .,Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
"Cancer Statistics in Japan, 2015 ; 2005. http://ganjoho.jp/en/professional/statistics/brochure/2015_en.",Non-OADS,/arxiv_data1/oa_pdf/6b/9b/main.PMC5363789.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.003 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S9 eS21,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
https://biobankjp.org/work/ public.html ; Updated 30.06.16.,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
National Health and Nutrition Survey ; 2006. http://www.mhlw.go.jp/bunya/kenkou/eiyou08/01.html (in Jap- anese) Accessed 6 June 2016.,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
BMI Classi ﬁcation ; 2016. http://apps.who.int/bmi/ index.jsp?introPage ¼intro_3.html .,OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
Health Effects of Cigarette Smoking ; 2016. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/ effects_cig_smoking/ .,OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm .,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
Adult Obesity Causes &Conse- quences ; 2016. http://www.cdc.gov/obesity/adult/causes.html .,Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
"Guidelines for the Prevention, Care, and Treatment of Persons with Chronic Hepatitis B Infection ; 2015. http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/1b/4a/main.PMC5363792.pdf
"FASTQ files were imported into GENESIS (http://thegenesisprojectfoundation.org/) 7for further analysis using a pipeline build on BWA,8Picard, and FreeBayes.",OADS,/arxiv_data1/oa_pdf/8c/c5/NG2016003939.PMC5363873.pdf
"Journal, 2015. http://globocan.iarc.fr.",Non-OADS,/arxiv_data1/oa_pdf/35/9e/ijo-50-04-1147.PMC5363876.pdf
"To screen the aberrant miRNA expres- sion between NPC tissues and normal nasopharyngeal tissues, two microarray-based high-throughput datasets of NPC from GSE32960 (ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE32nnn/GSE32960/matrix/) and GSE36682 (ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE36nnn/GSE36682/matrix/) were analyzed and showed that miR -150 expression was downregulated in  NPC tissues compared with normal nasopharyngeal tissues (Fig.",OADS,/arxiv_data1/oa_pdf/f3/e0/ijo-50-04-1097.PMC5363880.pdf
A detailed CEP 8 FISH protocol can be found at the Abbott Molecular technical support website (http://www.abbottmolecular.com/contactus/fishtechsupport/keyproductinformation/vysisproducts/cep.html).,Non-OADS,/arxiv_data1/oa_pdf/14/38/ijo-50-04-1075.PMC5363882.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5363955.pdf
E-mail address: sedland@ucsd.edu http://dx.doi.org/10.1016/j.trci.2016.05.002 2352-8737/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5363955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/79/main.PMC5363955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
"These unique biochemical features, the abundance of polyelectrolytic ﬁbrils and hypersulfated HS, serve as speci ﬁc biomarkers for pathologic amyloidContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.08.007 2405-5808/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: TFE, tri ﬂuoroethanol; CD, circular dichroism; SPR, surface plasmon resonance; AL, light chain associated amyloid; ATTR, transthyretin-associated amyloid; AA, in ﬂammation-associated amyloidosis; IAPP, islet amyloid-associated polypeptide nCorrespondence to: University of Tennessee Medical Center, 1924 Alcoa High- way, Knoxville, TN 37920, USA.",Non-OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
"Peptide Mw AA % HelixaPrimary structure p5 3257.7 31 2.60 GGGYS KAQKA QAKQA KQAQK AQKAQ AK- QAK Q p5(D) 3257.7 31 nd [GGGYS KAQKA QAKQA KQAQK AQKAQ AK- QAK Q] D p5(sheet) 2106.6 18 0.05 VYKVK TKVKT KVKTK VKT p5(coil) 2491.7 31 0.02 GGGYS KGGKG GGKGG KGGGK GGKGG GKGGK G p5(Pro3) 3221.7 31 0.23 GGGYS KAQKA PAKQA KQPQK AQKAP AK- QAK Q aHelix content predicted of peptide, based on amino acid sequence, using Agadir ( http://agadir.crg.es/ ) with parameters of; pH ¼7; temperature 298 K, and; an ionic strength of 0.15 [29].",OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
"Computer modeling of peptide binding to amyloid ﬁbrils To obtain initial structures for molecular dynamics (MD) si- mulations, the ZDOCK server ( http://zdock.umassmed.edu/ )w a s used to generate 100 theoretical models of the interaction of peptides p5, p5 (sheet) and p5 (coil) with amyloid ﬁbrils composed of Aβ(17-42) (PDB # 2BEG) [22].",OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
Appendix A. Transparency document Transparency data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.08.007 .,Non-OADS,/arxiv_data1/oa_pdf/a8/ef/main.PMC5363963.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/02/cia-12-543.PMC5364002.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 543–548Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  543RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11539 7 Evaluation of the efficacy of randomized controlled  trials of sensory stimulation interventions for  sleeping disturbances in patients with dementia:  a systematic review Tatiana-Danai Dimitriou1 Magdalini Tsolaki2 1Neuroscience Department, Medical  School, Aristotle University of  Thessaloniki, Thessaloniki, 2Third  Department of Neurology, Aristotle  University of Thessaloniki, Macedonia,   GreeceObjective:  The current review aims to evaluate the sensory stimulation interventions in terms of  reducing sleeping disturbances in patients with dementia.",Non-OADS,/arxiv_data1/oa_pdf/27/02/cia-12-543.PMC5364002.pdf
"It causes significant distress and precipitates institutionalization.4 The most  common sleeping disorders of PwD are the difficulty in falling asleep, the patient may  wander or be involved in inappropriate activities during the night, getting up during  the night, waking up at night and act like it is morning, being awake too early in the Correspondence: Tatiana-Danai  Dimitriou  44 Salaminos Street, Halandri, 15232  Athens, Greece Tel +30 21 6978 113357 email tt.kirxof@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Dimitriou and Tsolaki Running head recto: Evaluation of the efficacy of randomized controlled trials DOI: http://dx.doi.org/10.2147/CIA.S115397",Non-OADS,/arxiv_data1/oa_pdf/27/02/cia-12-543.PMC5364002.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/27/02/cia-12-543.PMC5364002.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/27/02/cia-12-543.PMC5364002.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 229–241Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 229 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S131851 Students’ perceptions of lecturing approaches:  traditional versus interactive teaching Eiman Abdel Meguid1  Matthew Collins2 1Centre for Biomedical Sciences  Education, School of Medicine,   Dentistry and Biomedical Sciences,   2Centre for Computer Science,   School of Electronics, Electrical Engineering and Computer Science,  Queen’s University Belfast, Belfast,  Northern Ireland, UKBackground: There is an increasing trend toward transcending from traditional teaching to  student-centered methodologies that actively engage students.",Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
"4–8Correspondence: Eiman M Abdel Meguid Centre for Biomedical Sciences Education, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK   Tel +44 28 9097 2148   Email e.abdel-meguid@qub.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Abdel Meguid and CollinsRunning head recto: Traditional versus interactive teachingDOI: http://dx.doi.org/10.2147/AMEP .S131851",Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
Available from: http://www.ceebl.manchester.ac.uk/resources/papers/ceeblgr002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 241 Traditional versus interactive teaching,Non-OADS,/arxiv_data1/oa_pdf/d0/73/amep-8-229.PMC5364003.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/61/dddt-11-851.PMC5364004.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 851–864Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  851Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12439 9 Efficacy of cytokine-induced killer cell infusion as  an adjuvant immunotherapy for hepatocellular  carcinoma: a systematic review and meta-analysis ruili Yu,1 Bo Yang,2 Xiaohua  chi,3 lili cai,4 cui liu,5 lei  Yang,6 Xueyan Wang,1 Peifeng  he,7 Xuechun lu2 1Department of allergy, Beijing shijitan  hospital, affiliated to capital Medical  University, 2Department of geriatric  hematology, chinese P la general hospital,   3Department of Pharmacy, chinese  PLA Rocket Force General Hospital,   4Department of geriatric laboratory  Medicine, 5Department of geriatric  Ultrasound, 6Medical Department, nanlou  clinic, chinese P la general hospital,   Beijing, 7school of Medical information  Management, shanxi Medical University,   Taiyuan, People’s republic of chinaAbstract:  This study was designed to evaluate the efficacy and safety of cytokine-induced killer  (CIK) cell-based immunotherapy as an adjuvant therapy for hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/98/61/dddt-11-851.PMC5364004.pdf
"Immunotherapy has been considered as a potential treatment option for HCC for a  number of years.6,7 Several approaches to immunotherapy for HCC have shown promise correspondence: Xuechun lu Department of geriatric hematology, chinese  Pla general hospital, Fuxing road 28, handian  District, Beijing 100853, People’s republic  of china Tel +86 10 6687 6237 email luxuechun@126.co m  Peifeng he school of Medical information Management,  shanxi Medical University, Xinjian south road  56, Yingze District, Taiyuan 30001, People’s  republic of china Tel +86 0351 4135699 email hepeifeng2006@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Yu et al Running head recto: CIK cell infusion for hepatocellular carcinoma DOI: http://dx.doi.org/10.2147/DDDT.S124399",Non-OADS,/arxiv_data1/oa_pdf/98/61/dddt-11-851.PMC5364004.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/98/61/dddt-11-851.PMC5364004.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/61/dddt-11-851.PMC5364004.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 587–595Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  587OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12460 5 Treatment adherence in patients with type 2  diabetes mellitus correlates with different coping  styles, low perception of self-influence on disease,  and depressive symptoms Andrzej Kokoszka1,2 1ii Department of Psychiatry, Medical  University of Warsaw, 2Department of  Psychology, sWP s University of social  sciences and humanities, Warsaw,   PolandBackground:  Insulin analogs are regarded as more convenient to use than human insulin;  however, they require a different administration scheme due to their unique pharmacokinetic and  pharmacodynamic properties.",Non-OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
"Kondratowicza 8, 03-242 Warszawa,  Poland Tel/fax +48 22 326 5892 email andrzej.kokoszka@wum.edu.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kokoszka Running head recto: Treatment adherence in patients with T2DM DOI: http://dx.doi.org/10.2147/PPA.S124605",Non-OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
Available from: http://www.icd10data.com/ICD10CM/Codes/ E00-E89/E08-E13/E11-/E1 1.,OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
"Available from: http://www.psykiatri-regionh.dk/ who-5/Documents/WHO5_Polish.pd f. Accessed September 20, 2010.",OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/36/34/ppa-11-587.PMC5364005.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/db/4c/copd-12-931.PMC5364006.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 931–936International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  931OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13124 6 association between RTEL1  gene polymorphisms  and COPD susceptibility in a Chinese han  population Yipeng Ding* heping Xu* Jinjian Yao Dongchuan Xu Ping he shengyang Yi Quanni li Yuanshui liu Cibing Wu Zhongjie Tian Department of emergency, People’s  hospital of hainan Province, haikou,   hainan, People’s republic of China *These authors contributed equally  to this workObjective:  We investigated the association between single-nucleotide polymorphisms in  regulation of telomere elongation helicase 1 ( RTEL1 ), which has been associated with telom ere  length in several brain cancers and age-related diseases, and the risk of chronic obstructive  pulmonary disease (COPD) in a Chinese Han population.",Non-OADS,/arxiv_data1/oa_pdf/db/4c/copd-12-931.PMC5364006.pdf
"In the past few years, cigarette smoking is considered as the most significant risk  factor of COPD; however, not all smokers will develop COPD.3 The development of  COPD is a result of the interaction between environment factors and a complex array  of genetic traits.4 Regulator of telomere elongation helicase1 (RTEL1) is a DNA helicase crucial  for regulation of telomere length that plays a role in a variety of fundamental cellular  mechanisms such as DNA replication, genome stability, DNA repair, and telomere  maintenance.5,6 Several genome-wide association studies have revealed statistically  significant associations between glioma susceptibility and single-nucleotide polymor - phisms (SNPs) in RTEL1 , such as rs4809324, rs6010620,7 and rs2297440.8 A recent  study showed that mutations in RTEL1  represent an important contributor to pulmonary Correspondence: Yipeng Ding Department of emergency, People’s  hospital of hainan Province, 19 Xiuhua  road, haikou, hainan, 570311,  People’s republic of China Tel/fax +86 898 6622 2502 email dryipengding@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ding et al Running head recto: Association between RTEL1 and COPD risk DOI: http://dx.doi.org/10.2147/COPD.S131246",Non-OADS,/arxiv_data1/oa_pdf/db/4c/copd-12-931.PMC5364006.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/db/4c/copd-12-931.PMC5364006.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/copd-12-931.PMC5364006.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 243–246Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 243 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S131780 Self-regulated learning: why is it important  compared to traditional learning in medical  education?",Non-OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
"Correspondence: Manjunath  Siddaiah-SubramanyaDepartment of General Surgery, Logan Hospital, Armstrong Road, Meadowbrook, Brisbane, QLD 4131, AustraliaTel +61 44 771 9975Email manjunathbss9@yahoo.comJournal name: Advances in Medical Education and Practice Article Designation: PERSPECTIVESY ear: 2017V olume: 8Running head verso: Siddaiah-Subramanya et alRunning head recto: Importance of self-regulated learning in medical educationDOI: http://dx.doi.org/10.2147/AMEP .S131780",Non-OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 246 Siddaiah-Subramanya et al,Non-OADS,/arxiv_data1/oa_pdf/93/6e/amep-8-243.PMC5364007.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/9f/ijn-12-2129.PMC5364008.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2129–2142International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2129OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12601 6 human cytotoxic T -lymphocyte membrane- camouflaged nanoparticles combined with low- dose irradiation: a new approach to enhance drug  targeting in gastric cancer Lianru Zhang rutian li Hong Chen Jia Wei Hanqing Qian shu su Jie shao Lifeng Wang Xiaoping Qian Baorui liu The comprehensive cancer centre of  Drum Tower hospital, Medical school  of Nanjing University and Clinical  Cancer Institute of Nanjing University,   Nanjing, People’s Republic of ChinaAbstract:  Cell membrane-derived nanoparticles are becoming more attractive because of their  ability to mimic many features of their source cells.",Non-OADS,/arxiv_data1/oa_pdf/74/9f/ijn-12-2129.PMC5364008.pdf
"Paclitaxel (PTX) is the most common hydrophobic, chemothera - peutic drug used in gastric cancer treatment,6 but it also exhibits significant adverse  effects because of the drug itself and the co-administered solvent.7 Nanoparticles have been shown to effectively increase chemotherapeutic drug  concentration at tumor sites and to decrease systemic exposure.8 The passive accu - mulation ability of nanoparticles can be attributed to the well-known enhanced per - meability and retention effect.9 The nanoparticles can also be engineered to actively correspondence: Baorui liu The comprehensive cancer centre of  Drum Tower hospital, Medical school  of Nanjing University and Clinical Cancer  Institute of Nanjing University, 321  Zhongshan Road, Nanjing, Jiangsu 210008,  People’s Republic of China Tel +86 25 8310 7081 Fax +86 25 8331 7016 email baoruiliu@nju.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: A new approach to enhance drug targeting in gastric cancer DOI: http://dx.doi.org/10.2147/IJN.S126016",Non-OADS,/arxiv_data1/oa_pdf/74/9f/ijn-12-2129.PMC5364008.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/74/9f/ijn-12-2129.PMC5364008.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/9f/ijn-12-2129.PMC5364008.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 907–922International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  907OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13048 2 laBa/laMa combinations versus laMa  monotherapy or laB a/ICs in COPD: a  systematic review and meta-analysis gustavo J rodrigo1 David Price2,3 antonio anzueto4,5 Dave singh6 Pablo altman7 giovanni Bader8 Francesco Patalano8 robert Fogel7 Konstantinos Kostikas8 1Departamento de emergencia,   hospital Central de las Fuerzas  armadas, Montevideo, Uruguay;   2academic Primary Care, Division of  applied health sciences, University  of aberdeen, aberdeen, scotland,   UK; 3Observational and Pragmatic  research Institute, singapore;   4University of Texas health science  Center, 5south T exas Veterans health  Care system, san antonio, TX, Usa;   6Medicines evaluation Unit, national  Institute for health research  respiratory and allergy Clinical  research Facility, University hospital  of south Manchester nhs Foundation  Trust, University of Manchester,   Manchester, england, UK; 7novartis  Pharmaceuticals Corporation, east  hanover, nJ, Usa; 8novartis Pharma  ag, Basel, switzerlandBackground:  Randomized controlled trials (RCTs) indicate that long-acting bronchodilator  combinations, such as β2-agonist (LABA)/muscarinic antagonist (LAMA), have favorable  efficacy compared with commonly used COPD treatments.",Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
"Keywords:  LABA/LAMA combinations, COPD, LAMA, LABA/ICS, meta-analysis Introduction Long-acting bronchodilators, whether β2 agonists (LABAs) or muscarinic antagonists  (LAMAs), are central to symptom management in patients with COPD.1 As well as  improving lung function and health-related quality of life (HRQoL), they help prevent  exacerbations and increase exercise endurance by reducing pulmonary hyperinflation Correspondence: gustavo J rodrigo Departamento de emergencia, hospital  Central de las Fuerzas armadas, avenue  8 de Octubre 3020, Montevideo  11300, Uruguay Tel +598 9 383 4050 email gustavo.javier.rodrigo@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rodrigo et al Running head recto: LABA/LAMA versus LAMA monotherapy or LABA/ICS in COPD DOI: http://dx.doi.org/10.2147/COPD.S130482",Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
"Available from:  http://goldcopd.or g. Accessed December 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
Available from: http://training.cochrane.org/ handboo k  23.,Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/72/copd-12-907.PMC5364009.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 221–227Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 221 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S127318 Medical students’ perception of the learning  environment at King saud University Medical  college, saudi Arabia, using DrEEM inventory Mona M soliman1,2 Kamran sattar2 sami Alnassar3 Faisal Alsaif4 Khalid Alswat5 Mohamed Alghonaim6 Maysoon Alhaizan7 nawaf Al-furaih7 1Department of Physiology,   2Department of Medical Education,   3Department of surgery, college  of Medicine, King saud University,   4Department of surgery, King saud  University Medical city, 5Department  of internal Medicine, 6Department of  Medicine, 7college of Medicine, King  saud University, riyadh, saudi ArabiaBackground: The students’ perception of the learning environment is an important aspect  for evaluation and improvement of the educational program.",Non-OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
"Box 29825 (29), riyadh 11461, saudi ArabiaTel +966 1 147 0191Email msoliman1@ksu.eduJournal name: Advances in Medical Education and Practice Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: Soliman et alRunning head recto: Medical students’ perception about the learning environmentDOI: http://dx.doi.org/10.2147/AMEP .S127318",Non-OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 227 Medical students’ perception about the learning environment  13.,Non-OADS,/arxiv_data1/oa_pdf/e1/53/amep-8-221.PMC5364010.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/2a/opth-11-529.PMC5364011.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 529–540Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  529Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12917 8 Influence on ocular surface after cataract   surgery and effect of topical diquafosol on   postoperative dry eye: a multicenter  prospective randomized study Kensaku Miyake1 norihiko Y okoi2 On behalf of Dry Eye  After Cataract Surgery  investigational study group  (DASIS group) 1Miyake eye hospital, nagoya,   2Department of Ophthalmology,   Kyoto Prefectural University of  Medicine, Kyoto, JapanPurpose:  To investigate influences of 3% diquafosol sodium ophthalmic solution (DQS) on  ocular surface after cataract surgery and effects on postoperative dry eye.",Non-OADS,/arxiv_data1/oa_pdf/e6/2a/opth-11-529.PMC5364011.pdf
"Factors that contribute to such improvements are  optics of the IOLs,1 including the so-called premium IOLs, corneal configuration,2  and tear film condition.3,4Correspondence: Kensaku Miyake shohzankai Medical Foundation, Miyake  eye hospital, 3-14-20, Ozone, Kita-Ku,  nagoya 462-0825, Japan Tel +81 52 915 8001 Fax +81 52 915 8525 email miyake@spice.or.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Miyake and Y okoi Running head recto: Dry eye after cataract surgery and its treatment by topical diquafosol DOI: http://dx.doi.org/10.2147/OPTH.S129178",Non-OADS,/arxiv_data1/oa_pdf/e6/2a/opth-11-529.PMC5364011.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e6/2a/opth-11-529.PMC5364011.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/2a/opth-11-529.PMC5364011.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2017:10 9–13Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  9 ORiginAL  ReseARch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S129811Assessment of risk factors for postdural puncture  headache in women undergoing cesarean delivery  in Jordan: a retrospective analytical study Wail n Khraise1 Mohammed Z Allouh2 Khaled M el-Radaideh1 Raed s said2 Anas M Al-Rusan1 1Department of Anesthesia,   2Department of Anatomy, Faculty of  Medicine, Jordan University of science  and T echnology, irbid, JordanPurpose: Postdural puncture headache (PDPH) is one of the most recognized complications  after spinal anesthesia in women undergoing cesarean delivery.",Non-OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
"If the complication correspondence: Wail n Khraise Department of Anesthesia, Faculty of Medicine, Jordan University of science and Technology, PO Box 3030, irbid 22110, JordanTel +962 79 905 1295Fax +962 2 720 1064email wnkhraise@just.edu.joJournal name: Local and Regional Anesthesia Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Khraise et alRunning head recto: Postdural puncture headache in women undergoing cesarean sectionDOI: http://dx.doi.org/10.2147/LRA.S129811",Non-OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
"Local and Regional Anesthesia 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 13 Postdural puncture headache in women undergoing cesarean section Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/2c/0a/lra-10-009.PMC5364012.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 923–929International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  923RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S11988 9 A review of general pain measurement tools and  instruments for consideration of use in COPD  clinical practice Alisha Maree Johnson1 Sheree MS Smith1,2 1School of Nursing and Midwifery,   western Sydney University, Penrith,   2Respiratory, Sleep, and environmental  Health Research Academic Unit,   Liverpool Hospital, Liverpool,   NSw , AustraliaBackground:  The experience of pain can have a significant impact on the everyday  life of individuals including those with COPD.",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"More recently, pain has been reported as a frequent symptom in addition to  breathlessness.4 Pain is known to affect psychological well-being5 and has also been linked with a  decrease in quality of life.6 Reviews of pain and COPD indicate that pain may contribute  to an increase in poor clinical outcomes.7 COPD patients with pain are prescribed more  short-acting beta-agonist therapy and oral steroids than those without pain.8 Outpatient  prescription data9 suggest that many COPD patients use opioid pain medications on Correspondence: Alisha Maree Johnson School of Nursing and Midwifery,  western Sydney University,  Locked Bag 1797, Penrith Sydney,  NSw 2751, Australia Tel +61 2 4620 3532 email alisha.j@westernsydney.edu.a u Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Johnson and Smith Running head recto: A review of general pain measurement tools DOI: http://dx.doi.org/10.2147/COPD.S119889",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
Available from: http://www.cosmin.nl/images/upload/ files/COSMIN%20checklist%20manual%20v9.pdf.,Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"Avail - able from: http://sosmanuals.com/manuals/cae48184b7bae3b1 - d85105ea85375b60.pd f. Accessed January 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"Available from: https://www.nhmrc.gov.au/_files_nhmrc/file/ guidelines/developers/nhmrc_levels_grades_evidence_120423.pd f.  Accessed May 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/46/47/copd-12-923.PMC5364013.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/ott-10-1665.PMC5364014.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1665–1671OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1665Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12978 1 Role of cytokines and chemokines in alcohol- induced tumor promotion Danlei Chen1 Fengyun Zhang1 Haifeng Ren1 Jia Luo2 Siying wang1 1School of Basic Medical Sciences,   Anhui Medical University, Hefei,   Anhui, People’s Republic of China;   2Department of Pharmacology and  Nutritional Sciences, University  of Kentucky, College of Medicine,   Lexington, KY, USAAbstract:  Excessive chronic alcohol consumption has become a worldwide health problem.",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/ott-10-1665.PMC5364014.pdf
"We specifically focus on Correspondence: Siying wang School of Basic Medical Sciences,  Anhui Medical University, 81 Meishan  Road, Hefei 230032, Anhui, People’s  Republic of China Tel/fax +86 6 516 1215 email sywang@ahmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: Regulation of cytokines in alcohol-induced tumor promotion DOI: http://dx.doi.org/10.2147/OTT.S129781",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/ott-10-1665.PMC5364014.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/e2/ott-10-1665.PMC5364014.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/e2/ott-10-1665.PMC5364014.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 621–624Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  621 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S133462Treatment application of rivaroxaban in Chinese  patients with livedoid vasculopathy Wenji Chen1  Lina Fan1  Yanyan Wang2  Xiaohu Deng2 1Department of Rheumatology,   Hainan Branch of Chinese People’s  Liberation Army General Hospital,  Sanya,  2Department of Rheumatology,   Chinese People’s Liberation Army General Hospital, Beijing, People’s Republic of ChinaAbstract:  Livedoid vasculopathy (L V) is a chronic prothrombotic disease of cutaneous micro- circulation resulting in cutaneous ischemia and infarction.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
"4 As the first multi- center study, rivaroxaban for livedoid vasculopathy (RILIV A) trial has been published by Weishaupt et al 5 and suggested that rivaroxaban is a suitable treatment option for Correspondence: Xiaohu Deng   Department of Rheumatology, Chinese  People’s Liberation Army General Hospital, Fuxing Road 28, Beijing 100853, People’s Republic of China   Tel +86 136 9123 5155   Email dengxh1970@sina.comJournal name: Journal of Pain Research  Article Designation: CASE SERIESY ear: 2017V olume: 10Running head verso: Chen et alRunning head recto: Treatment application of rivaroxaban in patients with L VDOI: http://dx.doi.org/10.2147/JPR.S133462",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 624 Chen et al chronic disease, and patients with L V complain about daily  injections of LMWH and repeated monitoring of international normalized ratio.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/jpr-10-621.PMC5364015.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 625–634Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  625 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S126851A review and survey of policies utilized   for interventional pain procedures:   a need for consensus Lynn Kohan1  Reza Salajegheh1  Robin J Hamill-Ruth1  Sandeep Yerra1  John Butz2 1Department of Anesthesiology,   University of Virginia, Charlottesville,   VA, 2West River Anesthesiology  Consultants, Rapid City, SD, USABackground: Other than the newly published anticoagulation guidelines, there are currently  few recommendations to assist pain medicine physicians in determining the safety parameters  to follow when performing interventional pain procedures.",Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
"1 The American Society of Anesthesiologists (ASA) suggested  in 2010 that minor pain procedures, under most routine circumstances, do not require Correspondence: Sandeep Yerra   Department of Anesthesiology,  University of Virginia, PO Box 800710, Charlottesville, VA 22908-0710, USA Tel +1 434 924 2283   Fax +1 434 982 0019   Email drsandeepyerra@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Kohan et alRunning head recto: A review of policies utilized for interventional pain proceduresDOI: http://dx.doi.org/10.2147/JPR.S126851",Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
Available from: https://www.asahq.org/quality-and-practice-management/standards-and-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
Available from: http://www.asahq.org/~ /media/Sites/ASAHQ/ Files/Public/Resources/standards-guidelines/statement-on-anesthetic-care-during-interventional-pain-procedures-for-adults.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 634 Kohan et al  12.,Non-OADS,/arxiv_data1/oa_pdf/af/87/jpr-10-625.PMC5364016.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 97–108Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  97 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S128095Alternative remedies for insomnia: a proposed  method for personalized therapeutic trials Kate Romero1,2  Balaji Goparaju1,2  Kathryn Russo1,2  M Brandon Westover1  Matt T Bianchi1,2 1Neurology Department,   Massachusetts General Hospital,   2Division of Sleep Medicine, Harvard  Medical School, Boston, MA, USAAbstract:  Insomnia is a common symptom, with chronic insomnia being diagnosed in 5–10%  of adults.",Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"7,10–13 Certain hypnotics may objec- tively worsen sleep: benzodiazepines might worsen breathing (although the evidence Correspondence: Matt T Bianchi   Wang 7 Neurology, Massachusetts  General Hospital, 55 Fruit Street, Boston, MA 02114, USA Tel +1 617 724 7426   Fax +1 617 724 6513   Email mtbianchi@partners.orgJournal name: Nature and Science of Sleep Article Designation: PERSPECTIVESY ear: 2017V olume: 9Running head verso: Romero et alRunning head recto: Alternative remedies for insomniaDOI: http://dx.doi.org/10.2147/NSS.S128095",Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"Methods We performed a manual search of several print and online resources concerning herbal and supplement remedies of potential relevance for insomnia: The Physician’ s Desk Reference for Herbal Medicines (PDR); 34 the Encyclopedia  of Herbal Medicine,35 The Drug and Natural Medicine Advi- sor (Time Life);36 Medline Plus ( https://medlineplus.gov/ druginfo/herb_All.html), the National Center for Comple-mentary and Integrative Health Database (https://nccih.nih.gov/health/herbsataglance.htm), and the Natural Medicines online database (http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=&s=ND; paid access).",OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
The NIH main-tains a public database for searching for liver toxicity for drugs and supplements (http://www.livertox.nih.gov/).,Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"In addition, UpToDate recommends www.consumerlab.com,  for checking which brands have undergone independent testing, and the FDA has a web resource for safety and recalls that includes foods and herbals (http://www.fda.gov/Safety/Recalls/).",Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/48/ce/nss-9-097.PMC5364017.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/a4/ppa-11-579.PMC5364019.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 579–586Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  579OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S13285 9 health-related quality of life, visual function  and treatment satisfaction following intravitreal  dexamethasone implant for diabetic macular edema Jayashree ramu1 irini chatziralli1 Yit Yang2 geeta Menon3 clare Bailey4 Michael eckstein5 Phil hykin1 sobha sivaprasad1 On behalf of the OZDr Y  study group 1nihr  Moorfields Biomedical  research centre, london, 2The royal  Wolverhampton hospitals nhs Trust,   Wolverhampton, 3Frimley health nhs  Foundation Trust, surrey, 4Bristol eye  hospital, Bristol, 5Brighton and sussex  University hospital, Brighton, UKPurpose:  The aim of this study was to explore and describe quantitatively patient-reported  outcome measures (PROMs), ie, health-related quality of life (QoL), visual function and  treatment satisfaction, in patients with diabetic macular edema (DME) receiving two different  regimens of Ozurdex (intravitreal dexamethasone implant).",Non-OADS,/arxiv_data1/oa_pdf/6f/a4/ppa-11-579.PMC5364019.pdf
"Keywords:  VFQ-25, RetTSQ, RetDQoL, Ozurdex, PRN, treat-and-extent, treatment Introduction Diabetic retinopathy (DR) is one of the most common complications of diabetes  mellitus and is considered to be the leading cause of visual impairment among  adults ,45 years old in the industrialized world.1,2 Diabetic macular edema (DME)  is a sight-threatening complication of DR, and its prevalence has been estimated cur - rently to be ~6.8%, ranging from 3% in people with newly diagnosed diabetes to 28%  in the population with diabetes for 20 years.2,3 Macular laser photocoagulation was the  gold standard for the treatment of DME before the advent of anti-vascular endothelial correspondence: sobha sivaprasad NIHR Moorfields Biomedical Research  centre, 162 city road, ec1V 2PD,  london, UK Tel +44 20 7566 2039 Fax +44 20 7566 2472 email senswathi@aol.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ramu et al Running head recto: Quality of life and treatment satisfaction after Ozurdex for DME DOI: http://dx.doi.org/10.2147/PPA.S132859",Non-OADS,/arxiv_data1/oa_pdf/6f/a4/ppa-11-579.PMC5364019.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6f/a4/ppa-11-579.PMC5364019.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2017:10 19–28Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 19 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S127892 Association of self-reported symptoms with  serum levels of vitamin D and multivariate  cytokine profile in healthy women Fawaz Y Azizieh1 Khulood O Alyahya2 Kamaludin Dingle1 1Department of Mathematics and  Natural Sciences, Gulf University for  Science and T echnology, International Centre for Applied Mathematics and Computational Bioengineering, West Mishref, Kuwait;  2Science Department,   College of Basic Education, Public Authority for Applied Education and Training, Kuwait City, KuwaitBackground:  Although a large number of studies have investigated possible relationships  among serum levels of vitamin D or cytokines with disease progress and prognosis, similar  studies on self-reported symptoms are still controversial.",Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
"10–12Correspondence: Fawaz Y Azizieh Department of Mathematics and Natural Sciences, Gulf University for Science and Technology, Building 1, Block 5, Mubarak Al-Abdullah, West Mishref, KuwaitTel + 965 2 530 7499Email Azizieh.F@gust.edu.kwJournal name: Journal of Inflammation Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Azizieh et alRunning head recto: Association of self-reported symptoms with vitamin D and cytokinesDOI: http://dx.doi.org/10.2147/JIR.S127892",Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
Available from: https://www.rstudio.com.,Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
"Journal of Inflammation Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 28 Azizieh et al 54.,Non-OADS,/arxiv_data1/oa_pdf/01/db/jir-10-019.PMC5364022.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/08/ott-10-1655.PMC5364023.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1655–1663OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1655Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12950 2 human omental adipose-derived mesenchymal  stem cell-conditioned medium alters the  proteomic profile of epithelial ovarian cancer  cell lines in vitro Yanling Zhang1,* Weihong Dong1,* Junjie Wang2 Jing cai1 Zehua Wang1 1Department of Obstetrics and  gynecology, Union hospital, Tongji  Medical college, huazhong University  of Science and Technology, Wuhan,  2Department of Obstetrics and  gynecology, renhe hospital, china  Three gorges University, Yichang,  People’s Republic of China *These authors contributed equally  to this workAbstract:  Mesenchymal stem cells (MSCs) have been reported to participate in the formation  of supportive tumor stroma.",Non-OADS,/arxiv_data1/oa_pdf/25/08/ott-10-1655.PMC5364023.pdf
"O-ADSCs could engraft  in ovarian cancer stroma and contribute to the formation of a hospitable environment correspondence: Zehua Wang Department of Obstetrics and  gynecology, Union hospital, Tongji  Medical college, huazhong University  of Science and Technology, 1277 Jiefang  Avenue, Wuhan, Hubei 430022, People’s  Republic of China Tel/fax +86 27 8535 1649 email zehuawang@163.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhang et al Running head recto: Human O-ADSCs-conditioned medium DOI: http://dx.doi.org/10.2147/OTT.S129502",Non-OADS,/arxiv_data1/oa_pdf/25/08/ott-10-1655.PMC5364023.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/25/08/ott-10-1655.PMC5364023.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/08/ott-10-1655.PMC5364023.pdf
TIC frequency calculated by limiting dilution analysis using http://bioinf.wehi.edu.au/software/elda/.,OADS,/arxiv_data1/oa_pdf/a7/1b/onc2016337a.PMC5364039.pdf
TIC frequency calculated by limiting dilution analysis using http://bioinf.wehi.,OADS,/arxiv_data1/oa_pdf/a7/1b/onc2016337a.PMC5364039.pdf
"MATERIALS AND METHODS Cell culture The BPE, BPLER and OCI cells and their culture media BMI-P, BMI-T and OCMI are available from the Live Tumor Culture Core (LTCC) LTCC@med.miami.edu, at Sylvester Comprehensive Cancer Center (SCCC), MillerSchool of Medicine, University of Miami http://sylvester.org/shared-resources/Live-Tumor-Culture-Core.",OADS,/arxiv_data1/oa_pdf/a7/1b/onc2016337a.PMC5364039.pdf
Limiting dilution analysis was done with http://bioinf.wehi.edu.au/software/elda/index.html.59 CONFLICT OF INTEREST Tan A. Ince discloses pending patent intellectual proprietary interest as the inventor of BMI and OCMI media.,OADS,/arxiv_data1/oa_pdf/a7/1b/onc2016337a.PMC5364039.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Identi ﬁcation of cancer stem cell-speci ﬁc function for HDACs AE Witt et al 1720 Oncogene (2017) 1707 –1720",Non-OADS,/arxiv_data1/oa_pdf/a7/1b/onc2016337a.PMC5364039.pdf
www.ogscience.org 139 Review Obstet Gynecol Sci 2017;60(2):139-144 https://doi.org/10.5468/ogs.2017.60.2.139 pISSN 2287-8572  · eISSN 2287-8580Introduction No fault compensation in perinatal medicine has been estab - lished to provide aid to patients in the event of disability due  to a medical accident during delivery and to strive to resolve  disputes quickly that contributes to reduce medical malpractice  suit in the field of perinatal medicine.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/ogs-60-139.PMC5364095.pdf
"Corresponding author: Mitsutoshi Iwashita Department of Obstetrics and Gynecology, Kyorin University School of  Medicine, 6-20-2, Shinkawa, Mitaka City, Tokyo 181-8611, Japan Tel: +81-422-40-0572  Fax: +81-422-40-0572 E-mail: iwashita@ks.kyorin-u.ac.jp http://orcid.org/ 0000-0002-7137-1613 This abstract was presented at the 21st Seoul International Symposium  as oral presentation in Seoul, K orea, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/ogs-60-139.PMC5364095.pdf
Available from: http://www.sanka-hp.jcqhc.or.jp/documents/prevention/index.html.,OADS,/arxiv_data1/oa_pdf/8f/ec/ogs-60-139.PMC5364095.pdf
Publications by recurrence prevention committee.Find them @ http://www.sanka-hp.jcqhc.or.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/ogs-60-139.PMC5364095.pdf
"www.ogscience.org 145 Original  Article Obstet Gynecol Sci 2017;60(2):145-153 https://doi.org/10.5468/ogs.2017.60.2.145 pISSN 2287-8572  · eISSN 2287-8580Introduction Depression during pregnancy is highly prevalent, affecting be - tween 10% and 16% of pregnant women.",Non-OADS,/arxiv_data1/oa_pdf/8c/45/ogs-60-145.PMC5364096.pdf
"Corresponding author: Soon-Cheol Hong Department of Obstetrics and Gynecology, Korea University Anam  Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk- gu, Seoul 02841, Korea Tel: +82-2-920-6602  Fax: +82-2-921-5357 E-mail: novak082@naver.com http://orcid.org/ 0000-0002-9330-7620 *These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/8c/45/ogs-60-145.PMC5364096.pdf
"For a reliable review process, we checked the quality of  the reviewed papers using the systematic review appraisal  sheet in Critical Appraisal Topic (http://www.cebm.net/critical- appraisal/).",Non-OADS,/arxiv_data1/oa_pdf/8c/45/ogs-60-145.PMC5364096.pdf
"www.ogscience.org 154 Original  Article Obstet Gynecol Sci 2017;60(2):154-162 https://doi.org/10.5468/ogs.2017.60.2.154 pISSN 2287-8572  · eISSN 2287-8580Introduction Pre-eclampsia (PE) is a multi-system disorder characterized by  the new onset of hypertension and proteinuria or end-organ  dysfunction, or both during the second half of pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/8d/8d/ogs-60-154.PMC5364097.pdf
"Corresponding author: Eui Hyeok Kim Department of Obstetrics and Gynecology, National Health Insurance  Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea  Tel: +82-31-900-0211  Fax: +82-31-900-0138 E-mail: raksumi10@gmail.com http://orcid.org/ 0000-0002-3264-3620",Non-OADS,/arxiv_data1/oa_pdf/8d/8d/ogs-60-154.PMC5364097.pdf
"www.ogscience.org 163 Original  Article Obstet Gynecol Sci 2017;60(2):163-169 https://doi.org/10.5468/ogs.2017.60.2.163 pISSN 2287-8572  · eISSN 2287-8580Introduction Induction of labor is an increasingly common obstetric pro - cedure, involving about 20% of all pregnant women [1].",Non-OADS,/arxiv_data1/oa_pdf/85/7e/ogs-60-163.PMC5364098.pdf
"Corresponding author: Soo-young Oh Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3517  Fax: +82-2-3410-0630 E-mail: ohsymd@skku.edu http://orcid.org/ 0000-0003-3002-0048",Non-OADS,/arxiv_data1/oa_pdf/85/7e/ogs-60-163.PMC5364098.pdf
Original  Article Obstet Gynecol Sci 2017;60(2):170-177 https://doi.org/10.5468/ogs.2017.60.2.170 pISSN 2287-8572  · eISSN 2287-8580www.ogscience.org 170 Introduction Epithelial ovarian cancer is the most lethal gynecological can - cer.,Non-OADS,/arxiv_data1/oa_pdf/f2/76/ogs-60-170.PMC5364099.pdf
"Corresponding author: Chel Hun Choi Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3519  Fax: +82-2-3410-0630 E-mail: huna0@naver.com http://orcid.org/ 0000-0002-0199-6669",Non-OADS,/arxiv_data1/oa_pdf/f2/76/ogs-60-170.PMC5364099.pdf
Supplemental Figure  Supplementary figures associated with this article can be  found online at https://doi.org/10.5468/ogs.2017.60.2.170.,Non-OADS,/arxiv_data1/oa_pdf/f2/76/ogs-60-170.PMC5364099.pdf
www.ogscience.org 178 Original  Article Obstet Gynecol Sci 2017;60(2):178-186 https://doi.org/10.5468/ogs.2017.60.2.178 pISSN 2287-8572  · eISSN 2287-8580Introduction Large ovarian tumors are frequently encountered in the gyne - cological field.,Non-OADS,/arxiv_data1/oa_pdf/85/37/ogs-60-178.PMC5364100.pdf
"Corresponding author: Sang Wun Kim Division of Gynecologic Oncology, Department of Obstetrics and  Gynecology, Women’s Cancer Center, Y onsei Cancer Center, Institute of  Women's Life Medical Science, Y onsei University College of Medicine,  50-1 Y onsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-2230  Fax: +82-2-313-8350 E-mail: san1@yuhs.ac http://orcid.org/ 0000-0002-8342-8701",Non-OADS,/arxiv_data1/oa_pdf/85/37/ogs-60-178.PMC5364100.pdf
www.ogscience.org 187 Original  Article Obstet Gynecol Sci 2017;60(2):187-192 https://doi.org/10.5468/ogs.2017.60.2.187 pISSN 2287-8572  · eISSN 2287-8580Introduction Polycystic ovary syndrome (PCOS) is essentially a group of  endocrine disorders that commonly affect women during re - productive age [1].,Non-OADS,/arxiv_data1/oa_pdf/7d/9a/ogs-60-187.PMC5364101.pdf
"Corresponding author: Ishag Adam Faculty of Medicine, University of Khartoum, PO Box 102, 11111,  Khartoum, Sudan Tel: +249-912168988  Fax: +249-183771211 E-mail: ishagadam@hotmail.com http://orcid.org/ 0000-0001-5031-7741",Non-OADS,/arxiv_data1/oa_pdf/7d/9a/ogs-60-187.PMC5364101.pdf
http://dx.doi.org/10.1159/000375530.,Non-OADS,/arxiv_data1/oa_pdf/7d/9a/ogs-60-187.PMC5364101.pdf
http://dx.doi.org/10.1210/jc.0000-9999.,Non-OADS,/arxiv_data1/oa_pdf/7d/9a/ogs-60-187.PMC5364101.pdf
www.ogscience.org 193 Original  Article Obstet Gynecol Sci 2017;60(2):193-199 https://doi.org/10.5468/ogs.2017.60.2.193 pISSN 2287-8572  · eISSN 2287-8580Introduction Uterine leiomyoma is the most common uterine neoplasm.,Non-OADS,/arxiv_data1/oa_pdf/5e/93/ogs-60-193.PMC5364102.pdf
"Corresponding author: Ki Hwan Lee Department of Obstetrics and Gynecology, Chungnam National  University Hospital, Chungnam National University School of Medicine,  282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea Tel: +82-42-280-7260  Fax: +82-42-280-7264 E-mail: oldfox@cnuh.co.kr http://orcid.org/ 0000-0001-9888-8332",Non-OADS,/arxiv_data1/oa_pdf/5e/93/ogs-60-193.PMC5364102.pdf
"www.ogscience.org 200 Original  Article Obstet Gynecol Sci 2017;60(2):200-206 https://doi.org/10.5468/ogs.2017.60.2.200 pISSN 2287-8572  · eISSN 2287-8580Introduction Cervical intraepithelial neoplasia (CIN) is a precancerous le - sion, which can be treated effectively before the transition  to cervical cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/22/14/ogs-60-200.PMC5364103.pdf
"Corresponding author: Y ong Beom Kim Department of Obstetrics and Gynecology, Seoul National University  Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  13620, Korea Tel: +82-31-787-7253  Fax: +82-31-787-4054 E-mail: ybkimlh@snubh.org  http://orcid.org/ 0000-0001-6557-1937",Non-OADS,/arxiv_data1/oa_pdf/22/14/ogs-60-200.PMC5364103.pdf
www.ogscience.org 207 Original  Article Obstet Gynecol Sci 2017;60(2):207-212 https://doi.org/10.5468/ogs.2017.60.2.207 pISSN 2287-8572  · eISSN 2287-8580Introduction Pelvic floor disorders (PFDs) affect a large number of women;  more than 11% undergo at least one surgery to treat these  conditions in their lifetime [1].,Non-OADS,/arxiv_data1/oa_pdf/d4/b4/ogs-60-207.PMC5364104.pdf
"Corresponding author: Eun-Hee Y oo Department of Obstetrics and Gynecology, Kyung Hee University  Hospital at Gangdong, Kyung Hee University College of Medicine, 892  Dongnam-ro, Gangdong-gu, Seoul 05278, Korea  Tel: +82-2-440-6141  Fax: +82-2-440-6295 E-mail: yooe7@khu.ac.kr http://orcid.org/ 0000-0001-6126-3582   This is presented with oral presentation in the session of free com - munication at the 17th annual meeting of Korean Urogynecologic  Society, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d4/b4/ogs-60-207.PMC5364104.pdf
"www.ogscience.org 213 Short Communication   Obstet Gynecol Sci 2017;60(2):213-217 https://doi.org/10.5468/ogs.2017.60.2.213 pISSN 2287-8572  · eISSN 2287-8580Introduction Menopausal hormone therapy is the most effective treatment  for menopausal symptoms of any severity for women under  the age of 60 or for women within 10 years of menopause  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b9/12/ogs-60-213.PMC5364105.pdf
"Corresponding author: Eun Sil Lee Department of Obstetrics and Gynecology, Soonchunhyang University  College of Medicine, 59 Daesagwan-ro, Y oungsan-gu, Seoul 04401, Korea  Tel: +82-2-709-9325  Fax: +82-2-709-9332 E-mail: eslee165@schmc.ac.kr http://orcid.org/ 0000-0003-4132-5533",Non-OADS,/arxiv_data1/oa_pdf/b9/12/ogs-60-213.PMC5364105.pdf
Available from: http://www.fda.gov/Safety/MedWatch/ HowToReport/ucm053087 .,Non-OADS,/arxiv_data1/oa_pdf/b9/12/ogs-60-213.PMC5364105.pdf
"www.ogscience.org 218 Case Report Obstet Gynecol Sci 2017;60(2):218-222 https://doi.org/10.5468/ogs.2017.60.2.218 pISSN 2287-8572  · eISSN 2287-8580Introduction In pregnancy, Tuberculous peritonitis (TP) is an uncommon  form of extrapulmonary tuberculosis, and its diagnosis is likely  to be delayed because the results of radiologic evaluations  and laboratory investigations are usually non-specific [1].",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ogs-60-218.PMC5364106.pdf
"Corresponding author: Soo Ran Choi Department of Obstetrics and Gynecology, Inha University Hospital,  Inha University College of Medicine, 27 Inhang-ro, Jung-gu, Incheon  22332, Korea Tel: +82-32-890-3501  Fax: +82-32-890-2274 E-mail: csran@inha.ac.kr http://orcid.org/ 0000-0003-3371-9102",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ogs-60-218.PMC5364106.pdf
www.ogscience.org 223 Case Report Obstet Gynecol Sci 2017;60(2):223-226 https://doi.org/10.5468/ogs.2017.60.2.223 pISSN 2287-8572  · eISSN 2287-8580Introduction Compartment syndrome is the increased pressure within one  of the body’s compartments that contains muscles and nerves  and can lead to serious problems [1].,Non-OADS,/arxiv_data1/oa_pdf/88/90/ogs-60-223.PMC5364107.pdf
"Corresponding author: Heon Jong Y oo Department of Obstetrics and Gynecology, Chungnam National  University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015,  Korea Tel: +82-42-280-7260  Fax: +82-42-280-7264 E-mail: bell4184@cnuh.co.kr http://orcid.org/ 0000-0003-4808-3450",Non-OADS,/arxiv_data1/oa_pdf/88/90/ogs-60-223.PMC5364107.pdf
www.ogscience.org 227 Case Report Obstet Gynecol Sci 2017;60(2):227-231 https://doi.org/10.5468/ogs.2017.60.2.227 pISSN 2287-8572  · eISSN 2287-8580Introduction Epithelial ovarian tumors are rare in children comprising 15%  to 20% of cases [1].,Non-OADS,/arxiv_data1/oa_pdf/cf/41/ogs-60-227.PMC5364108.pdf
"Corresponding author: Barkha Gupta Department of Pathology, Room no.62, Pathology Block, Maulana Azad  Medical College, Delhi 110002, India Tel: +91-8130068106  Fax: +91-1294164609 E-mail: barkhaguptadr@gmail.com http://orcid.org/ 0000-0001-6594-6989",Non-OADS,/arxiv_data1/oa_pdf/cf/41/ogs-60-227.PMC5364108.pdf
"www.ogscience.org 232 Case Report Obstet Gynecol Sci 2017;60(2):232-235 https://doi.org/10.5468/ogs.2017.60.2.232 pISSN 2287-8572  · eISSN 2287-8580Introduction Since Jordan reported a case of venous thrombosis associ - ated with contraceptive use for the first time in 1961 [1],  many studies have identified the increased risk of venous  thromboembolism (VTE)  in current combined oral contracep - tive ( COC) users [2,3] .",Non-OADS,/arxiv_data1/oa_pdf/18/19/ogs-60-232.PMC5364109.pdf
"Corresponding author: Gyun-Ho Jeon Department of Obstetrics and Gynecology, Haeundae Paik Hospital, Inje  University College of Medicine, 875 Haeun-daero, Haeundae-gu, Busan  48108, Korea  Tel: +82-51-797-2020  Fax: +82-51-797-2030  E-mail: jeon285@hotmail.com  http://orcid.org/ 0000-0003-1128-1656",Non-OADS,/arxiv_data1/oa_pdf/18/19/ogs-60-232.PMC5364109.pdf
"www.ogscience.org 236 Case Report Obstet Gynecol Sci 2017;60(2):236-239 https://doi.org/10.5468/ogs.2017.60.2.236 pISSN 2287-8572  · eISSN 2287-8580Introduction Endometriosis is a common disease, affecting 10% to 15%  of reproductive aged women.",Non-OADS,/arxiv_data1/oa_pdf/a6/75/ogs-60-236.PMC5364110.pdf
"Corresponding author: Tae-Joong Kim Department of Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam- gu, Seoul 06351, Korea Tel: +82-2-3410-3547  Fax: +82-2-3410-0630 E-mail: tj28.kim@gmail.com http://orcid.org/ 0000-0002-9693-9164",Non-OADS,/arxiv_data1/oa_pdf/a6/75/ogs-60-236.PMC5364110.pdf
"[cited 2016 Jan. 5].Available from: http://www.who.int/features/factfiles/mental_health/en/ 20.Grinsvall C, Törnblom H, Tack J, Van Oudenhove L, Simrén M. Psychological factors selectively upregulate rectal pain perception",OADS,/arxiv_data1/oa_pdf/2e/76/1349-7235-56-0383.PMC5364189.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2e/76/1349-7235-56-0383.PMC5364189.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/2e/76/1349-7235-56-0383.PMC5364189.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/18/93/1349-7235-56-0389.PMC5364190.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/18/93/1349-7235-56-0389.PMC5364190.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/45/a5/1349-7235-56-0395.PMC5364191.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/45/a5/1349-7235-56-0395.PMC5364191.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/71/b9/1349-7235-56-0401.PMC5364192.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/71/b9/1349-7235-56-0401.PMC5364192.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f1/15/1349-7235-56-0409.PMC5364193.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f1/15/1349-7235-56-0409.PMC5364193.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/90/cc/1349-7235-56-0413.PMC5364194.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/90/cc/1349-7235-56-0413.PMC5364194.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a6/f1/1349-7235-56-0419.PMC5364195.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a6/f1/1349-7235-56-0419.PMC5364195.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5a/0d/1349-7235-56-0425.PMC5364196.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/5a/0d/1349-7235-56-0425.PMC5364196.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/1349-7235-56-0429.PMC5364197.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/5f/a4/1349-7235-56-0429.PMC5364197.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/17/ff/1349-7235-56-0435.PMC5364198.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/17/ff/1349-7235-56-0435.PMC5364198.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/31/b4/1349-7235-56-0441.PMC5364199.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/31/b4/1349-7235-56-0441.PMC5364199.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/66/07/1349-7235-56-0445.PMC5364200.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/66/07/1349-7235-56-0445.PMC5364200.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6f/7f/1349-7235-56-0449.PMC5364201.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6f/7f/1349-7235-56-0449.PMC5364201.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b5/fe/1349-7235-56-0455.PMC5364202.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b5/fe/1349-7235-56-0455.PMC5364202.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/26/7a/1349-7235-56-0461.PMC5364203.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/26/7a/1349-7235-56-0461.PMC5364203.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/80/dc/1349-7235-56-0463.PMC5364204.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/80/dc/1349-7235-56-0463.PMC5364204.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f7/f4/1349-7235-56-0465.PMC5364205.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f7/f4/1349-7235-56-0465.PMC5364205.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/12/f2/1349-7235-56-0467.PMC5364206.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/12/f2/1349-7235-56-0467.PMC5364206.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9a/23/1349-7235-56-0469.PMC5364207.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/9a/23/1349-7235-56-0469.PMC5364207.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/06/ea/1349-7235-56-0471.PMC5364208.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/06/ea/1349-7235-56-0471.PMC5364208.pdf
"Prof., Division of Cardiac Surgery, The Johns Hopkins Hospital, Sheikh Zayed Tower – Suite 7107,  1800 Orleans St, Baltimore, MD 21287, USA, e-mail: nhibino1@jhmi.edu Received: 14.02.2017, accepted: 14.02.2017.Left heart decompression in patients supported with  extracorporeal membrane oxygenation for cardiac disease Chin Siang Ong, Narutoshi Hibino Division of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, MD, USA Adv Interv Cardiol 2017; 13, 1 (47): 1–2 DOI: https://doi.org/10.5114/aic.2017.66179 Patients on extracorporeal membrane oxygenation  (ECMO) for cardiac disease frequently have some de- gree of left ventricular (LV) distension due to incomplete  unloading.",Non-OADS,/arxiv_data1/oa_pdf/2b/ce/PWKI-13-29534.PMC5364275.pdf
"3 Advances in Interventional Cardiology 2017; 13, 1 (47)Review paper Corresponding author:  Prof. Elżbieta K. Biernacka MD, PhD, Department of Congenital Heart Diseases, Institute of Cardiology, 42 Alpejska St, 04-628 Warsaw, Poland, phone: +48 22 34 34 634, e-mail: k.biernacka@ikard.pl Received: 7.01.2017, accepted: 11.01.2017.Percutaneous pulmonary valve implantation – state of the  art and Polish experience Elżbieta K. Biernacka1, Witold Rużyłło2, Marcin Demkow3 1Department of Congenital Heart Diseases, Institute of Cardiology, Warsaw, Poland  2Institute of Cardiology, Warsaw, Poland  3Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland Adv Interv Cardiol 2017; 13, 1 (47): 3–9 DOI: https://doi.org/10.5114/aic.2017.66180 Abstract Percutaneous pulmonary valve implantation (PPVI) is a relatively new method of treating patients with right ventricular outflow  tract (RVOT) dysfunction after surgical repair of congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/PWKI-13-29535.PMC5364276.pdf
"Medtron-ic, IncInternational Section, 2009.2009: http://www.medtronic.com/intl/melody/melody_warn.html.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/PWKI-13-29535.PMC5364276.pdf
19. http://www.edwards.com/devices/heart-valves/transcathe-ter-sapien-xt-valve-pulmonic.20.,Non-OADS,/arxiv_data1/oa_pdf/cc/27/PWKI-13-29535.PMC5364276.pdf
"10 Advances in Interventional Cardiology 2017; 13, 1 (47)Original paper Corresponding author:  Jacek Legutko MD, PhD, 2nd Department of Cardiology, Jagiellonian University Medical College, 17 Kopernika St, 31-501 Krakow, Poland,   phone: +48 12 424 71 81, e-mail: jacek.legutko@uj.edu.pl Received: 23.11.2016, accepted: 30.12.2016.The Polish Interventional Cardiology TAVI Survey  (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland Radosław Parma1, Maciej Dąbrowski2, Andrzej Ochała1, Adam Witkowski2, Dariusz Dudek3,   Zbigniew Siudak3, Jacek Legutko4 13rd Department of Cardiology, Medical University of Silesia, Katowice, Poland  2Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland  3Department of Interventional Cardiology, Jagiellonian University Medical College, Kraków, Poland   42nd Department of Cardiology, Jagiellonian University Medical College, Kraków, Poland Adv Interv Cardiol 2017; 13, 1 (47): 10–17 DOI: https://doi.org/10.5114/aic.2017.66181 Abstract Introduction: Few studies have assessed the development of transcatheter aortic valve implantation (TAVI) in Poland since its  introduction in 2008, and data on current TAVI activity or practice are missing.",Non-OADS,/arxiv_data1/oa_pdf/76/99/PWKI-13-29536.PMC5364277.pdf
"18 Advances in Interventional Cardiology 2017; 13, 1 (47)Original paper Corresponding author:  Lukasz Mazurkiewicz MD, PhD, Department of Cardiomyopathies, CMR Unit, Institute of Cardiology, 42 Alpejska St, 04-628 Warsaw, Poland, phone: +48 501 717 527, e-mail: lmazurkiewicz@ikard.pl Received: 13.04.2016, accepted: 19.08.2016.ANP and BNP plasma levels in patients with rheumatic  mitral stenosis after percutaneous balloon mitral valvuloplasty Łukasz Mazurkiewicz1, Witold Rużyłło2, Zbigniew Chmielak3, Ewa Opalińska-Ciszek2, Jadwiga Janas2,   Piotr Hoffman4, Tomasz Hryniewiecki5, Jacek Grzybowski6 1Department of Cardiomyopathies, CMR Unit, Institute of Cardiology, Warsaw, Poland   2Institute of Cardiology, Warsaw, Poland   3Department of Cardiology and Interventional Angiology, Institute of Cardiology, Warsaw, Poland  4Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland   5Department of Acquired Cardiac Defects, Institute of Cardiology, Warsaw, Poland   6Department of Cardiomyopathies, Institute of Cardiology, Warsaw, Poland  Adv Interv Cardiol 2017; 13, 1 (47): 18–25 DOI: https://doi.org/10.5114/aic.2017.66182 Abstract Introduction: Atrial (ANP) and B-type (BNP) natriuretic peptides are hormones secreted by the heart as a response to volume  expansion and pressure overload.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/PWKI-13-29537.PMC5364278.pdf
"Paweł Siastała, Jacek Kądziela, Łukasz A. Małek, Mateusz Śpiewak, Katarzyna Lech, Adam Witkowski Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland Adv Interv Cardiol 2017; 13, 1 (47): 26–31 DOI: https://doi.org/10.5114/aic.2017.66183 Abstract Introduction: Coronary artery revascularization is indicated in patients with documented significant obstruction of coronary  blood flow associated with a large area of myocardial ischemia and/or untreatable symptoms.",Non-OADS,/arxiv_data1/oa_pdf/88/a4/PWKI-13-29538.PMC5364279.pdf
"32 Advances in Interventional Cardiology 2017; 13, 1 (47)Original paper Corresponding author:  Fatih Uzun MD, Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey, phone: +90 5057705766, e-mail: fatihuzun28@gmail.com   Received: 6.08.2016, accepted: 24.10.2016.Usefulness of the platelet-to-lymphocyte ratio   in predicting long-term cardiovascular mortality  in patients with peripheral arterial occlusive disease Fatih Uzun1, Mehmet Erturk1, Huseyin Altug Cakmak2, Ali Kemal Kalkan1, Ibrahim Faruk Akturk1,   Ahmet Arif Yalcin1, Begum Uygur1, Umit Bulut1, Kursat Oz3 1Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Training Hospital, Istanbul, Turkey  2Department of Cardiology, Mustafakemalpasa State Hospital, Bursa, Turkey  3 Department of Cardiovascular Surgery, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Training Hospital, Istanbul,  Turkey Adv Interv Cardiol 2017; 13, 1 (47): 32–38 DOI: https://doi.org/10.5114/aic.2017.66184 Abstract Introduction: Inflammation and increased platelet activation play a crucial role in the initiation and progression of atherosclero- sis.",Non-OADS,/arxiv_data1/oa_pdf/17/a9/PWKI-13-29539.PMC5364280.pdf
"Prof., Department of Cardiology, School of Medicine, Trakya University, 22300 Edirne, Turkey,  phone: +90 5335205712, e-mail: mayilmaztepe@yahoo.com Received: 9.09.2016, accepted: 17.10.2016.The impact of a single episode of remote ischemic  preconditioning on myocardial injury after elective percutaneous coronary intervention Mustafa A. Yılmaztepe1, Gökay Taylan1, Meryem Aktoz1, Hanefi Y. Gürlertop1, Yüksel Aksoy1, Fatih Özçelik1,  Kenan Yalta1, Galip Ekuklu2 1Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey  2Department of Public Health, School of Medicine, Trakya University, Edirne, Turkey Adv Interv Cardiol 2017; 13, 1 (47): 39–46 DOI: https://doi.org/10.5114/aic.2017.66185 Abstract Introduction: Myocardial injury after percutaneous coronary intervention (PCI) occurs in approximately 30% of procedures, and  is related to worse prognosis.",Non-OADS,/arxiv_data1/oa_pdf/aa/ab/PWKI-13-29540.PMC5364281.pdf
"47 Advances in Interventional Cardiology 2017; 13, 1 (47)Original paper Corresponding author:  Stanisław Bartuś MD, 2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, 36 Kopernika St, 31-501 Krakow,  Poland, phone: +48 12 424 71 74, e-mail: mbbartus@cyfronet.krakow.pl Received: 3.03.2016, accepted: 28.08.2016.T welve months follow-up after retrograde recanalization  of superficial femoral artery chronic total occlusion Joanna Wojtasik-Bakalarz, Salech Arif, Michał Chyrchel, Tomasz Rakowski, Krzysztof Bartuś, Dariusz Dudek,  Stanisław Bartuś 2nd Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland Adv Interv Cardiol 2017; 13, 1 (47): 47–52 DOI: https://doi.org/10.5114/aic.2017.66186 Abstract Introduction: Fifty percent of cases of peripheral artery disease are caused by chronic total occlusion (CTO) of the superficial  femoral artery (SFA).",Non-OADS,/arxiv_data1/oa_pdf/14/2c/PWKI-13-29541.PMC5364282.pdf
"53 Advances in Interventional Cardiology 2017; 13, 1 (47)Original paper Corresponding author:  Paweł Latacz MD, PhD, Department of Vascular Surgery, University Hospital, 3 Botaniczna St, 31-503 Krakow, Poland, phone: +48 501 730 853, e-mail: pawlat@me.com Received: 7.06.2016, accepted: 12.10.2016.Patient- and lesion-tailored algorithm of endovascular  treatment for arterial occlusive disease of extracranial arteries supplying the brain: safety of the treatment  at 30-day follow-up Paweł Latacz1, Marian Simka2, Paweł Brzegowy3, Piotr Janas4, Marek Kazibudzki5, Piotr Pieniążek6,   Andrzej Ochała7, Tadeusz Popiela3, Tomasz Mrowiecki1 1Department of Vascular Surgery, University Hospital, Krakow, Poland 2Department of Angiology, Private Healthcare Institution SANA Outpatient, Pszczyna, Poland 3Chair of Radiology, Jagiellonian University Medical College, Krakow, Poland 4Department of Neurology, Murcki Hospital, Katowice, Poland 5Department of Vascular Surgery, John Paul II Hospital, Krakow, Poland 6Department of Interventional Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland 73rd Department of Cardiology, Medical University of Silesia, Katowice, Poland Adv Interv Cardiol 2017; 13, 1 (47): 53–61 DOI: https://doi.org/10.5114/aic.2017.66187 Abstract Introduction: Although surgical endarterectomy remains the treatment of choice for carotid artery stenosis, stenting plays an  important role as an alternative treatment modality, especially in high-risk patients.",Non-OADS,/arxiv_data1/oa_pdf/4e/d7/PWKI-13-29542.PMC5364283.pdf
"62 Advances in Interventional Cardiology 2017; 13, 1 (47)Short communication Corresponding author:  Marek Grygier MD, Chair and 1st Department of Cardiology, Poznan University of Medical Sciences, 1/2 Długa St, 61-848 Poznan, Poland,  phone: +48 501 066 432, e-mail: mgrygier@wp.pl Received: 17.11.2016, accepted: 20.12.2016.The Watchman FLX – a new device for left atrial  appendage occlusion – design, potential benefits and first clinical experience Marek Grygier1, Anna Olasińska-Wiśniewska1, Aleksander Araszkiewicz1, Olga Trojnarska1,   Anna Babicz-Sadowska2, Maciej Lesiak1 1Chair and 1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland  2Cardiology Department, Copper Health Center, Lubin, Poland Adv Interv Cardiol 2017; 13, 1 (47): 62–66 DOI: https://doi.org/10.5114/aic.2017.66188 Introduction Although convincing data showed that left atrial ap- pendage (LAA) occlusion could be used as an alternative  to oral anticoagulants, LAA occlusion has emerged as  a  common procedure for stroke prevention in patients  with atrial fibrillation and absolute or relative contrain- dications for oral anticoagulation in many European cen-ters, based on current recommendations of the European  Society of Cardiology.",Non-OADS,/arxiv_data1/oa_pdf/c7/fa/PWKI-13-29543.PMC5364284.pdf
"1, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus  University in Torun, Poland 2Department of Cardiology, The Ludwik Rydygier Provincial Polyclinical Hospital, Torun, Poland Adv Interv Cardiol 2017; 13, 1 (47): 67–71 DOI: https://doi.org/10.5114/aic.2017.66189 Introduction Advanced age and additional co-morbidities in pa- tients suffering from coronary artery disease (CAD), with  complex coronary lesions including multi-vessel and un-protected left main (ULM), preclude surgical revascular - ization due to high perioperative morbidity and mortali-ty.",Non-OADS,/arxiv_data1/oa_pdf/c3/dd/PWKI-13-29544.PMC5364285.pdf
"72 Advances in Interventional Cardiology 2017; 13, 1 (47)Short communication Corresponding author:  Paweł Litwiński MD, PhD, Department of Cardiosurgery and Transplantology, Institute of Cardiology, 42 Alpejska St, 04-628 Warsaw-Anin, Poland, phone: +48 608 165 808, e-mail: open4cor@gmail.com Received: 12.11.2016, accepted: 8.02.2017.Transseptal balloon atrial septostomy for decompression  of the left atrium during extracorporeal membrane oxygenation support as a “bridge to transplantation”  in dilated cardiomyopathy Paweł Litwiński1, Marcin Demkow2, Małgorzata Sobieszczańska3, Jarosław Szymański1, Józef Stolarek1,  Mariusz Kuśmierczyk1 1Department of Cardiosurgery and Transplantology, Institute of Cardiology, Warsaw, Poland  2Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland  3Department of Heart Failure and Transplantology, Institute of Cardiology, Warsaw, Poland Adv Interv Cardiol 2017; 13, 1 (47): 72–74 DOI: https://doi.org/10.5114/aic.2017.66190 Introduction We report the case of a 54-year-old woman with di- lated cardiomyopathy who developed severe biventric- ular failure unresponsive to conventional therapy.",Non-OADS,/arxiv_data1/oa_pdf/df/f1/PWKI-13-29545.PMC5364286.pdf
"75 Advances in Interventional Cardiology 2017; 13, 1 (47)Short communication  Corresponding author:  Sheng-hua Zhou MD, PhD, Department of Cardiology, Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan 410011, China, phone: +86 731 85292012, fax: +86 731 85294038, e-mail: zhoushenghua_guo@163.com Received: 28.08.2016, accepted: 10.11.2016.Transcatheter closure of multi-hole perimembranous  ventricular septal defect with aneurysm using two occluders Yi-yuan Huang, Zhen-fei Fang, Jian-jun Tang, Liang Tang, Xin-qun Hu, Sheng-hua Zhou Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China Adv Interv Cardiol 2017; 13, 1 (47): 75–77 DOI: https://doi.org/10.5114/aic.2017.66191 A 33-year-old man presented to our department for  recurrent respiratory tract infections since early child- hood.",Non-OADS,/arxiv_data1/oa_pdf/b3/18/PWKI-13-29546.PMC5364287.pdf
"Krzysztof Błaszyk, Anna Komosa, Marek Grygier, Anna Olasińska-Wiśniewska, Aleksander Araszkiewicz,  Maciej Lesiak Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland Adv Interv Cardiol 2017; 13, 1 (47): 78–81 DOI: https://doi.org/10.5114/aic.2017.66192 Introduction Transcatheter aortic valve implantation (TAVI) in- cludes the risk for development of heart block.",Non-OADS,/arxiv_data1/oa_pdf/d5/4d/PWKI-13-29547.PMC5364288.pdf
"A novel maneuver of the old technique Mariusz Dębski1, Artur Dębski2, Paweł Tyczyński2, Adam Witkowski2, Marcin Demkow1 1Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland  2Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland Adv Interv Cardiol 2017; 13, 1 (47): 82–83 DOI: https://doi.org/10.5114/aic.2017.66193 Percutaneous coronary intervention (PCI) of chronic  total occlusion (CTO) remains one of the most challeng- ing procedures in interventional cardiology.",Non-OADS,/arxiv_data1/oa_pdf/68/a7/PWKI-13-29548.PMC5364289.pdf
"84 Advances in Interventional Cardiology 2017; 13, 1 (47)Image in intervention  Corresponding author:  Alaa Quisi MD, Department of Cardiology, Adana Numune Training and Research Hospital, 01170 Adana, Turkey, phone: +90 554 202 77 90, e-mail: dr.quisi@hotmail.com Received: 28.09.2016, accepted: 24.10.2016.Congenital aortocaval fistula mimicking atrial septal  defect on transthoracic echocardiography Alaa Quisi, Gülhan Yüksel Kalkan, Ahmet Oytun Baykan, Murat Çaylı Department of Cardiology, Adana Numune Training and Research Hospital, Adana, Turkey Adv Interv Cardiol 2017; 13, 1 (47): 84–85 DOI: https://doi.org/10.5114/aic.2017.66194 An 18-year-old woman was admitted to our clinic for  advanced cardiac evaluation due to long-standing exer - cise-induced dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/04/28/PWKI-13-29549.PMC5364290.pdf
"86 Advances in Interventional Cardiology 2017; 13, 1 (47)Image in intervention  Corresponding author:  Tariq Enezate MD, Division of Cardiology, School of Medicine, University of Missouri-Columbia, 5 Hospital Drive, 65201 Columbia, USA,  phone: 5738827272, e-mail: enezatet@health.missouri.edu Received: 1.08.2016, accepted: 19.09.2016.Super-dominant right coronary artery, absent left  circumflex artery and left anterior descending artery arising from right coronary sinus Tariq Enezate, Jad Omran, Kul Aggarwal Division of Cardiology, School of Medicine, University of Missouri-Columbia, Columbia, USA Adv Interv Cardiol 2017; 13, 1 (47): 86–87 DOI: https://doi.org/10.5114/aic.2017.66195 Introduction Coronary artery anomalies are a diverse group of con- genital disorders whose manifestations and pathophys- iological mechanisms are highly variable, with a  global  incidence of 5.64% [1].",Non-OADS,/arxiv_data1/oa_pdf/39/b0/PWKI-13-29550.PMC5364291.pdf
Available at: http://www.hcplive.com/journals/cardiology-review-online/2007/may2007/may-2007-gandhi.,Non-OADS,/arxiv_data1/oa_pdf/39/b0/PWKI-13-29550.PMC5364291.pdf
"88 Advances in Interventional Cardiology 2017; 13, 1 (47)Image in intervention Corresponding author:  Jakub Baran, Department of Interventional Cardiology, Medical College Jagiellonian University and the John Paul II Hospital, 80 Pradnicka St, 31-202 Krakow, Poland, phone: +48 791 330 302, e-mail: jakub_baran@yahoo.pl Received: 26.10.2016, accepted: 19.02.2017.Intravascular ultrasonography guided 60-mm long   drug-eluting tapered stent implantation in a long calcified lesion in a patient with stable coronary artery disease Jakub Podolec, Jakub Baran, Łukasz Niewiara, Piotr Odrowąż-Pieniążek, Krzysztof Żmudka Department of Interventional Cardiology, Medical College Jagiellonian University and the John Paul II Hospital, Krakow, Poland Adv Interv Cardiol 2017; 13, 1 (47): 88–89 DOI: https://doi.org/10.5114/aic.2017.66196 Patients with stable coronary artery disease and dif- fuse long lesions are becoming more often a challenge for  interventional cardiologists.",Non-OADS,/arxiv_data1/oa_pdf/da/a5/PWKI-13-29551.PMC5364292.pdf
"Michael R. Dashwood1, Andrzej Loesch2 1Surgical and Interventional Sceiences, Royal Free Hospital Campus, University College London Medical School, London, United Kingdom  2 Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School,  London, United Kingdom Adv Interv Cardiol 2017; 13, 1 (47): 90–91 DOI: https://doi.org/10.5114/aic.2017.66197 In their recent article, “Neotinima development in ex- ternally stented vein grafts”, Węglarz et al.",Non-OADS,/arxiv_data1/oa_pdf/35/1a/PWKI-13-29552.PMC5364293.pdf
"Michał Krejca 1, Przemysław Węglarz2, Maria Trusz-Gluza1, Krystyna Bochenek1 1Upper Silesian Cardiology Centre, Silesian University of Medicine, Katowice, Poland  2Department of Human Anatomy, Silesian University of Medicine, Katowice, Poland Adv Interv Cardiol 2017; 13, 1 (47): 92–93 DOI: https://doi.org/10.5114/aic.2017.66199 The saphenous vein (SV) used for coronary artery  bypass graft (CABG) in the described clinical trial was  harvested in a conventional way and stripped of its sur - rounding tissue.",Non-OADS,/arxiv_data1/oa_pdf/3e/66/PWKI-13-29553.PMC5364294.pdf
MLST loci were blasted against the Wolbachia MLST database (http://pubmlst.org/ Wol bachia ).,Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ismej2016164a.PMC5364347.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Plant-mediated Wolbachia transmission S-J Li et al 1028 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/c5/7c/ismej2016164a.PMC5364347.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/Rare microbes and ecosystem function A Jousset et al 862 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/d6/66/ismej2016174a.PMC5364357.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies t his paper on The ISME Journal websit e (http://www.nature.com/ismej)Microbiota network of human milk L Drago et al 884 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/42/11/ismej2016183a.PMC5364364.pdf
"The area under receiver-operating characteristic (AUROC)  curves were used to assess predictive performance of each  score using the R package pROC (R Foundation for Statistical  Computing, c/o Institute for Statistics and Mathematics,  Vienna, Austria; http://www.r-project.org) (8), functions roc   and auc (partial.auc = FALSE) with differences in ROC curves  tested using “roc.test.” Patients were propensity score matched  to adjust for differences in baseline variables associated with  outcome.",OADS,/arxiv_data1/oa_pdf/7b/35/ccm-45-e49.PMC5364515.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16Furthermore, there are many Islamic teachings and  recommendations regarding handwashing before and after  eating and washing the whole body after contact with the  human cadaver.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16which method is more effective in preventing the  transmission of the pathogenic bacteria.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16importance of hands washing for healthy life and  reduce the transmission of infectious agents by medical  employees.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16WHEN HANDS SHOULD BE WASHED The common question on every physician and nurse’s  minds is that when they should wash their hands.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16and Streptococcus pneumoniae.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
The red areas are points of the hands that often  left out of the affected of eluting (this picture was taken out from  Google image search by fraise; hand washing methods and most  frequently  missed which is available  on: http://image.slidesharecdn.,Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"Traditionally, some people are habiting to use toothpicks, in  this way possibility of hands contamination taken place  (this picture  was taken out from Google image search by “mouth disease and  teeth decay which available  on: https://www.google.com/search?q  and hl = en and tbm = isch and tbs = rimg%3ACdN32FuZwAF2I jiBcZWlXdNoTOpM2wI0CisvF9Co5oESlB2jz8eT1G8ahdWdv)",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16GENERAL CARE REMARK 6 Sometimes, an important question has arising, what is  the origin of the community‑acquired bacterial infections  (CABI)?",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16DISCUSSION AND CONCLUSIONS Few exceptions, no part of the human body is free from  the bacterial flora; bacterial are everywhere.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/16an electronic hand hygiene monitoring system on healthcare workers’  compliance to guidelines.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
"International Journal of Preventive Medicine 2017, 8:16 http://www.ijpvmjournal.net/content/8/1/1664.",Non-OADS,/arxiv_data1/oa_pdf/20/71/IJPVM-8-16.PMC5364736.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/3a/89/JPI-8-8.PMC5364737.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:8  http://www.jpathinformatics.org/content/8/1/8workshop  on Integrated  dIagnostIcs A central component of this year’s NDP was a workshop  discussing collaboration between radiology and pathology and  how digital tools relate to developments in this area.",Non-OADS,/arxiv_data1/oa_pdf/3a/89/JPI-8-8.PMC5364737.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:8  http://www.jpathinformatics.org/content/8/1/8Bodén (Linköping, Sweden), Prof. Peter Hamilton (Belfast,  United Kingdom), Assoc.",Non-OADS,/arxiv_data1/oa_pdf/3a/89/JPI-8-8.PMC5364737.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:8  http://www.jpathinformatics.org/content/8/1/8takeaways from his PhD thesis, devoted to new opportunities  for pathologist interaction in digital image review.",Non-OADS,/arxiv_data1/oa_pdf/3a/89/JPI-8-8.PMC5364737.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10SubjectS  and MethodS This study was approved by our Institutional Review  Board (IRB #Pro00013561).",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"To attract worldwide interest and share our educational  resources with pathologists outside our institution, we shared  the web address (http://www.RecutClub.com/) on a Facebook  pathology interest group and on Twitter.Table 1: Survey questions used during the evaluation  period Overall, the interface was easy to use The interface became easier to use with experience The speed of moving between different magnifications was acceptable Digital pathology is a safe alternative to light microscopy in the setting of  unknowns Overall, digital pathology is equivalent to light microscopy in terms of  being able to identify key diagnostic features Figure 1: Mean user ratings for the virtual slide viewing systems.",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10reSultS Initial whole slide image system evaluation results A majority of residents surveyed during the 4-week pilot preferred  the maps’ style web viewers (Google Maps or OpenLayers) to  Ventana Virtuoso or OpenSlide [ Figure  1].",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"The  largest randomly selected image files took nearly 30 min to  process and upload.Table 2: Services utilized during development Scanner iScan Coreo, Ventana Medical Systems Computing AWS cloud server: t2.micro EC2 instance with 1 vCPU and 1 GB of  memory Image processing and upload machine: Xeon E3-1241 v3 processor,  16 GB of RAM, 1 TB Hard Drive, Windows 7 64-bit Statistics Microsoft Excel 2013 functions and two sample t-test Survey systems Google forms: https://www.google.com/forms/about/ LimeSurvey 2.06: https://www.limesurvey.org/ WSI viewing system OpenLayers 3.15.1: http://www.openlayers.org/ JQuery 2.2.2: https://www.jquery.com/ JQuery UI 1.11.4: https://www.jqueryui.com/ Bootstrap 3.3.6: http://www.getbootstrap.com/ Image conversion VIPS 8.3: http//www.vips.ecs.soton.ac.uk/ Kakadu 7.7: http://www.kakadusoftware.com/ File transfer Plupload 2.1.2: http://www.plupload.com/ AWS SDK for Java: https://www.aws.amazon.com/sdk-for -java/ Cloud Computing AWS: http://www.aws.amazon.com/ Programming languages PHP 5.6.22: http://www.php.net/ JavaScript HTML5 CSS Database and server MySQL: https://www.mysql.com/ Apache: http://www.apache.org/ WSI: Whole slide image, AWS: Amazon Web Services Figure 2: Workflow from glass slide to website",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10Website access and social media results A total of 1914 unique IP addresses from 68 countries accessed  the website from 247 unique browser -device combinations.",OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10Pathobin strives to make available and host WSI obtained  through low-resource image acquisition by semiautomated  stitching of manually captured still images.",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
IP address geolocation data acquired using http://www.ipinfo.io,OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10scanning change.",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10 Figure 6: Viewing patterns from 12 individual IP addresses.",OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
We host the system at http://www.RecutClub.,Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:10  http://www.jpathinformatics.org/content/8/1/10Conflicts of interest There are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
Available from: http://www.openslide.org/.,Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
Available from: http://www.openlayers.,Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
Available from:  https://www.digitalpathologyassociation.org/whole-slide-imaging- repository.,OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
Available from: https://www.pathobin.com/.,Non-OADS,/arxiv_data1/oa_pdf/1b/3b/JPI-8-10.PMC5364738.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13having the data elements as discrete elements in a true  database (i.e., SQL, etc.,) which most commonly is achieved by  creating a data file (i.e., comma separated value, tab delimited,  or excel file for examples) with discrete data elements rather  than a free text narrative text file such as “Word”  (most surgical  pathology reports).",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13the information was in a rich text format table  that placed all  information related to the data element before any information  related to the response.",OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13We constructed our synoptic report for this test from an  invasive breast carcinoma using the tumor protocol from  CAP.",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13Third, reminders or warning flags to identify missing items  or additional studies that need to be performed improves  the completeness of the report, and when these reminders  are appropriately designed may reduce the need for force  functions to ensure completeness.",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13use of a pipe as we describe is in no way limited to the website  we use, and any interested laboratory could use this technique  regardless of how their synoptic reports are generated.",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/13There are several limitations to this study.",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
Available  from: http://www.cap.org/.,Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
Available from: http://www.cap.,Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:13  http://www.jpathinformatics.org/content/8/1/1331.",Non-OADS,/arxiv_data1/oa_pdf/79/f8/JPI-8-13.PMC5364739.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12the microscope in many medical schools, clinical conferences,  and medical board tests[7‑9] and is diffusing into clinical practices  for telemedicine and archiving, including rapid retrieval.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12desired a second opinion for each case.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Table 1: Characteristics of the 208 participating pathologists shown aggregated and by Phase I random assignment to  traditional glass or digital whole slide imaging interpretation Characteristics Pathologists, n (%) Total Phase I randomizationa Glass format Digital format Total 208 (100.0) 115 (55.3) 93 (44.7) Demographics Age at survey (years) 30‑39 28 (13.5) 16 (13.9) 12 (12.9) 40‑49 70 (33.7) 41 (35.7) 29 (31.2) 50‑59 74 (35.6) 42 (36.5) 32 (34.4) 60+ 36 (17.3) 16 (13.9) 20 (21.5) Sex Male 132 (63.5) 69 (60.0) 63 (67.7) Female 76 (36.5) 46 (40.0) 30 (32.3) Clinical practice and breast pathology expertise Laboratory group practice size <10 pathologists 134 (64.4) 68 (59.1) 66 (71.0) ≥10 pathologists 74 (35.6) 47 (40.9) 27 (29.0) Fellowship training in breast pathology or surgical pathology No 105 (50.5) 56 (48.7) 49 (52.7) Yes 103 (49.5) 59 (51.3) 44 (47.3) Affiliation with academic medical center No 153 (73.6) 87 (75.7) 66 (71.0) Yes, adjunct/affiliated 35 (16.8) 17 (14.8) 18 (19.4) Yes, primary appointment 20 (9.6) 11 (9.6) 9 (9.7) Do your colleagues consider you an expert in breast pathology?",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12mostly during conferences and teaching.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Table 2: Pathologists’ accuracy by interpretive format (Phase I interpretations compared with the consensus panel  reference interpretations)a Consensus reference  interpretationBenign without  atypiaAtypia DCIS Invasive Total number of  interpretationsPercentage agreement of pathologists with  consensus reference (95% CI) Glass pathologists; interpretation on glass slides (6900 interpretations) Benign without atypia 1803 200 46 21 2070 87 (85‑89) Atypia 719 990 353 8 2070 48 (44-52) DCIS 133 146 1764 54 2097 84 (82-86) Invasive breast cancer 3 0 23 637 663 96 (94‑97) Digital pathologists’ interpretation on digital WSI Images (5580 interpretations) Benign without atypia 1380 216 62 16 1674 82 (79‑85) Atypia 583 720 356 15 1674 43 (39‑47) DCIS 170 147 1348 32 1697 79 (77‑82) Invasive breast cancer 14 1 22 498 535 93 (90‑95) aExpert consensus reference diagnosis obtained using the glass slide format.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12 Figure 3: Reproducibility of interpretations: Intraobserver agreement of participants’ interpretations of the same case in Phase I and Phase II by  diagnostic format used by the participant for interpretation in both phases.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12 Figure 4: Estimated numbers of breast biopsy cases that are under - and over -interpreted in the U.S.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 9 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12manufacturer provided use of a scanner to digitally archive  the glass slides.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Acknowledgments The collection of cancer and vital status data was supported  in part by several state public health departments and  cancer registries throughout the U.S. For a full description  of these sources, please see: http://www.breastscreening.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
HD View SL  was used as the source code to build our digital viewer; see  http://hdviewsl.codeplex.com/for details.,Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 10 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Conflicts of interest There are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
Available from: http://www.captodayonline.com/Archives/0112/0112a_ regulators.html.,OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
Avaiable from: http://www.fda.gov/ucm/ groups/fdagov‑public/@fdagov‑meddev‑gen/documents/document/ ucm435355.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 11 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Initial Invitation Assessed for  Eligibility ( n=691) Ineligible  (n=146) Invited ( n=545) No response (n=156) Responded to Invitatio n  (n=389) Pathologist Respond as Being  Eligible and Interested ( n=252)Excluded  (not interested,  eligibility unknown)  (n=137) Randomization Interpret Traditional Glas s  Slide Format (n=126)Interpret Digital Whole Slid e  Image Format of Each Case ( n=126) Randomization Randomization Set A (n=31)Set B (n=31)Set D (n=32)Set C (n=32) Completed  Set A (n=29)Completed  Set B (n=27)Completed  Set C (n=30)Completed Set D (n=29) Phase I Analysis (n=115)Set A (n=30)Set B (n=32)Set C (n=32)Set D (n=31) Completed  Set A (n=24)Completed  Set B (n=23)Completed  Set C (n=23)Completed  Set D (n=23) Phase I Analysis (n=93) ≥9month washout  before Phase II Appendix 1a:  Pathologist recruitment and randomization for Phase I",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 12 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Invited to Phase II (Randomized to Glass in Phase I) (n=115)Invited to Phase II (Randomized to Digital WSI in Phase I)   (n=93) Phase II Enrollment (n=85)Phase II Enrollment (n=107)Excluded  (not interested,  eligibilit y  unknown)   (n=8)Excluded  (not interested,  eligibilit y  unknown)  (n=8) Randomizatio n Randomization Glass (n=53) Digital (n=54) Glass (n=41) Digital (n=44) Phase II GlassP hase II Digital Randomized  to Format Completed  Phase IIA B C D AA A B B B C C DD D C 14 12 14 13 14 12 13 15 12 12 12 13 10 9 13 13Randomized  to Format Completed  Phase IIPhase II Glass Phase II Digita l 11 91 29 13 9 11 11 10 7 12 8 13 98 11 Phase II Analysis  (n=49) Phase II Analysi s  (n=37) Phase II Analysi s  (n=41) Phase II Analysi s  (n=45)  Appendix 1b:  Phase II detailed flow diagram for pathologist randomization Appendix 2: Rates of over‑ and under‑interpretation and agreement with the reference diagnosis for glass interpretation  and digital interpretation using the digital consensus reference interpretations Consensus  reference  interpretation  based on  digital slide  formataGlass interpretation Digital interpretation Rate of over‑ and under‑interpretation  compared to the reference diagnosisAgreement  with reference  diagnosis  Rate (95% CI)Rate of over‑ and under‑interpretation  compared to the reference diagnosisAgreement  with reference  diagnosis  Rate (95% CI)Over‑interpretation  Rate (95% CI)Under‑Interpretation  Rate (95% CI)Over‑interpretation  Rate (95% CI)Under‑interpretation  Rate (95% CI) Benign  without atypia18 (15-20) - 82 (80-85) 20 (17‑23) - 80 (77‑83) Atypia 19 (16‑22) 36 (32‑39) 46 (42‑49) 22 (19‑26) 34 (30‑38) 44 (39‑48) DCIS 3 (2‑4) 16 (14-18) 81 (78‑83) 2 (2‑3) 19 (17‑22) 78 (76-81) Invasive breast  cancer- 1 (0‑3) 99 (97‑100) - 4 (2-7) 96 (93‑98) DCIS: Ductal carcinoma in situ , CI: Confidence interval",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 13 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Appendix 3: Associations between pathologist and case characteristics and rates of agreement with expert consensus  reference diagnosis when 115 pathologists interpreted breast biopsy cases in glass format, and 93 participants  interpreted in digital format Pathologist characteristics  (n=115 glass, 93 WSI)Number of  pathologistsNumber of  interpretationsPercentage  of diagnoses  over‑interpreted  (95% CI)Percentage  of diagnoses  under‑interpreted  (95% CI)Agreement rate  with reference  diagnosis (95% CI)Pa Age Glass <40 16 960 9 (6‑13) 18 (14-22) 74 (69‑78) 0.16b 40‑49 41 2460 10 (8-12) 13 (11‑16) 77 (74-80) 50‑59 42 2520 11 (9‑13) 13 (11‑16) 76 (73‑79) 60+ 16 960 9 (6‑15) 20 (16-25) 70 (66-74) Digital <40 12 720 14 (8‑23) 18 (12-26) 68 (61-74) 0.98b 40‑49 29 1740 13 (9‑16) 15 (12‑19) 72 (68-76) 50‑59 32 1920 12 (9‑15) 17 (14-20) 71 (68-74) 60+ 20 1200 13 (9‑17) 18 (14-22) 69 (65‑74) Academic affiliation Glass None 87 5220 11 (9‑12) 15 (14-17) 74 (72-76) 0.007c Adjunct affiliation 17 1020 8 (5-12) 14 (10‑19) 78 (74-82) Primary academic 11 660 7 (5-11) 12 (8-16) 81 (76-85) Digital 0.96c None 66 3960 12 (10-14) 17 (15-20) 71 (68‑73) Adjunct affiliation 18 1080 13 (9‑17) 15 (12-20) 72 (67-77) Primary academic 9 540 15 (8-27) 16 (10-25) 68 (61-75) Estimated number of breast  cases interpreted per week Glass <5 31 1860 11 (8-14) 17 (15-21) 72 (68-75) 0.001d 5‑9 44 2640 10 (8‑13) 15 (12-18) 75 (72-78) 10‑19 31 1860 9 (6‑11) 13 (11‑16) 78 (75-81) 20+ 9 540 9 (5‑15) 12 (7-18) 80 (70-87) Digital <5 16 960 13 (9‑19) 22 (17-28) 65 (60‑69) <0.001d 5‑9 47 2820 13 (10‑15) 16 (14‑19) 71 (68-74) 10‑19 22 1320 13 (10‑18) 16 (12-20) 71 (67-75) 20+ 8 480 9 (5‑16) 12 (8-18) 79 (72‑84) Practice sizee Glass 1‑9 pathologists 68 4080 10 (8-12) 16 (14‑19) 74 (71-76) 0.034 ≥10 pathologists 47 2820 9 (8‑12) 13 (11‑15) 78 (75-80) Digital 1‑9 pathologists 66 3960 13 (11‑15) 18 (16-20) 69 (67‑72) 0.06 ≥10 pathologists 27 1620 12 (9‑16) 14 (12-17) 74 (70-77) Expertise in breast pathologyf Glass Nonexpert 88 5280 10 (9‑12) 16 (14-17) 74 (72-76) 0.055 Expert 27 1620 9 (7‑12) 12 (9‑16) 79 (75‑82) Digital Nonexpert 74 4440 13 (11‑16) 17 (15‑19) 69 (67‑72) 0.02 Expert 19 1140 9 (6‑14) 15 (11-20) 76 (71-80) Experience with digital  pathology Glass No 63 3780 10 (8-12) 15 (13‑18) 75 (72-77) 0.61 Yes 52 3120 10 (8-12) 14 (12-17) 76 (73‑78) Contd...",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 14 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Appendix 3: Contd... Pathologist characteristics  (n=115 glass, 93 WSI)Number of  pathologistsNumber of  interpretationsPercentage  of diagnoses  over‑interpreted  (95% CI)Percentage  of diagnoses  under‑interpreted  (95% CI)Agreement rate  with reference  diagnosis (95% CI)Pa Digital No 46 2760 12 (10-15) 19 (16‑22) 69 (66‑72) 0.09 Yes 47 2820 13 (10‑16) 15 (12-17) 72 (69‑75) Test case patient  characteristics ( n=240  test cases)Number of  casesNumber of  interpretationsPercentage  of diagnoses  overinterpreted  (95% CI)Percentage  of diagnoses  underinterpreted  (95% CI)Agreement rate  with reference  diagnosis (95% CI)Pa Patient age at time of  biopsy (years) Glass 40‑49 118 3391 11 (9‑13) 14 (12-16) 76 (73‑78) 0.45 ≥50 122 3509 9 (8‑11) 16 (14-18) 75 (73‑77) Digital 40‑49 118 2744 13 (11‑16) 16 (14‑19) 71 (68‑73) 0.81 ≥50 122 2836 12 (10-14) 17 (15-20) 71 (68‑73) Breast density Glass Low 118 3391 8 (7-10) 14 (12-16) 77 (75-80) <0.001 High 122 3509 11 (10‑13) 16 (14-18) 73 (71‑75) Digital Low 118 2744 12 (10-14) 16 (14-18) 73 (70‑75) <0.001 High 122 2836 13 (11‑16) 18 (16-20) 69 (66‑71) Type of biopsy Glass Core needle 138 3953 11 (9‑13) 14 (13‑16) 75 (73‑77) 0.35 Excisional 102 2947 9 (7‑10) 15 (13‑18) 76 (74-78) Digital Core needle 138 3207 15 (12-17) 15 (13‑17) 70 (68‑73) 0.61 Excisional 102 2373 10 (8-12) 19 (17‑22) 71 (68-74) Pathologist assessment of  test caseNumber of  interpretationsPercentage  of diagnoses  overinterpreted  (95% CI)Percentage  of diagnoses  underinterpreted  (95% CI)Agreement rate  with reference  diagnosis (95% CI)Pa Difficulty rating Glass Low (1‑3) 4829 6 (5-7) 13 (11‑15) 81 (79‑83) <0.001 High (4-6) 2071 19 (17‑22) 19 (16‑22) 62 (59‑64) Digital Low (1‑3) 3432 8 (6‑9) 15 (13‑17) 77 (75‑79) <0.001 High (4-6) 2148 20 (17‑23) 19 (17‑22) 60 (58‑63) Case considered “borderline” Glass No 5097 7 (5-8) 13 (11‑15) 81 (79‑82) <0.001 Yes 1803 19 (17‑23) 20 (17‑23) 60 (57-64) Digital No 4208 9 (8‑11) 15 (13‑17) 75 (73‑78) <0.001 Yes 1372 22 (19‑26) 22 (19‑25) 56 (53‑60) Second opinion desired Glass No 4449 6 (5-7) 12 (11-14) 82 (80-84) <0.001 Yes 2451 17 (15-20) 20 (17‑23) 63 (60‑66) Contd...",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
"Journal of Pathology Informatics 15 J Pathol Inform 2017, 1:12  http://www.jpathinformatics.org/content/8/1/12Appendix 3: Contd... Pathologist characteristics  (n=115 glass, 93 WSI)Number of  pathologistsNumber of  interpretationsPercentage  of diagnoses  over‑interpreted  (95% CI)Percentage  of diagnoses  under‑interpreted  (95% CI)Agreement rate  with reference  diagnosis (95% CI)Pa Digital No 3208 7 (6‑9) 15 (13‑17) 78 (76-80) <0.001 Yes 2372 20 (17‑23) 20 (17-22) 61 (58-64) Confidence in assessment Glass High 5640 8 (7‑9) 13 (12‑15) 79 (77‑80) <0.001 Low 1260 19 (15‑24) 21 (17-26) 60 (55-65) Digital High 4385 11 (9‑13) 16 (14-18) 73 (71‑75) <0.001 Low 1195 18 (15‑23) 20 (17-24) 61 (57-66) aP value for covariate effect on agreement rate, bA test for trend based on a logistic regression model, which includes a single 4-category ordinal variable  for pathologist age category, cP value comparing none versus any academic affiliation (adjunct or primary), dA test for trend based on a logistic regression  model, which included a single 4-category ordinal variable for number of cases interpreted per week, e <10 versus ≥10 other pathologists in the same  laboratory who also interpret breast tissue, fExpertise defined as self‑reported completion of a fellowship in breast pathology and/or their peers considering  them an expert in breast pathology Appendix 4: Reproducibility of interpretations: Intraobserver agreement between interpretations of the same case in  Phase I and Phase II by diagnostic format used for interpretation.",Non-OADS,/arxiv_data1/oa_pdf/d8/17/JPI-8-12.PMC5364740.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9nuclear atypia, microvascular proliferation, and presence of  absence of necrosis.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9of larger tissues, automatically classify fundamental tissue  lineages, and detect pathological malignancies in basal cell  carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
Histological sections  from the top (long OS) and bottom (short OS) terciles were then  downloaded from the TCGA ftp site (https://www.tcga‑data.nci.nih.gov/tcgafiles/ftp_auth/distro_ftpusers/anonymous/ tumor/lgg/) and subjected to subsequent analysis.,OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9opening, closing, and Gaussian smoothing.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9was then obtained by identifying the image patch  (tile) nearest  to the corresponding cluster centroid [ Figure  3b].",OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
[41] (https://www.confluence.broadinstitute.org/display/ GDAC/Home).,OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9and possibly, time ‑to‑MT.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9molecular signaling motifs which have previously been  associated with OS [ Figure  5].",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/9Collectively, these data provide potentially interesting insights  into the molecular correlates of the identified visual words;  however, detailed experiments to confirm these associations  are required but outside the scope of this paper.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"The availability of large‑scale cloud‑based storage and analytic infrastructure (TCGA,  Genomic Data Commons, The Cancer Digital Slide Archive[48]  [http://cancer.digitalslidearchive.net/], etc.,) might provide a  possible solution to overcome these resource challenges.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
"Journal of Pathology Informatics 9 J Pathol Inform 2017, 1:9  http://www.jpathinformatics.org/content/8/1/96.",Non-OADS,/arxiv_data1/oa_pdf/48/da/JPI-8-9.PMC5364741.pdf
Available FREE in open access from:  http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 2 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11teachIng  consIderatIons At UCPH, coursework is presented either as lectures or as  lessons with classrooms of up to 24 students.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 3 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11that many medical doctors use microscopes as part of their  daily routine.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 4 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11linked to the faculty servers, access to these repositories was  restricted to persons with a faculty user account.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 5 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11capable of accommodating login spikes, which occur at  the beginning of examinations when approximately 250  students may login simultaneously.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 6 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11 Figure 3: (a-c) Screenshots of the latest PathXL viewer in the VIRMIK virtual microscopy platform (available from April 2016).",OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 7 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11The transition from conventional microscopy and boxed glass  slide collections was accomplished in different ways.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 8 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11ImPact on teachIng The transition from conventional to virtual microscopy  presented certain challenges for teachers.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 9 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/11Toronto and New York.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"Journal of Pathology Informatics 10 J Pathol Inform 2017, 1:11  http://www.jpathinformatics.org/content/8/1/1119.",Non-OADS,/arxiv_data1/oa_pdf/84/af/JPI-8-11.PMC5364742.pdf
"International Journal of Preventive Medicine 2017, 8:17 http://www.ijpvmjournal.net/content/8/1/17period, concerns about pain and worry about changes  in their personal lives as a result of pregnancy and  childbirth.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
"International Journal of Preventive Medicine 2017, 8:17 http://www.ijpvmjournal.net/content/8/1/17or fear of the changes in personal life of mother  (three  items).",Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
"International Journal of Preventive Medicine 2017, 8:17 http://www.ijpvmjournal.net/content/8/1/17Table   3 results shows the results of indicators model  for examining the factor structure of the questionnaire  through confirmatory factor analysis.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
"International Journal of Preventive Medicine 2017, 8:17 http://www.ijpvmjournal.net/content/8/1/17calculate reliability, split‑half coefficient  (split method)  and test‑retest method is used by Pearson correlation.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
"International Journal of Preventive Medicine 2017, 8:17 http://www.ijpvmjournal.net/content/8/1/17From obtained correlations, pregnancy anxiety has the  most positive correlation with “relationship during  pregnancy oneself and the partner concern for” subscale  which is equal to r =  0.77.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
Available from: http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
Available from: http://www.dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6c/94/IJPVM-8-17.PMC5364743.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18to human fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18Bank of Iran, Pasteur Institute of Iran, Tehran, Iran  and were cultured according to the source’s guidelines.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18The data showed significant (P < 0.05) difference in  the toxicity of methanolic extract of A. capillus‑veneris   between doses 1000, 1500, and 2000 µg/mL in comparison  to the control cells, and there was no significant  (P > 0.05) difference at doses of 5, 50, 250, and 500 µg/ mL, in comparison to the cells group at 24, 48, and 72 h  after treatment [ Figure s 1‑3 and Table  3].group means for target genes Tgfβ1and Vegf‑A  versus the  normalizing Gapdh  gene.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18There was a significant difference in the toxicity of  methanolic extract of C. molmol  between doses 1500  and 2000 µg/mL in comparison to the control cells,  whereas there was no significant ( P > 0.05) difference  at doses at 5, 50, 250, 500, and 1000 µg/mL in  comparison to the control cells at 24, 48, and 72 h after  treatment [ Figure s 1‑3 and Table  4].",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18DISCUSSION In recent years, the investigation on herbal treatment has  improved worldwide.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18Cell migration is an extremely coordinated, multi‑step  course that organizes embryonic morphogenesis, tissue  healing, and redevelopment.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18granulation tissue of a healing wound.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
"International Journal of Preventive Medicine 2017, 8:18 http://www.ijpvmjournal.net/content/8/1/18Circ Res 2007;100:782‑94.",Non-OADS,/arxiv_data1/oa_pdf/8c/cc/IJPVM-8-18.PMC5364744.pdf
Available	at:	http://www.amar.org.ir.,Non-OADS,/arxiv_data1/oa_pdf/93/b2/IJNMR-22-1.PMC5364745.pdf
Available	 from:	 http://www.who.int/features/factfiles/ noncommunicable_diseases/en.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/IJNMR-22-57.PMC5364754.pdf
Available	 from:	http://www.who.int/mediacentre/ factsheets/fs348/en/[Last	 accessed	on	2016	Apr	17].,OADS,/arxiv_data1/oa_pdf/1f/cd/IJNMR-22-81.PMC5364760.pdf
Available	 from:	http://lac.unfpa.,Non-OADS,/arxiv_data1/oa_pdf/1f/cd/IJNMR-22-81.PMC5364760.pdf
ORCID ID: http://www.orcid.or/0000-0001-7960-6707.,OADS,/arxiv_data1/oa_pdf/b9/49/MA-71-62.PMC5364781.pdf
"Confirmation of pri-mary hyperthyroidism today is based ORIGINAL PAPER © 2017 Edo Hasanbegovic, Snijezana  Hasanbegovic, Edin Begic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.62-65 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/b9/49/MA-71-62.PMC5364781.pdf
Phone: +387 33 297 012; ORCID ID: http://orcid.org/0000-0003-2206-2555.,Non-OADS,/arxiv_data1/oa_pdf/94/be/MA-71-29.PMC5364782.pdf
"In literature reports, the prevalence of thyroid autoimmunity in CU patients varies from 4.3% to 57% and another 5-10% have clini-cally apparent thyroid disease (7-9).ORIGINAL PAPER © 2017 Emina Kasumagic Halilovic,  Nermina Beslic, Nermina Ovcina Kurtovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.29-31 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/94/be/MA-71-29.PMC5364782.pdf
"To ensure basic rights and freedom, healthcare interventions should be guided by the value of benefiting others; individuals should be treat - ed honestly, equally, and impartially ORIGINAL PAPER © 2017 Ferid Krupic, Kristian Samuelsson,  Nabi Fatahi, Olof Skoldenberg, Arkan S. Sayed-Noor This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.42-47 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/MA-71-42.PMC5364783.pdf
Statistics/Statistical Yearbook 12th September 2013 Available from http://www.unhcr.org/cgi- bin/texis/vtx/home.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/MA-71-42.PMC5364783.pdf
(Accessed  August 2008) http://g3.spraakdata.gu.se.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/MA-71-42.PMC5364783.pdf
http://www.epn.se/eng/ start/2003_460.apsx (last accessed Juni 2015).,OADS,/arxiv_data1/oa_pdf/8b/4e/MA-71-42.PMC5364783.pdf
"Wet cough is a specific feature of exudation phase, except in lower respiratory diseases it can be found as productive cough or sore throat lasting secretion of hypertrophic and chronically inflamed adenoid vegeta-tions.REVIEW © 2017 Edin Begic, Zijo Begic, Amra  Dobraca, Edo Hasanbegovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.66-68 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/5c/2f/MA-71-66.PMC5364784.pdf
"CASE REPORT A 58-year old female was referred  for evaluation due to persistent exo-CASE REPORT © 2017 Mirna Erman-Vlahovic, Jelena  Vlahovic, Milanka Mrcela, Zlatko Hrgovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.72-75 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/57/42/MA-71-72.PMC5364785.pdf
ORCID ID http://orcid.org/0000-0002-9546-6756 Phone: +38761 623 933.,Non-OADS,/arxiv_data1/oa_pdf/31/f6/MA-71-20.PMC5364786.pdf
"The treatment response and out -ORIGINAL PAPER © 2017 Azra Jahic, Ermina Iljazovic,  Samira Hasic, Aida Custovic Arnautovic, Damir Sabitovic, Semir Mesanovic, Haris Sahovic, Vlastimir Simendic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.20-24 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/31/f6/MA-71-20.PMC5364786.pdf
"Recent scientific findings indicate that factors associ-ated with poor living habits are also ORIGINAL PAPER © 2017 Radojka Bijelic, Snjezana  Milicevic, Jagoda Balaban This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.25-28 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/e6/93/MA-71-25.PMC5364787.pdf
"Good nutrition is es -ORIGINAL PAPER © 2017 Merita Berisha, Naser Ramadani,  Rina Hoxha, Sanije Gashi, Valbona Zhjeqi, Drita Zajmi, Ilir Begolli This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.37-41 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
Avail - able from: http://siteresources.worldbank.org/Kosovo_PA_re - port_final-16 June 2005.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
Avail - able from: http://www.who.int/nutrition/topics/complemen - tary_feeding/en/ 6.,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
Available from: http://www.interesjournals.org 17.,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
Available from: http://www.ijhsonline.com 24.,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
Available from: https://data.unicef.org/resources/first- hour-life-new-report-breastfeeding-practices/.,Non-OADS,/arxiv_data1/oa_pdf/9e/2f/MA-71-37.PMC5364788.pdf
ORCID ID: http://orcid.org/0000-0002-9080-5456.,OADS,/arxiv_data1/oa_pdf/0d/46/MA-71-4.PMC5364789.pdf
"Th  e most com-EDITORIAL © 2017 Izet Masic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.4-6 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/MA-71-4.PMC5364789.pdf
"However, at the time of diag-nosis of uveitis a significant number ORIGINAL PAPER © 2017 Almira Cosickic, Meliha Halilbasic,  Amela Selimovic, Harun Avdagic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.52-55 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/c3/57/MA-71-52.PMC5364790.pdf
"Clinical examination shows painful joint on palpation, crepitus phenomenon in movements, decreased range of mo-tion, deformation of a joint, disorder of a joint axis, swelling, effusion and ORIGINAL PAPER © 2017 Adnana Talic-Tanovic, Zoran  Hadziahmetovic, Ivanka Madjar-Simic, Adnan Papovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.48-51 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/11/c8/MA-71-48.PMC5364791.pdf
"We report the case of a 14-year-old boy with a stage IV keratoconus in both eyes, which has been treated with a combined MARK + CXL intervention, known CASE REPORT © 2017 Marco Abbondanza, Gabriele  Abbondanza, Valentina De Felice This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.69-71 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/1d/1b/MA-71-69.PMC5364792.pdf
"On the other hand numerous pub- lications have suggested alterations of autonomic nervous system mod-ORIGINAL PAPER © 2017 Meldijana Omerbegovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.12-15 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/a2/60/MA-71-12.PMC5364793.pdf
2010. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/a2/60/MA-71-12.PMC5364793.pdf
"There is great interest in the study of common pathophysiological mecha-nisms between LUTS/BPH and ED, primarily due to the high prevalence of both conditions, their frequent as -ORIGINAL PAPER © 2017 Amel Kardasevic, Snjezana  Milicevic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.32-36 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/a7/19/MA-71-32.PMC5364794.pdf
2013; 67(1): 32-45. http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a7/19/MA-71-32.PMC5364794.pdf
2003 Dec; 44(6): 637- 49. http://www.ncbi.nlm.nih.gov/pubmed/146441 14 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/19/MA-71-32.PMC5364794.pdf
2013 Jan; 67(1): 32-45. http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/a7/19/MA-71-32.PMC5364794.pdf
"Impact of psychological conditions of fathers – the veterans of war with post-traumatic stress dis-order to children is strong and they represent a significant risky group for development of mental disorders.Keywords: behavioral problems, emotional difficulties, children and early adolescents, veterans of war, post-traumatic stress disorder.ORIGINAL PAPER © 2016 Zihnet Selimbasic, Osman  Sinanovic, Esmina Avdibegovic, Maja Brkic, Jasmin Hamidovic This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2016.70.56-61 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/4e/76/MA-71-56.PMC5364795.pdf
"2015; 20; 21(3): 1-22.LETTER TO EDITOR © 2017 Jasmin Zvornicanin This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.76-76 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/c6/b2/MA-71-76.PMC5364796.pdf
ORCID ID http://orcid.org/0000-0003-4936-1475.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
"A study of hand hy - giene’ compliance in Intensive Care ORIGINAL PAPER © 2017 Idriz Sopjani, Patrick Jahn, Johann  Behrens This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.16-19 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2006 Oct 31; 6(10): 641-52. doi: http://dx.doi.org/10.1016/S1473-3099(06)70600-4 2.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2003 Aug 31; 54(4): 258-66. doi: http://dx.doi.org/10.1016/S0195-6701(03)00150-6 3.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2006 Apr 1; 27(04): 421-3. doi: http://dx.doi.org/10.1086/503387 5.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2008 Nov 30; 36(9): 627-37. doi: http://dx.doi.org/10.1016/j.ajic.2008.03.003 6.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2016 Feb 1; 44(2): 222-7. doi: http://dx.doi.org/10.1016/j.ajic.2015.10.004 8.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2015 May 1; 43(5): 533-6. doi: http://dx.doi.org/10.1016/j.ajic.2015.01.024 12.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2012 Dec 1; 18(12): 1212-8. doi: http://dx.doi.org/10.1111/j.1469-0691.2011.03735.x 14.,Non-OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2016 Feb 1; 44(2): 222-7. doi: http://dx.doi.org/10.1016/j.ajic.2015.10.004 15.,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2015 Oct; 4(4): 582. doi: http://dx.doi.org/10.4103/2249-4863.174298 16.,Non-OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2004 Jul 6; 141(1): 1-8. doi: http://dx.doi.org/10.7326/0003-4819-141-1-200407060-00008 17.,Non-OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
2006 Mar; 84(3): 181-8. doi: http://dx.doi.org/10.1590/S0042-96862006000300012 19.,Non-OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
Retreived on http://epubs.rcsi.ie/cgi/viewcontent.cgi?article=1075&contex - t=mscttheses,OADS,/arxiv_data1/oa_pdf/8b/ee/MA-71-16.PMC5364797.pdf
"AIM The aim of the study was to inves - tigate neuroimaging findings in chil-ORIGINAL PAPER © 2017 Feriha Hadzagic-Catibusic, Edin  Avdagic, Smail Zubcevic, Sajra Uzicanin This is an Open Access article distributed  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/ ) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi: 10.5455/medarh.2017.71.5-11 Med Arch.",Non-OADS,/arxiv_data1/oa_pdf/cb/5c/MA-71-7.PMC5364798.pdf
The percentage of children who are black or  Hispanic was obtained from the U.S. Census Bureau [ http://quickfacts.census.gov/qfd/states/ 37000.html ].,OADS,/arxiv_data1/oa_pdf/92/a0/nihms846095.PMC5364800.pdf
"The percentage of  extremely low birth weight (<1,000 g) births by county in 2010 was obtained from the NC  State Center for Health Statistics [ http://www.schs.state.nc.us/ ].",OADS,/arxiv_data1/oa_pdf/92/a0/nihms846095.PMC5364800.pdf
Information on the number  of doctors by county was obtained from the North Carolina Health Professions Data System  [http://www.shepscenter.unc.edu/hp/prof2011.htm ].,OADS,/arxiv_data1/oa_pdf/92/a0/nihms846095.PMC5364800.pdf
The percentage of persons below the  poverty level was obtained from the U.S. Census Bureau [ http://quickfacts.census.gov/qfd/ states/37000.htm ].,OADS,/arxiv_data1/oa_pdf/92/a0/nihms846095.PMC5364800.pdf
